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Abstract 
Ultraviolet radiation (UVR) plays an important a role in melanmaogenesis. This may 
occur by inducing reactive oxygen species (ROS) formation in melanocytes 
however, antioxidants may stabilise these levels post-UV exposure. Melanin itself 
may also play a role in melanmaogenesis, and the enzyme tyrosinase plays a key role 
in the synthesis of this molecule. 
Melanin is a very effective natural sunscreen and individuals possessing higher 
levels in their skin are less sensitive to the effects of UV light than those who have 
lower levels. It is known that exposure to UV radiation, especially UVA radiation, 
can generate high levels of reactive oxygen species (ROS) in the cell.  Through the 
addition of exogenous antioxidants, such as vitamin C or E, these cells would be 
better protected against the deleterious effects of these UV-induced ROS. The 
current study investigates the effects of UV radiation on melanocyte-derived cells 
which contain differing melanin levels along with the protective effect(s) that 
exogenous antioxidants (Vitamin C and E) confer. 
It is hypothesised that cells with higher melanin levels will produce less ROS than 
those with lower levels and that exogenously added antioxidants will confer a 
protective effect to these cells when exposed to UV radiation. The mechanism of 
ROS production and of the signalling pathways activated by UV radiation will be 
different in melanoma cells compared to those in melanocytes, and these differences 
may be a means by which treatment regimens may be devised that could protect 
those untransformed skin cells from the deleterious effects of UV radiation.  
In this thesis, the effect of UVR on cell viability, melanin content, ROS levels, 
Tumour Necrosis Factor-α (TNF-α), TNF-α Converting Enzyme (TACE), and furin 
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expression as well as the phosphorylation of Mitogen-activated protein kinases 
(MAPK) including p-38, c-Jun N-terminal kinases (JNK), extracellular-signal-
regulated kinases (ERK), as well as B-RAF were investigated. In addition, the effect 
of antioxidants on the above mentioned changes were examined. Lightly pigmented 
MM418-C1 and darkly pigmented MM418-C5 melanoma cells and primary human 
melanocytes (HEM) were treated with either vitamin C (1 mM) or the vitamin E 
analogue trolox (0.1 mM). Cells were exposed to either UVA and/or UVB radiation, 
and the cell viability measured after 24 h using the MTS assay.  Melanin content was 
determined spectrophotometrically, while intracellular ROS levels 2’, 7’–
dichlorofluorescein (DCFDA assay), and mitochondrial superoxide (MSO) levels 
(MitoSOx assay) were measured using flow cytometry. TNF-α was measured using 
the enzyme-linked immunosorbent assay (ELISA assay) and TACE and furin 
expression were measured using western blots. Also, changes in the expression of 
the phosphorylated signalling intermediaries p-p38, p-JNK, p-ERK and p-B-RAF 
were investigated in the first two hours post-UV exposure using Western blots. 
The effect of UVR on cell viability was examined in order to determine what doses 
will be used to investigate the effect antioxidants as outlined in this thesis. In order 
to investigate the protective effect of antioxidants on pigmented melanoma cell lines 
and melanocytes, the cells were treated with antioxidants then exposed to either 
UVA and/or UVB radiation, and the cell viability measured 24 h post-irradiation 
using the MTS assay. The MM418-C5 cells were more sensitive to UVAB radiation 
than were either    MM418-C1 or HEM cells (50% cell viability: MM418-C1 – 0.04 
J/cm
2
 UVB and 0.8 J/cm
2
 UVA; MM418-C5 – 0.03 J/cm2 UVB and 0.6 J/cm2 UVA; 
HEM – 0.16 J/cm2 UVB and 3.2 J/cm2 UVA). Only vitamin C conferred a protective 
effect to MM418-C1 cells, but not MM418-C5 and HEM cells, exposed to UVB 
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radiation. However, treating MM418-C1 cells with the antioxidants for 1 h had no 
protective effect post-UV radiation when compared to cells treated for 24 h 
before/after UV radiation. Therefore, while sensitivity to UVB was significantly 
greater than to UVA (about 20 fold) in each cell line, the melanoma cells were 
susceptible to UVR than were the melanocytes. Vitamin C afforded protection only 
to the less-pigmented melanoma cell line, suggesting that melanin might compete 
with its antioxidants effect. 
The effect of antioxidants on melanin content and tyrosinase expression post-acute 
and chronic UVR exposure was examined. The effect of acute or chronic dose of 
UVR were examined in order to see if a single large UV dose enhanced tyrosinase 
expression and increased melanin levels to a greater extent than did two smaller 
doses (with 0.5 single dose each exposure) given 24 h apart. Tyrosinase expression 
was measured by western blot, while melanin content was determined 
spectrophotometrically. Acute and chronic doses of UVA or/and UVB did not 
significantly alter tyrosinase expression in MM418-C1, MM418-C5 and HEM cells. 
Moreover, acute doses of UVB and UVAB radiation significantly increased melanin 
levels in MM418-C1 cells, but not MM418-C5 cells, while chronic doses of UVR 
had no effect on these levels in both melanoma cell lines. In addition, when both 
melanoma cell lines were treated with antioxidants, neither vitamin C nor trolox had 
an effect on intracellular melanin levels. Therefore acute UVB appears to be 
essential for tyrosinase induction in lightly pigmented melanoma cells, but not in 
highly pigmented melanoma cells, as tyrosinase levels may already be maximal in 
the latter cells and exposure to UV radiation was unable to stimulate further 
expression. There was no evidence that vitamin C-sensitive oxidative reactions were 
required for melanogenesis. 
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The effect of antioxidants on ROS production (including peroxide and superoxide) 
post-UVR exposure was examined in order to investigate the role of UVR and 
melanin in the production of ROS in melanocytes and melanoma cells. Intracellular 
ROS levels 2’, 7’–dichlorofluorescein (DCFDA assay), and mitochondrial 
superoxide (MSO) levels (MitoSOx assay) were measured using flow cytometry. 
Intracellular ROS (peroxide but not superoxide levels) were increased in       
MM418-C1, MM418-C5 and HEM cells following exposure to UVB and UVAB 
radiation. These increased ROS levels were about twice in MM418-C1 and HEM 
cells when compared to MM418-C5 cells. In UV-irradiated MM418-C1, MM418-C5 
and HEM cells, vitamin C and trolox did not significantly reduce peroxide formation 
Moreover, vitamin C and trolox had no significant effect on superoxide levels in all 
three cell lines. These results suggest UVB and UVAB significantly induced 
peroxide levels in these cells. However, melanin may have a negative regulatory 
effect post-UVR exposure, as the highest pigmented cell (MM418-C5) had the 
lowest increase in peroxide levels. 
The effect of antioxidants on TNF-α release, TACE and furin expression post-UVR 
exposure was also examined in these pigmented melanoma cells to investigate the 
role melanin may have in the presence or absence of antioxidants  on TNF-α release, 
TACE and furin expression post-UVR exposure. TNF-α was measured using the 
enzyme-linked immunosorbent assay (ELISA assay) and TACE and furin expression 
were measured using western blots. TNF-α levels released from the MM418-C1 cells 
were much higher than those from MM418-C5 cells. UVB and UVAB non-
significantly increased these levels in MM418-C1 cells in the presence of 
Interleukin-1α (IL-1α).  Exposure to UVB and UVAB radiation also non-
significantly increased TNF-α levels in MM418-C5 cells, but the addition of IL-1α 
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was not stimulatory. The antioxidants did not significantly change TNF-α levels in 
both UV-irradiated cell lines. Neither TACE nor furin expression were altered post-
UVR exposure, while the addition of IL-1α had no stimulatory effect on the 
expression of these proteins. When these cells were treated with antioxidants it did 
not affect the expression of TACE and furin. Therefore, as the TNF-α levels released 
from the UV-irradiated MM418-C1 were much higher than that from MM418-C5 
cells, it suggests that high melanin levels may negatively regulate TNF-α 
formation/release from these irradiated cells. 
UVR is known to activate signalling pathways in the cell. The effect of antioxidants 
on these pathways in the UV-irradiated cells was examined with respect to the 
expression of the phosphorylated signalling intermediaries p-p38, p-JNK, p-ERK 
and p-B-RAF in the first two hours post-UV exposure. With regards to cellular 
signalling pathways, maximal expression of p-p38 and p-JNK occurred 30 min post-
UVR in MM418-C1 and MM418-C5 cells, while p-B-RAF and p-ERK levels were 
unaffected in the irradiated cells. p-p38 and p-JNK were increased post-UVB and -
UVAB in both melanoma cell lines and HEM cells. UVB and UVAB caused the 
highest change in p-p38 and p-JNK levels in MM418-C5 compared to MM418-C1 
and HEM cells. The addition of vitamin C and trolox did not reduce the expression 
levels of p-p38 and p-JNK significantly post-UVR exposure in these cell lines. It 
appears that melanin levels affected the stimulation of p-p38 and p-JNK-1 in these 
cells where those with high levels (MM418-C5) had increased p38 signalling but 
reduced p-JNK-1 signalling compared to those cells containing less melanin 
(MM418-C1 and HEM cells). 
In summary, vitamin C and trolox did not confer protection to both pigmented 
melanoma cell lines and melanocytes from UVR-induced cell death. From this study 
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we conclude that the use of UVR doses which caused 50% cell death probably 
overwhelmed the ability of these cells to overcome this UV-induced damage, thereby 
negating any potential protective effect that may have been conferred by the 
antioxidants. Hence, in order to investigate the protective effect of externally added 
antioxidants, a lesser dose of UVR which causes 25-30% cell death is suggested for 
future studies. In addition, treating the cells with other antioxidants may help confer 
protection to the UV-irradiated cells.  
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Chapter 1. Literature Review 
1.1 Introduction 
The UV radiation component of sunlight plays an important role in the formation of 
vitamin D, which is necessary for human health. In contrast, extreme exposure to UV 
radiation can cause sunburn, accelerated skin ageing and skin cancer (1). It is well 
known that UV radiation is considered to be the primary cause of skin cancer (2) and 
as such is a major public health problem (3). In the world, an estimated 132,000 
cases of melanoma are diagnosed annually (4). As well as this, ~2.5 million cases of 
non-melanoma cancers, including basal cell carcinoma (BCC) and squamous cell 
carcinoma (SCC), are also diagnosed annually (4). In Australia, about 80% of all 
newly diagnosed cancers are skin cancers (4), the incidence rate of which is four 
times that seen in Canada, the USA and the UK (5). 
The most widespread variety of skin cancer is non-melanoma skin cancer. In 
Australia, over 434,000 people are diagnosed with one or more non-melanoma skin 
cancers each year, with almost double the incidence in men compared to women (5). 
In 2012, research published by Cancer Council Australia (CCA) showed that in 2010 
non-melanoma skin cancers cost the Australian Health System over $500m; and by 
2015, this was expected to increase to $700m (6). Melanoma is the fourth most 
common cancer diagnosed in Australia and New Zealand – which incidentally are 
the two countries with highest prevalence rate for melanoma in the world (5). 
Accounting for approximately one in ten cancer diagnoses, over 11,000 new cases of 
melanoma were diagnosed in Australia in 2010. Melanoma is more frequently 
diagnosed in men than women, and by the age of 85, males have a 1:14 probability 
of being diagnosed with melanoma while females the probability is 1:24. In 2011, 
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there were over 1,500 human deaths due to melanoma in Australia alone. As such, 
melanoma is the sixth most common cause of cancer deaths in Australian males and 
the tenth most common in Australian females (5). In order to decrease the harmful 
effects of UV radiation on the skin and to prevent skin cancer formation, it is 
essential to understand the role UV plays in tumorigenesis (5). 
 
1.2 Ultraviolet Radiation 
Our largest organ, the skin, is exposed to an elevated degree of oxidative stress from 
both exogenous and endogenous sources, such as smoking, chemical air pollutants, 
wind, etc., with the most important being ultraviolet radiation (UVR) (7, 8). UVR is 
a part of the electromagnetic spectrum emitted by the sun with wavelengths between 
100-400 nm (9). Other components of this spectrum include visible light and x-rays. 
Depending on the wavelength, UVR can be divided into three main groups: UVC 
(100-280 nm), UVB (280-320 nm) and UVA (320-400 nm) radiation (10) (See 
Figure 1.1). The ozone layer blocks all of UVC, while only 5% of UVB and 95% of 
UVA radiation emitted by the sun reaches the Earth’s surface (11, 12). 
Exposure to UVA and UVB radiation can cause health problems (11, 12). It has been 
shown that exposure to UVR can cause deleterious effects on skin tissue including 
molecular damage (11, 13). More specifically, the stimulation of oxidative damage 
by UVR induces the formation of reactive oxygen (ROS) and nitrogen species 
(RNS) (e.g. superoxide anion, hydroxyl radical, hydrogen peroxide and nitric oxide). 
The damage elicited by such species has been demonstrated to occur in lipids, 
proteins and DNA (7, 8). Furthermore, UVB has been shown to be the primary 
source of photodamage that causes DNA damage directly in the epidermis. 
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Figure ‎1.1 The ultraviolet (UV) component of the electromagnetic spectrum including the main three types 
UVA (320-400 nm), UVB (280-320 nm) and UVC (200-280 nm) (14) 
 
UVR is known to increase the level of ROS in irradiated skin cells (13, 15). Elevated 
levels of ROS can result in molecular and cellular damage which can bring about 
genetic mutations and/or activation of signal transduction pathways (13, 15), which 
may eventually cause cell carcinogenesis (13, 15). Short-term exposure to sunlight 
can cause adverse reactions such as sunburn. However, in long-term exposure, 
harmful consequences include Langerhans cell depletion and local 
immunosuppression to become systemic, both of which can lead to cutaneous 
photoageing and skin cancer (16-18). While it is acknowledged that UVR can induce 
skin cancer, the relationship between the dose, time, and tumour development is still 
being elucidated (11). 
 
1.3 Histology of the Skin 
The skin is the largest organ of the body, and represents ~15% of the total body 
weight in an adult human (19). It plays a vital role in protecting the body against 
negative environmental effects.  
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The skin provides an extensive physical barrier against mechanical, chemical, and 
microbial factors that might distress the physiological state of the body (20, 21). 
Besides those functions, the skin also operates as an immune network and provides a 
distinctive defence system against UVR through its pigments (21). 
The skin is composed of three main layers which are, from outside to inside, the 
epidermis, the dermis, and the hypodermis (subcutis) (19). The epidermis is the 
outermost layer of the skin and is also called the epithelial layer. It prevents water 
loss in order to maintain fluid homeostasis in the body. Moreover, it also prevents 
the entry of unwanted substances and organisms such as bacteria into the body. 
However, UVA and UVB can penetrate into the epidermis (Figure 1.2) and cause 
cellular damage (22). 
 
 
Figure ‎1.2 UVR penetration of the skin (22) 
 
The epidermis is thicker on some sites of the body than on others, and is composed 
of four different distinct layers which are from the bottom to the top: stratum basale, 
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stratum spinulosum, stratum granulosum and stratum corneum (21, 23). In thick skin 
only, a fifth layer of epidermis is found and is known as the stratum lucidum (24). 
The main cells found in the epidermis are keratinocytes (90-95%) and melanocytes. 
Over time the keratinocytes mature, differentiate and accumulate keratin.  
The epidermis and the dermis are separated by a single layer of cells called the 
stratum basale which is attached to a noncellular basement membrane (Figure 1.3). 
The stratum basale predominantly comprises of basal keratinocytes, and two 
differing types of neural crest-derived cells; Merkel cells which are responsible for 
transmitting the sensations of touch through the cutaneous nerves, and melanocytes 
(21). 
 
 
Figure ‎1.3 Structure of human skin 
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Contained within the stratum spinulosum are the Langerhans’ cells, which represent 
the antigen-presenting cells of the skin and perform a fundamental role in 
immunological reactions, for instance, allergic contact dermatitis (21). 
In the stratum granulosum there are keratinocytes that are flattened, polyhedral, 
nondividing and generate protein granules called keratinohyalin. These granules 
grow in size and increase in number as the nuclei of the cell progressively deteriorate 
and the cells die. These cells become flattened as the dividing cells beneath them 
increasingly thrust them toward the surface of the skin (21). 
In the stratum corneum there are corneocytes which are nonviable cells but are 
biochemically active. As keratinocytes move from the basal layer to the stratum 
corneum, they continue to differentiate resulting in cornified cells that contain 
keratin but lack cytoplasmic organelles. The cornified cells form a barrier against 
those physical and chemical environmental agents that might harmfully affect the 
body (21).  
Melanocytes originate in the embryonic neural crest and move to the epidermis 
where they produce melanin, the natural pigment in the skin. The enzyme tyrosinase 
and the melanin they produce are stored in melanosomes (Section 1.5.3). Mature 
melanosomes migrate to nearby keratinocytes to protect them from the deleterious 
effects of UVR (19, 23).  
The middle layer of the skin is the dermis (Figure 1.3). It is a supportive and fibrous 
connective tissue that protects the epidermis, however only UVA can penetrate into 
this layer (19, 23). It possesses two types of fibres: collagen and elastin. Collagen 
fibres predominate in the dermis and have enormous tensile strength, giving the skin 
its strength and toughness. Elastin gives the skin elasticity and pliability. The dermis 
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is composed of different types of cells such as fibroblasts, mast cells, vascular 
smooth muscle cells and leucocytes such as macrophages (19, 23).  
Within the dermis, fibroblasts are needed to synthesise and degrade the extracellular 
matrix (ECM). This matrix is a complex structure made up of greatly organised 
collagen, elastic, and reticular fibres (21). Mast cells are able to trigger allergic 
reactions by secreting bioactive mediators such as histamine. Furthermore, the 
dermis includes structures such as excretory and secretory glands, hair follicles and 
sensory nerve receptors (21). 
The bottom layer of the skin is the hypodermis, which is mainly composed of fatty 
tissue and represents the deepest layer of the skin. It plays a major role in 
thermoregulation, insulation, nutritional storage, as well as protection from 
mechanical injuries. The main cells found in the hypodermis are adipocytes, vascular 
endothelial cells and neurons (19, 23). 
 
1.4 Effects of Ultraviolet Radiation 
1.4.1 Skin Photoresponses 
The exposure to sunlight, containing different wavelengths of ultraviolet radiation, is 
necessary for the normal function of human skin. One of the main advantages of 
UVR exposure is the synthesis of vitamin D (25).  Vitamin D3 is synthesized via the 
action of UVB radiation (wavelength, 280–320 nm) on 7-dehydrocholesterol in the 
skin. Previtamin D3 is directly transformed to vitamin D in a heat-dependent 
process. However, excess UVB rays can convert previtamin D3 into biologically 
inactive tachysterol, lumisterol and metabolites (26). The status of vitamin D is 
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largely determined by this process, as the majority of adults are unable to obtain 
more than 5–10% of their daily requirements from food sources (27, 28). 
Calcium absorption in the human body is regulated by vitamin D in conjunction with 
the parathyroid hormone. A deficiency in vitamin D causes a reduction in bone mass, 
which leads to the incapacitating diseases of osteomalacia and osteoporosis in adults 
and causes rickets in children (29). 
On the other hand UVR can have a beneficial effect on the human body. It can be 
used in treating skin diseases, such as psoriasis vulgaris (25). Psoriasis is an 
inflammatory skin disease which is characterised by the hyperproliferation of 
keratinocytes, and is prevalent in 1–2% of the general population. Traditionally, 
UVB phototherapy has been used as a standard treatment for psoriasis despite the 
mechanisms underlying its effectiveness being only partly understood (30). 
Exposure to UVB radiation is believed to momentarily hinder cell proliferation as a 
result of DNA photo-product formation. Therefore, it has been hypothesised that the 
therapeutic effectiveness of phototherapy predominantly relates to its 
antiproliferative properties (30, 31). Furthermore, UVB phototherapy is thought to 
be an effective treatment for psoriasis by restraining cutaneous immune functions 
(32). In recent years, vitamin D has been brought into focus with regards to the 
treatment of psoriasis (33-35). Topical vitamin D derivatives have been shown to be 
effective in relieving its symptoms. It has been suggested that the favourable effect 
of exposure to UVB radiation in patients with psoriasis may be partially rationalised 
by the induction of vitamin D (33-35). 
Humans need sunlight to make vitamin D, but the amount required depends on a 
variety of factors, some of which are UV type, type of skin and personal lifestyle. 
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Across Australia, UV levels differ throughout the year. As a result, in order to make 
vitamin D, the amount of time needed in the sun varies according to location, season 
and time of day (36). 
Furthermore, the area of bare skin exposed to the sun also affects the amount of 
vitamin D made. In most cases, the more skin exposed, the more vitamin D is made. 
However, vitamin D levels do not increase further with prolonged sun exposure, on 
the contrary, the risk of developing skin cancer is increased (36). With prolonged sun 
exposure, the skin’s structural integrity is compromised by a range of responses that 
are brought about at both molecular and cellular levels leading to an increase in the 
risk of skin cancer (36, 37). The effect of excessive  acute exposure to UVR results 
in histological changes of the skin as well as cellular and molecular damage, the 
most common being sunburn (2, 25). Chronic exposure to UVR can result in 
immunosuppression, and over time cause gene mutations which can give rise to skin 
cancer (2). 
Depending on the type of UV radiation, the dose and occurrences of exposure, the 
skin’s response may diverge from acute to chronic outcomes (37-39). The skin’s 
response to UV radiation also differs based on the individual’s skin type. There are 
six types which differ in their sensitivity to UV radiation, their susceptibility to 
sunburn and/or tanning, as well as risk of developing skin cancer (Table 1.1). People 
who have very fair, pale white and often freckled skin (Type I) are very sensitive to 
UV radiation and tend to easily sunburn. They also have the greatest susceptibility to 
develop skin cancer compared to people with very dark brown to black skin (Type 
VI) (40, 41). Dark-skinned individuals tend to be less sensitive to UV radiation, and 
are less vulnerable to UV-induced damage, like photoageing. People who have type 
VI skin also have the least risk of developing skin cancer (40, 41). 
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Table ‎1.1 The sensitivity to UV, susceptibility to sunburn, tan, and develop skin cancer based on skin types and 
colour (40, 41) 
Skin 
Type 
Natural Skin 
Colour 
UV Sensitivity 
Tendency to 
burn & tan 
Risk of Skin 
Cancer 
I 
Very fair, pale white, 
often freckled 
Very high 
Always burns, 
never tans 
Greatest 
II Fair, white High 
Burns easily, tans 
minimally 
High 
III Light brown Moderate 
Burns 
moderately, 
usually tans 
High 
IV Moderate brown Less sensitive 
Burns minimally, 
tans well 
At risk 
V Dark brown Minimal Rarely burns 
Low – usually 
detected at a late 
stage 
VI 
Very dark brown to 
black 
Minimal Never burns 
Very low – 
usually detected 
at a late stage 
 
1.4.2 Skin cancer 
The primary carcinogen known to induce skin cancer is the UVR component of 
sunlight (42, 43). Skin cancer is divided into three main types: (i) squamous cell 
carcinoma (SCC), (ii) basal cell carcinoma (BCC) which are collectively called non-
melanoma skin cancers (NMSC), and (iii) cutaneous malignant melanoma (CMM) 
(43). In basal cell and squamous cell carcinomas, the most important risk factor is 
exposure to UVR (44, 45). As seen in NMSC, exposure to UVR is also a significant 
risk factor for melanoma development (46, 47).  
According to de Gruijl et al. (2001), SCC and BCC are more widespread compared 
to CMM, with SCC being the greatest in frequency. SCC and BCC are less 
aggressive and rarely metastasize, unlike that seen for CMM (43). SCC are strongly 
associated with cumulative lifetime sun exposure, whereas, BCC are linked with 
intermittent sun exposure and perhaps, more importantly, exposure during childhood 
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(44, 48, 49). It was reported that UVR caused an increase in the occurrence of SCC, 
BCC and to a lesser extent CMM (50, 51). However, despite being less frequent, 
melanoma is an aggressive form of skin cancer where its incidence in the general 
population is still increasing (52, 53). 
 
1.4.2.1 Melanoma 
UVR has been shown to be both an initiator and/or promoter in the formation of both 
non-melanoma and melanoma skin cancer (54). A person’s lifetime risk factor for 
melanoma depends on different aspects such as age, exposure period, and the 
interaction between environmental and genetic factors (55). Family history, fair skin, 
multiple moles, immunosuppression, and UVR exposure are the strongest melanoma 
risk factors. Epidemiologic studies carried out by Whiteman et al. (2001) observed 
that the highest risk for melanoma development was associated with exposure to 
intense intermittent UVR exposure and serious sunburns during childhood (56). 
Boniol et al. (2012) investigated the use of sunbeds and observed that cutaneous 
melanoma can also be attributed to the use of indoor artificial tanning devices (57). 
According to Garibyan and Fisher (2010), UVR causes DNA mutations, induces 
ROS formations, alters cutaneous immune function, and the production of growth 
factors and cytokines (58). 
Recent studies conducted by Bald et al. (2014) in mice have shown that UVR 
provokes inflammatory responses that involve macrophages and neutrophils 
stimulating melanocytic cell survival, immunoevasion, and perivascular invasion 
(59). 
13 | P a g e  
 
 
The highest risk factor among all pigmentation phototypes is associated with the red 
hair/fair skin phenotype, categorised by fair skin, freckling, and an inability to tan 
(60). This observation was traditionally attributed to reduced protection against 
UVR, however in a recent study conducted by Mitra et al. (2012), it was 
demonstrated that pheomelanin synthesis contributes to melanomagenesis via a 
UVR-independent mechanism believed to involve higher levels of ROS (61). 
Consequently, high melanoma susceptibility in individuals with red hair/fair skin is 
likely attributable to the inherent carcinogenic effects of pheomelanin synthesis in 
addition to UVR exposure (52). 
Recent studies showed that molecular defects in both tumour suppressor genes and 
oncogenes also play a role in the development of melanoma (62, 63). One of the 
main tumour suppressor genes involved in melanoma is ‘p16’, which is also known 
as CDKN2A (63). According to Agarwal et al. (2013), p16/INK4A/CDKN2A is an 
essential tumour suppressor gene that impedes cell cycle in G1 by preventing the 
binding of CDK4/6 with cyclin D1, leaving the Retinoblastoma (Rb) tumour 
suppressor protein unphosphorylated and E2F bound and inactive (64). p16 has been 
found either mutated or deleted in most melanoma cell lines (63), and as such its 
ability to exert its regulatory effect is decreased. 
Mutations in B-RAF are found in up to 50% of human melanomas (65, 66) and is 
also observed in benign melanocytic nevi (58, 67). The B-RAF gene has emerged as 
an important therapeutic target for melanoma because it encodes a serine/threonine 
kinase that plays a key role in the mitogen-activated protein kinase (MAPK) 
signalling pathway (58, 68). In melanomas, the most common B-RAF mutation 
found is a glutamic acid for valine substitution at codon 600 (B-RAF
V600E
). This 
mutation (B-RAF
V600E
) results in the constitutive activation of B-RAF, and 
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consequently MAPK. Intriguingly, <30% of mutations that cause a change at V600E 
are tandem base substitutions on the same allele, and is rarely observed in 
nonmelanocytic tumours (58, 68). 
 In addition, activation of MAPK signalling pathway, which enhances cell 
proliferation, survival invasion and tumorigenesis, has been thought to play a major 
role in melanoma formation (69, 70). 
 
1.5 Skin Molecular Response 
The development of skin cancer by UV is caused by molecular and/or cellular 
damage (14, 71). There are at least two important distinct cellular processes involved 
in skin tumorigenesis. Firstly, as a result of the effect that (direct and indirect) UV 
has on DNA to form neoplastic transformations to cause mutations, and secondly the 
interaction between UV-mediated bioactive molecules and the immune system 
which creates an environment that allows for these cells to mutate and become 
cancerous due to a suppression of the immune system’s tumour surveillance activity 
(14, 71). 
 
1.5.1 Molecular Damage 
UVR plays an important role in different biological events, including protein 
alteration, the structure of DNA and essential molecules that are involved in 
biological processes (72). Ring structures and conjugated bonds make up the 
molecular bases of DNA. These ring structures and conjugated bonds absorb photons 
of UVR with wavelengths from 200 to 300 nm (73, 74). Following UV irradiation, it 
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has been proposed that DNA damage initiates activated signalling pathways (73, 74). 
The reason being that UVR wavelengths ranging from 280 to 315  nm (UVB) are 
absorbed by DNA causing the formation of cyclopyrimidine dimers and pyrimidine-
pyrimidone photoproducts, as seen in Figure 1.4 (73, 74). UVA exposure has been 
shown to generate ROS, which can cause DNA damage, via a type II reaction (74, 
75). The main oxidised DNA base generated after UVA exposure is 8-oxo-7,8-
dehydroguanine (8-oxoGua) as seen in Figure 1.4. This oxidised base can be formed 
as an outcome of type I and II photosensitisation reactions during exposure to UV, 
by the attack of numerous ROS, including singlet oxygen (
1
O2) (74, 75). 
The formation of 8-hydroxyguanosine (8-OHG) is the most comprehensively studied 
DNA lesion (76). The importance of this lesion is due to the relative ease in which it 
is formed and because it is mutagenic, and thus it is a potential carcinogenic 
biomarker (76). Furthermore, ROS are known to be highly reactive towards DNA, 
with the oxidation of guanine to 8-OHG believed to be characteristic of such damage 
(77, 78). 
After UV irradiation, it has also been shown that damaged RNA plays a role in 
facilitating the ribotoxic stress response signalling in ribosomes. Jun N-terminal 
Kinase Pathways (JNK) and p38 MAPK pathways, as well as inhibiting protein 
synthesis, are also believed to be activated by oxidative damage of ribosomal RNA 
(37). 
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Figure ‎1.4 DNA damage induced by UV 
Sunlight induces DNA modifications. The three wavebands of UV light: below 280 nm is UVC which is 
completely blocked by the ozone layer and is principally absorbed by biomolecules. UVB (280-315 nm) is the 
minimal part, and UVA (315-400 nm) in its totality reach the surface of the Earth and can be absorbed by DNA. 
Therefore, UVA and UVB can directly initiate the formation of pyrimidine dimers (e.g. CPDs and 6-4PPs), or 
indirectly damage lipids and proteins, which in turn can also cause DNA damage, in addition to generating 
oxidised DNA bases such as 8-oxoGua (74).  
 
1.5.2 Tumour Suppressor Genes 
Tumour suppressor genes such as p53 or p16 are responsible for repairing DNA 
and/or regulating of the cell cycle clock by inhibiting the action of cyclin-dependent 
kinases (CDK) (79, 80). Many tumour suppressor genes are deleted or mutated in a 
wide range of cancers, which reduce their ability to stop or decrease neoplastic 
transformations (80).  
The p53 gene is a key tumour suppressor gene which plays an important role as a 
regulator of the genotoxic response. It is often found to be mutated in many cancers, 
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including skin cancer (46, 81). This protein controls several signalling pathways that 
respond to stimuli such as oxidative stress, hypoxia, heat shock, and DNA damage, 
to name a few (46, 81). Chen et al. (2014) showed that p53 contributed to DNA 
repair via multiple mechanisms, including control of cell cycle checkpoint activity 
along with regulation of the DNA repair machinery (46). 
UV radiation causes mutations which often lead to skin cancer. Armstrong and 
Kricker (2001) observed that p53 mutations were prevalent in NMSC (50). A single 
compromised functional copy of p53 gene can increase the susceptibility of 
keratinocytes to UV photocarcinogenesis (39), while in melanoma cells mutations in 
the p16(INK4a) gene are more common (50). 
The p16 gene is a tumour suppressor gene that is often mutated or deleted in 
melanoma cells (82). It plays an  inhibitory role in the cell cycle process, but it is still 
unclear why it is so heavily mutated in melanoma (82). Recently, it was shown to 
play an important role in controlling oxidative stress in UV-irradiated melanocytes 
(82). These cells were more susceptible to oxidative stress when this gene was 
compromised (82), which suggests that there is a potential correlation between the 
actions of this gene in regulating intracellular ROS levels (82). The p16 gene was 
activated in the epidermis exposed to 2 minimal erythemal doses (MED) of UVB 
radiation, which suggested that it may play a role in suppressing the 
hyperproliferation of the epidermis (83). 
Berking (2005) and Wang et al. (2001) suggested that UVA may be indirectly 
involved in the occurrence of melanoma via immunosuppression or stimulation of 
growth factors in the skin (84, 85). On the other hand, studies conducted by De Fabo 
et al. (2004) and Atillasoy et al. (1998) have shown that UVB, but not UVA, 
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initiates melanoma (86, 87). Therefore, it is still not clear as to how these different 
types of UV radiation can directly cause melanoma. However, it is probable that 
both UVA and UVB are synergistically involved in instigating and promoting 
melanomagenesis due to their recognised effects at the molecular level (88). 
 
1.5.3 Melanin synthesis 
The type, amount and distribution of melanin contributes to the colour of the skin. 
Melanin also performs a fundamental role in protecting the skin against harmful 
effects of UVR (89, 90). Melanocytes possess membrane-bound organelles referred 
to as melanosomes, in which melanin biosynthesis takes place (90, 91). 
Melanosomes play a vital role in photoprotection as they are transported via 
dendrites to surrounding keratinocytes. According to Fitzpatrick and Breathnach 
(1963), there is an anatomical affiliation between melanocytes and keratinocytes that 
is known as “the epidermal melanin unit”. It has been estimated that each 
melanocyte is in contact with ~40 keratinocytes in the suprabasal and basal layers 
(91, 92).  
The composition of the diversified type of pheomelanin (yellow/red pigment) and 
eumelanin (black/brown pigment) is generally attributable to variations in skin 
and/or hair colour. Many enzymes are involved in melanin synthesis, as seen in 
Figure 1.5 (93-95). 
A disturbance in melanin production can cause aesthetic problems that include skin 
hypopigmentary disorders (e.g. vitiligo), and hyperpigmentary disorders (e.g. 
melasma, freckles and post-inflammatory hyperpigmentation) that might affect the 
patients’ quality of life (96).  
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Through various signalling pathways which influence tyrosinase regulation, 
environmental factors (e.g., UVR) and endogenous factors (e.g., hormone and age) 
can mediate the stimulation of melanin production. There are numerous ways in 
which UV can aggravate melanin production in melanocytes (97, 98).  It is either by 
directly affecting melanocytes or by stimulating  keratinocytes  to  release  signal  
molecules  such  as  prostaglandin E2 (PGE2), α-melanocyte-stimulating hormone 
(α-MSH), adenocorticotropic hormone (ACTH) and endotholin-1, which can 
upregulate tyrosinase mRNA expression (97, 98). 
 
 
Figure ‎1.5 Melanin synthesis pathway 
Melanin synthesis is initially catalysed by tyrosinase and is ultimately divided into eumelanin or pheomelanin by 
numerous enzymes. 3,4-dihydroxyphenylalanine (DOPA), chrome tautomerase (DCT), and tyrosinase-related 
protein 1 (TYRP1) are involved in eumelanogenesis. So far no specific enzymes have been found that are 
involved in pheomelanogenesis (93-95). 
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Melanogenesis is controlled by a number of important signalling pathways including 
cyclic 3'-5'-cyclic adenosine monophosphate (cAMP), MAPK, melanocortin-1 
receptor (MC1R), and microphthalmia-associated transcription factor (MITF). 
MC1R-MITF signalling in particular is critical to melanocyte viability and function.   
The binding of signal molecules or melanogenic proteins (especially α-MSH to 
MC1R in melanocytes) leads to the induction of MITF, which consequently activates 
transcription of the tyrosinase gene involved in melanin synthesis (81).  
UVR has been identified as a major environmental factor in the pathogenesis of 
photoageing and skin cancers including melanoma. Hypermelanosis caused by UVR 
has been formerly suggested to correlate with melanomagenesis. It is difficult to 
determine the exact role of UVR in the development of melanoma because 
melanomagenesis depends on several factors such as skin type, genetic influence, the 
extent of sun exposure (e.g., intensity, timing and duration of UVR) and types of 
moles representing disturbed melanin synthesis (90, 99-101). 
UVR, especially UVA, instigates an immediate response in the skin that includes 
tanning (102). Tanning occurs as a result of photooxidation of melanin, amplified 
dendrite formation and the consequential induction of melanosome transfer from 
melanocytes to keratinocytes (102). Furthermore, UVR instigates a delayed response 
in which pigmentation is generated by both UVB and UVA and is correlated to the 
proliferation of melanocytes. This results in an increased transfer of melanosomes to 
keratinocytes and an elevated synthesis of melanin.  
Melanogenesis induced in response to UVR also hinges on different melanocyte cell 
types, e.g. lightly-pigmented or darkly-pigmented cells (103). Melanogenesis has 
long been known to serve as a chief defence mechanism to safeguard the skin against 
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the detrimental effects of UVR, as both eumelanin and pheomelanin are able to 
absorb UVR, limit the penetration of UVR into the skin, as well as having protective 
antioxidant properties (104). UVR can cause detrimental DNA damage and the 
repair mechanisms could interfere with cellular signals and consequently encourage 
a melanogenic response (90, 105).  
The protective role of melanin against UVR-mediated skin damage is nevertheless 
controversial. Miyamura et al. (2011) and Ou-Yang et al. (2004) both observed that 
exposure of UVA-mediated skin pigmentation (occurring as a result of the 
photooxidation of melanin without increased melanin synthesis), failed to provide a 
photoprotective effect on the skin against UVR, including UVB radiation (106, 107). 
 The photoprotective properties of melanin are complex and are conceivably 
governed by several factors which include the types of melanin (eumelanin or 
pheomelain) and UV radiation (UVA or UVB) (108, 109). According to Takeuchi et 
al. (2004), when eumelanin – present in virtually all types of human skin – functions 
as a UV filter and ROS scavenger to counterbalance the toxic intermediates, 
pheomelanin – predominantly found in fair-skinned individuals with red hair – has 
been shown to be a photosensitizer aggravating ROS formation after UVR (110). 
 
1.5.4 Reactive Oxygen Species (ROS) 
At first, the connection between melanin generation and melanoma seems counter 
intuitive, especially since the melanin pigment is protective in general (111, 112). 
However, the synthesis of melanin involves cytotoxic molecules and is tightly 
correlated within melanocytic-derived cells (112-114). Both melanocytes and 
melanoma cells display higher basal levels of ROS in comparison with fibroblasts 
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and keratinocytes (112, 115, 116). One source of these ROS are from the 
melanosome and the melanin it contains (112, 117).  
ROS are molecules which contain one or more unpaired electron(s) (118). They can 
be either harmful or beneficial to living systems, therefore they are known to 
perform a dual role in biological systems (118, 119). Examples of the beneficial 
effects of ROS include physiological roles in cellular responses to anoxia, in the 
defence against infectious agents, and in the function of numerous cellular signalling 
pathways. At low concentrations, ROS have another beneficial role in the induction 
of a mitogenic response. At high concentrations, ROS can be an essential mediator 
of oxidative stress – i.e. damage to cell structures including nucleic acids, 
membranes and lipids, and proteins (118, 120). These harmful effects of ROS can be 
balanced by both enzymatic and non-enzymatic antioxidants (118, 121). 
The skin is constantly the target of endogenous and exogenous ROS. According to 
Ibañez et al. (2011) ROS are counteracted by a vigorous system of defence – in 
particular, the biopolymer melanin performs as an intrinsic free radical trap (122). 
ROS are generally present as pollutants in the atmosphere. They are also a product of 
numerous reactions including metal-catalysed reactions, mitochondria-catalysed 
electron transport chain reactions, and are produced by neutrophils and macrophages 
during inflammation. ROS are also formed during exposure to X-rays, γ-rays and 
UV radiation (118, 123). 
UVR has been found to take part in ROS generation – the action of UVB is 
facilitated by specific photoproducts (e.g. pyrimidine dimers), whereas UVA is well 
known to act mainly through the induction of ROS (10, 124). Additionally, in the 
presence of molecular oxygen, ROS are formed from the reaction between light and 
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photosensitizers (125). UVR has been shown to generate superoxide (O2
•−
) radicals, 
hydroxyl radical, hydrogen peroxide (H2O2), and singlet oxygen (126-128). 
Larsson et al. (2006) and Van Laethem et al. (2006) have shown that UVB radiation 
also stimulates the production of ROS (124, 129). It is possible that ROS may: (i) 
serve as an upgrade to intensify the signal for activation of pathways besides the 
main UVB-induced DNA damage signalling; or (ii) behave as a substitute 
mechanism, when DNA damage has been repaired, and as a result, UVB-induced 
signalling does not advance through this route (130). 
It has also been found that irradiating human melanocytes with UVR (UVA 25%, 
75% UVB) caused dose-dependent generation of H2O2 (131, 132). Also, the same 
UVR dose resulted in a decrease in the expression of Heme oxygenase-1 and the 
activity of catalase (132-134). 
Moreover, H2O2 is thought to be the main type of ROS produced by UVR, as a 
product of melanomagenesis itself. Since it is able to diffuse outside the melanosome 
to reach other cellular compartments, H2O2 is suggested to play an important role in 
melanoma. In pigmented melanomas, structural alterations of melanosomal 
membranes may lead to significant leakage of reactive melanin precursors, including 
free radical species (114, 122). Ibañez et al. (2011) and Policastro et al. (2009) 
observed that tumour cells produce high levels of ROS. With regards to melanoma, 
they have found an increase in H2O2 levels in human melanoma cells in comparison 
with primary melanocytes (122, 135).  
In addition, an imbalance in the antioxidant system has been observed in human 
melanomas. This imbalance can generate endogenous ROS. Moreover, it has been 
suggested that this melanin dysregulation effect results in it becoming a prooxidant 
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(136), where it can also induce damage to the DNA (122, 137). Thus, increased 
DNA damage and high rates of mutation is associated with the oxidative stress 
characteristic of melanoma cells. In relation to this, Ibañez et al. (2009; 2011) and 
Warters et al. (2005) have shown high levels of basal DNA damage in melanoma 
cells (122, 137, 138).  
It is reported that H2O2 is involved in signal transduction pathways in cancer (122). 
In melanoma for example, increased levels of H2O2 induce mitogenic signals, such 
as those related to extracellular signal-regulated kinases 1/2 (ERK-1/2) pathway,  
epidermal growth factor receptor (EGFR), and signal responses to stress, for 
example p38 MAPK pathways and  JNK (122). Following acute and chronic 
exposure to UVR, ROS are produced in the skin and are involved in signal 
transduction pathway activation (139). ROS have been shown to phosphorylate cell 
surface receptors, which sequentially activate the MAPK signalling pathway (129, 
140).   
Generation of ROS, apart from activating cell survival signalling pathways, can also 
induce cell cycle arrest and apoptotic pathways, which may play a role in the 
pathogenesis of cancer and melanoma in particular (122, 141). Meyskens et al. 
(2001) suggested that there is a strong correlation between UVR effects and their 
capability to create oxidative damage and the development of melanoma (139). 
 
1.5.5 Cell Signalling Pathways 
Numerous different physiological processes are mediated in part by the MAPK 
signalling cascades, such as: development, growth and proliferation, stress 
responses, and immunity (142, 143). The MAPKs include three main signalling 
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pathways: ERK, JNK and p38 (142, 144). Both JNK and p38 MAPKs are activated 
by environmental stressors, such as heat, oxidative stress and ionizing radiation (142, 
145). 
In most melanomas, the MAPK pathway is activated as a result of mutations in 
either B-RAF or NRAS (65, 66). These mutations are known as a marker for benign 
melanocytic proliferation and every stage of invasive and metastatic melanoma (65, 
66). 
Dysregulation of the signalling pathways caused by UVR exposure can result in 
altered gene expression, the production and release of cytokines, as well as 
disruption of the cell cycle (43, 130). In this section, I have focused on the effect that 
UVR has on the B-RAF and MAPK signalling cascade (p38 MAPK, JNK and ERK 
signalling pathways) because they have been shown to play a role in the initiation of 
melanoma. Figure 1.6 illustrates the role of UV radiation in the activation of cell 
signalling pathways in melanocytes. 
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Figure ‎1.6 Proposed role UVR may play in the signalling pathways and activation of genes in melanocytic 
cells 
RAS is believed to be activated by unknown receptors in the melanocyte as a response to UVR. This leads to the 
activation of B-RAF, which further leads to the activation of ERK. RAS also plays a role in the activation of JNK 
and p38 as a response to UVR. Cross talk is assumed to occur between these signalling pathways suggesting that 
ERK, JNK and p38 would ultimately activate each other. Following activation of gene transcription the relevant 
profurin is activated, which in turn cleaves mTACE from its precursor protein (pTACE). mTACE then cleaves 
sTNF-α from its precursor mTNF-α on the cell membrane (37, 146). 
 
 
1.5.5.1 B-RAF 
B-RAF is a serine/threonine protein kinase and a member of the RAF family (147-
149). A-RAF, B-RAF and C-RAF are three isoforms of the RAF protein kinase, 
which lie downstream from RAS (147-149). RAS activates RAF leading to 
activation of mitogen-activated ERK-activating kinase (MEK), and in turn activates 
other protein kinases like ERK (147, 148). ERK signalling is involved in regulating 
gene expression, cell proliferation, cell survival, various ion fluxes and apoptosis 
(147, 148). In addition, hyper-activation of MAPK pathway has been investigated in 
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melanoma caused by mutation of the B-RAF protein which may be involved in 
melanomagenesis (147, 148). 
In ~50% of human melanomas, activation of mutated B-RAF can be found (65, 66, 
150). Davies et al. (2002) found that a change from T → A at nucleotide 1796 was 
found in 35 of 38 (i.e. 92%) of B-RAF mutations in melanoma (151). Of all B-RAF 
mutations, the V600E mutation was found to be of high frequency in malignant 
melanoma (152). V600E was previously known as V599E; a change of designation 
from V599E to V600E resulted from difficulties in sequencing the GC-rich exon 1 of 
the B-RAF gene. The sequence was updated in 2003, following the insertion of 3 bp 
into the coding sequence. This resulted in the addition of one amino acid to the 
length of the B-RAF protein, leading to an increase in the positions of all published 
mutations by one – hence B-RAFV599E became B-RAFV600E (152).  
This mutation is distinct from the CC → TT or C → T alterations associated with 
pyrimidine dimer formation following UV exposure (151), and suggests that UVR 
was not responsible for this mutation in B-RAF (151, 153). It has been shown that 
there is a correlation in cancers between aberrant ERK signalling and the mutations 
of B-RAF, which can occur at different sites within the pathway (151). B-RAF
V600E
 
is one of the most active B-RAF mutants, and in murine melanocytes it enhanced the 
activation of ERK signalling to induce proliferation and transformation, which 
allowed the cells to become tumorigenic (148). While B-RAF
V600E
 plays an 
important role in the development of melanoma, it is unable to initiate 
melanomagenesis which requires the involvement of different factors and signalling 
pathways (147). For melanocytes to become cancerous, other mutations are required, 
such as UV-induced mutations in p16, p53 (Section 1.5.2) and NRAS that are the 
most noteworthy (122, 154).  
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Through two known cascades, the RAS/MAPK and the RAS/Phosphoinositide        
3-Kinase (PI3K) signalling streams, the RAS signalling network regulates cell 
growth, cell proliferation, survival and invasion. The RAS family of small GTP-
binding proteins lies at the start of the RAS/RAF/MEK/ERK MAPK pathway, which 
is responsible in activating a large number of growth-promoting genes in response to 
cytokines and growth factors (122, 155). A gene encoding a member of the RAS 
family is N-RAS, which has been shown to be mutated in 15-30% of melanomas 
(122, 155).  
It has been suggested by Ibañez et al. (2011) and Berger et al. (2009) that UV 
exposure has a probable association with the spatial distribution of N-RAS mutated 
tumours on the skin (122, 156). However, Edwards et al. (2004) showed that          
B-RAF
V600E
 is not a UV signature mutation (153). Moreover, activating mutations of 
both RAS and B-RAF are known to be harboured by melanomas (70, 152). This 
suggests that ERK, which is downstream of these pathways, may play a significant 
role in the oncogenic behaviour of these tumours (70). It is therefore essential to 
investigate the role ERK plays in melanocytes in response to UVR.   
 
1.5.5.2 Extracellular Signal-Regulated Kinase Pathway (ERK) 
ERK is a member of the MAPK family and is involved in cell proliferation (157). It 
exists in many isoforms with the main ones being ERK-1/2 (37, 158). ERK 
signalling has been shown to be involved in melanocyte proliferation (159). The 
activation of mutated B-RAF
V600E
 in turn hyper-activates ERK-1/2 signalling in 
melanoma (37, 160). 
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In order to survive, melanocytes need numerous growth factors, which are secreted 
by surrounding keratinocytes. However, the ability to secrete autocrine growth 
factors is acquired by melanocytic cells during the process of malignant 
transformation (70, 161, 162). Autocrine growth factors secreted by these 
transformed melanocytic cells include basic fibroblast growth factor (bFGF),           
α-MSH, epidermal growth factor (EGF) and stem cell factor (70, 161, 162). 
In melanoma, ERK can be activated by at least two pathways involving growth 
factors. The first “classical” pathway involves the direct activation of the RAS/RAF 
pathway that is regulated by receptor tyrosine kinases, such as the c-Kit ligand SCF 
(70, 163, 164). The second pathway involves the prior activation of adenylate 
cyclase that is used by G-protein-coupled receptors, such as the α-MSH activated 
melanocortin receptors (70, 163, 164). This leads to an increase in intracellular 
cAMP levels and RAS activation (70, 165). α-MSH can activate ERK in 
melanocytes/melanoma, but as this stimulation is only temporary it is not believed to 
be mitogenic (70, 165).  
Satyamoorthy et al. (2003) investigated the activation of MAPK in 19 different 
melanoma cell lines. They examined whether MAPK was mediated by a 
combination of B-RAF
V600E
 signalling and autocrine growth factor stimulation. All 
19 melanoma cell lines harboured     B-RAF mutations. This finding suggests that 
melanoma growth, invasion, and metastasis are ascribable to constitutively activated 
ERK. This activation is seemingly mediated by a combination of autocrine growth 
factors and activation of B-RAF
V600E
 signalling (160). 
Yanase et al. (2001) found that ERK-1/2 was activated by 1 kJ/m
2
 UVA in cultured 
human epidermal melanocytes. They suggested that UVA irradiation-
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induced melanin synthesis is correlated with the activation of ERK-1/2 via upstream 
signals. This activation can be caused by ROS or by activated tyrosine kinase 
receptors, but is not due to damaged DNA (166). Furthermore, treating the cells with 
antioxidants such as N-acetyl-L-cysteine (NAC), or tyrosine kinase inhibitors, 
suppressed the activation of ERK-1/2 (166). Yanase et al. (2001) suggested that 
ERK-1/2 was activated by UVA, which induces melanomagenesis; and that 
antioxidants played a role in regulating ERK, as well as controlling cell proliferation 
(166).  
He et al. (2008) found that exposing HaCaT cells to UVA induced cyclin D1 
accumulation and AKT (also known as protein kinase B-PKB) phosphorylation up to 
3 hours post-exposure. In contrast, UVA did not change ERK activation, which 
suggested that in low doses it has no effect on the ERK/MAPK pathway, but 
increased both cyclin D1 expression and AKT activation in these cells (167). 
According to Lee et al. (2010), mouse skin epidermal JB6 P+ cells exposed to 0.05 
J/cm
2
 UVB induced the phosphorylation of ERK, p38, and JNK. When the cells 
were treated with the antioxidant Kaempferol the phosphorylation of these cell 
signalling pathways was reduced (168).  
When melanocytes were irradiated with UVB, both JNK and p38 MAP kinase were 
activated, while that of ERK was transiently inactivated (169, 170). These results 
suggest the involvement of different cell signalling pathways (such as p38 and JNK) 
in the development of melanoma. 
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1.5.5.3 p38 Mitogen Activated Protein Kinase 
Many different factors including UVR and pro-inflammatory cytokines activate the 
p38 MAPK signalling cascade, of which there are four known isoforms: α, β, γ and δ 
(171). The isoform p38α has been examined extensively and is possibly the most 
physiologically relevant kinase implicated in the inflammatory response (172). 
UVR-induced p38 MAPK signalling ultimately results in the activation of numerous 
transcription factors, such as p53, c-Myc, and activating transcription factor 2 (ATF-
2) that promote the expression of genes involved in regulating cell proliferation, 
DNA repair, and apoptosis (173, 174). However, under most circumstances, acute 
UVR exposure induces pro-inflammatory cytokines which activate p38α and p38β 
MAPK leading to severe skin damage including apoptosis, necrosis and 
inflammation (173, 174). 
The activation of p38 MAPK following UV exposure plays a role in both cell 
survival and cell death pathways. Chouinard et al. (2002) found that UVB radiation 
activated p38 which led to stabilised p53. This activation provides an adaptive 
response by which keratinocytes can resist UVB-induced apoptotic cell death (175). 
Moreover, Bachelor et al. (2004) investigated the effect of inhibiting p38 MAPK on 
UVA-irradiated HaCaT cells. They found that 250 kJ/m
2
 UVA rapidly increased p38 
MAPK phosphorylation. Inhibition of p38 MAPK with SB202190 rapidly increased 
a cleavage of caspase-9, caspase-8, and caspase-3 in the UVA-irradiated cells. 
However, UVA irradiation alone had no effect on these activities in this cell line 
(176). 
It has been shown that stressful stimuli and/or pro-inflammatory cytokines activate 
the p38 MAPK and JNK signalling pathways, while ERK is activated by mitogens 
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involved in the regulation of cell survival (171). Moreover, exposure of melanocytes 
to UVB results in the activation of p38 and JNK, but not ERK-1/2 (170). It was also 
found that UVB exposure induces the phosphorylation of Ca
2+
/cAMP response 
element-binding protein (CREB) via the p38 MAPK signalling pathway in normal 
human melanocytes (170).  
Muthusamy and Piva (2013) observed the activation of the p38 MAPK pathway in 
melanocytes (HEM cells) and melanoma cells (MM96L cells) following UV 
irradiation over the first two hours (177). In HEM at 5 min post-irradiation, low 
doses of UV (4 kJ/m2 UVA and/or 0.2 kJ/m2 UVB) radiation immediately increased 
phospho-p38 (p-p38) levels. UVB stimulated the highest increase in p-p38 levels 
compared to other types of UVR, in comparison with sham-irradiated controls. 
Similar results were observed following exposure to higher doses of UVR             
(40 kJ/m2 UVA and/or 2 kJ/m2 UVB). At 5 min post-UV radiation,  p-p38 levels 
increased in comparison with sham-irradiated controls, with UVB inducing the 
highest increase (177).  
Muthusamy and Piva (2013) also found that in MM96L, UVR at low doses induced 
a small (<2-fold) increase in the levels of p-p38. In contrast, high UVR doses 
induced a greater increase (10-fold) in these levels and also in comparison with 
HEM cells (177). Thus, it can be seen that the activation of UVR-induced signalling 
pathways differs depending on cell type, UV type and dose. 
According to a study conducted by Liu et al. (2013) in N/TERT-1 cells (an 
immortalized human keratinocyte cell line), UVB (3.6 kJ/m
2
) and solar UV (SUV) 
(60 kJ UVA/m
2
 + 3.6 kJ UVB/m
2
), but not UVA (60 kJ UVA/m
2
), greatly activated 
p38α and its downstream target proteins, mitogen- and stress-activated protein 
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kinases (MSK2) and heat shock protein 27 (HSP27). Following UV exposure, the 
other isoforms of p38, including p38β, p38γ, and p38δ were not activated. These 
results provide supporting evidence that SUV strongly activates the p38α signalling 
pathway (178). Additionally, Liu et al. (2013) found that JNK signalling was also 
activated post-irradiation, and thus the role of this pathway needs to be examined 
when investigating UV-induced cell signalling pathways (178). 
 
1.5.5.4 Jun N-terminal Kinase Pathway (JNK) 
A major subgroup of the MAPK pathway is c-Jun N-terminal kinase (JNK), which 
plays an important role in regulating cell death pathways. JNK consist of three main 
isoforms: JNK-1, JNK-2, and JNK-3 (179, 180). The phosphorylation of JNK/ 
Stress-activated protein kinases (SAPK) occurs in response to UV irradiation and 
other stress stimuli (181). The alternative forms of JNK, i.e. JNK-1, -2 and -3, appear 
to differ in their ability to bind and phosphorylate different substrate proteins, and 
can also be differentially activated (181, 182).  
The JNK signalling pathway is known to mediate both survival and apoptosis of 
tumour cells. Although JNK-1 and JNK-2 have been shown to differentially regulate 
the development of skin cancer, the underlying mechanism remains unclear (183). 
Lopez-Bergami et al. (2007) have found a mechanism that links ERK with JNK 
signalling in human melanoma cells (157). Phosphorylation of JNK via protein 
kinase C (PKC) results in its activation in response to numerous stimuli. JNK 
activation by PKC occurs through many stimuli including cytokines, such as TNF-α, 
and external stressors, such as UVR (157, 184).  The receptor for activated C-kinase 
(RACK1) is an adaptor protein that is involved in PKC signalling, which also 
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activates JNK. Increased  RACK1 expression has been found in melanoma, 
suggesting that it and JNK plays a role in tumorigenesis (157). That is, JNK is up-
regulated by the effect of ERK on c-Jun activation of RACK1 transcription (157). 
The function of JNK in apoptosis is poorly understood; it has been suggested 
previously that it is proapoptotic, antiapoptotic, or plays no role at all (185, 186). 
While JNK may play an important role in UVR-induced apoptosis, it has been found 
that it suppresses apoptosis in IL-3 dependent haematopoietic cells through the 
activation of Bcl-2-associated death promoter (BAD) which is a member of the 
proapoptotic Bcl-2 family of proteins (179). Therefore, the role of JNK in either pro- 
or antiapoptotic functions depends on many factors, including cell type, the nature of 
the cell-death stimuli, its activation period and the activity of other signalling 
pathways. Understanding the role of JNK in the regulation of apoptosis may help to 
find new strategies for the prevention and treatment of some cancers (179).  
Recently, Liu et al. (2013) indicated that the phosphorylation of JNKs was increased 
when N/TERT-1 cells were exposed to SUV (60 kJ UVA/m
2
 + 3.6 kJ UVB/m
2
) 
(178). Exposure to higher doses of SUV (90 kJ UVA/m
2
 + 5.4 kJ UVB/m
2
) caused 
the cells to undergo apoptosis within 3 h (178). In cell exposed to UVR, JNK 
signalling is activated, whereby JNK-1 is stimulated more than JNK-2.  
Muthusamy and Piva (2013) found that in melanocytic-derived cells, JNK-1 was 
highly activated post-UVR when compared to JNK-2. In HEM cells, low dose UV 
induced a 11-fold increase in phospho-JNK-1 (p-JNK-1) levels between 5 and 15 
min following UVB (0.2 kJ/m2) radiation, while for UVAB radiation the levels 
remained at 9-fold until 30 min post-exposure. Following UVA (4 kJ/m2), p-JNK-1 
levels increased by 7-fold between 5 and 30 min post-irradiation. After exposure to 
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high dose UVR, the pattern of p-JNK-1 was similar in HEM cells, where these levels 
peaked at 15 min post-irradiation. UVB (2 kJ/m2) radiation induced the highest 
levels (10-fold) of p-JNK-1 post-irradiation while UVA induced the lowest levels (7-
fold).  In contrast, phospho-JNK-2 (p-JNK-2) levels were less than 2-fold in HEM 
cells exposed to either low or high dose UV radiation (177). In MM96L cells,         
p-JNK-1 levels were highest (<2-fold) at 15 min following exposure to low UVB 
levels, while minimal phosphorylation of JNK-2 was observed following exposure to 
low dose UVR. In these cells, high dose UVR stimulated a rapid and sustained 
activation of p-JNK-1 over 60 min, except for those cells exposed to UVB radiation 
(177). UVA radiation triggered a 4 to   5-fold increase in p-JNK-1 levels, while UVB 
generated a weaker response (2-fold increase). P-JNK-2 levels were also elevated 
(4–8-fold) after high dose UV-irradiation, except for UVB-irradiated MM96L cells 
(177). In general, HEM cells had higher p-JNK levels than did MM96L cells 
following low dose UV radiation, however the responses at higher doses were 
greater in the melanoma cells, except when exposed to UVB radiation. This result 
suggests that UV-induced JNK pathways may play a different role in melanocytes 
compared to melanoma cells (177). 
As the p38 MAPK and JNK pathways are regulated differently in HEM and MM96L 
cells, it suggests that the functions performed by both pathways in melanocytes may 
differ to that seen in melanoma cells. While these pathways are usually involved in 
maintaining homeostasis in normal cells, they may also be involved in pro-
tumorigenic activities in tumour cells. This may in part be due to mutations acquired 
in MM96L cells, which are upstream of the MAPK pathways. These pathways may 
act on their own, or in conjunction with ERK, to promote oncogenesis. As such, 
besides the ERK pathway, the p38 and JNK pathway should be probed further in 
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identifying their supportive roles in melanomagenesis (177). Also, these signalling 
pathways play a role in regulating the production and release of the cytokines from 
skin cells exposed to UVR (130). 
 
1.5.6 Tumour Necrosis Factor-α (TNF-α) and Interleukin-1α (IL-1α) 
TNF-α belongs to the TNF ligand superfamily, and can exist in one of two forms; a 
26 kDa membrane-bound form (mTNF-α) and a 17 kDa soluble form (sTNF-α) 
(187-189). The action of the metalloproteinase TNF-α Converting Enzyme (TACE) 
can cleave TNF-α from its membrane bound precursor between Ala76 - Val77 to its 
mature form sTNF-α (190, 191). 
The pro-inflammatory cytokine TNF-α is produced by numerous cells including 
macrophages, lymphocytes, fibrobroblasts, keratinocytes and melanocytes in 
response to infection, inflammation, and other environmental stresses (187, 192-
194). A varied array of biological effects is induced by TNF-α. Depending on the 
cell type, TNF-α may stimulate cell proliferation, differentiation or apoptosis (192, 
195). Moreover, the biological responses of TNF-α are mediated through TNF-
Receptor 1 (192, 195). 
As an environmental stressor, UVR induces the production and release of cytokines 
such as TNF-α and Interleukin-1 (IL-1) from skin cells (190, 191). Following 
exposure to UVR, the release of TNF-α plays a role in the inflammatory response 
(190, 191). It has been found that in some skin cell lines, TNF-α can be mediate by 
UVR enhanced tumorigenesis (39, 130, 190, 191). In addition to UVR causing 
changes to cell signalling activity, it can also affect cytokine levels in melanocyte-
derived cells (177, 196). 
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In vitro studies performed by Rasmussen et al. (2010) and Marionnet et al. (1997) 
showed that in response to UVR, keratinocytes, fibroblasts, and skin equivalents can 
produce IL-1α (197, 198). Neighbouring cells, which express IL1 receptors such as 
melanocytes, can be activated via paracrine/autocrine signalling by IL-1α (199, 200).  
In a study carried out by Fujisawa et al. (1997), small amounts of TNF-α were 
released from dermal fibroblasts when exposed to UVB alone or treated with IL-1α. 
However, when the fibroblasts were exposed to both UVB and IL-1α ~10-fold 
greater quantities of TNF-α were released (201, 202). Therefore, it is suggested that 
the increase in TNF-α mRNA levels is mediated through a synergistic effect of UVB 
and IL-1α (201). 
Bashir et al. (2009) investigated the synergistic effect of UVB (30 mJ/cm
2
) in the 
presence/absence of numerous cytokines including IFN-α2b, TNF-α, or IL-1α in 
human keratinocytes. They found that UVB and IL-1α had a synergistic effect in 
increasing the secretion of TNF-α (protein and mRNA) levels in keratinocytes (203).  
Muthusamy et al. (2011) observed similar results in melanocytes to Bashir et al. 
(2009). They found that exposing melanocytes to UVB radiation alone did not 
induce high levels of TNF-α release. However, the addition of IL-1α enhanced TNF-
α levels post-UVB exposure in both HEM (120-fold) and in MM96L cells (101-
fold). As the TNF-α levels post-UVB exposure were higher in HEM than MM96L 
cells, this suggests that high levels of inflammation may not be necessary for cells 
which have acquired malignancy (196). 
Muthusamy and Piva (2013) observed that UVAB radiation generated a similar 
increase in TNF-α levels to that found in UVB radiation in both HEM and MM96L 
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cells; while the effects of UVA radiation were less than that for UVB and UVAB 
(177). 
Furthermore, Muthusamy and Piva (2013) found that HEM cells were less sensitive 
than MM96L cells to UVR. They suggested that high levels of TNF-α may confer 
protection to these cells from UV-induced cell death, while the lower levels in 
MM96L could have made them more susceptible (177).  
It has been suggested that TNF-α is involved in mediating immunosuppression in 
skin cells, however this mechanism is not well understood (130). There may be 
numerous factors that affect the function of TNF-α in immunosuppression post 
exposure to UVR; these include type and dose of UVR, and the effect of other 
cytokines (130).  
As mentioned earlier, the cleaving of TNF-α is carried out by the enzyme TACE. As 
a result, the role and function of TACE in the irradiated cells was also investigated.  
 
1.5.7 TNF-α Converting Enzyme (TACE) 
TACE is an enzyme that belongs to the disintegrin and metalloprotease (ADAM) 
family of proteases (204, 205). It is also known as ADAM 17 (204, 205), and cleaves 
mTNF-α to form sTNF-α (189, 204). Besides cleaving TNF-α, numerous diverse 
processing events, such as transforming growth factor-α (TGF-α) precursor, amyloid 
precursor protein (APP) cleavage TNF-R1, TNF-R2 and L-selectin, are also carried 
out by TACE (206, 207).  
39 | P a g e  
 
 
Some metalloproteases have been reported to be activated in epidermal cells after 
UV irradiation (146, 208). However, it is unknown if UV irradiation regulates the 
expression of TACE on the membrane of skin cells. 
Skiba et al. (2005) found that UVA and UVB irradiation significantly upregulated 
the induction of TACE mRNA in HaCaT cells, with highest levels detected after 
UVA irradiation. However, the time course of TACE mRNA induction did not 
appear to be related to that of TNF-α (209). Although their study suggested a 
potential role of TACE post-UVR in human keratinocyte cell lines, up to date, no 
studies have been performed using melanocytes. 
Sharma et al. (2014) demonstrated the role of TACE in skin inflammation and 
associated carcinogenesis. The data from this study suggested that selective blockade 
of TACE suppressed 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced 
epidermal hyperplasia, the infiltration of inflammatory cells and cytokine levels 
leading to protection against skin inflammation. The results also indicated that 
blockade of inflammatory events facilitated via TACE inhibition may play an 
important role in preventing skin tumorigenesis in mice. These findings provide a 
new approach for the topical delivery of a TACE inhibitor against skin inflammation 
and tumorigenesis, which may overcome the toxicity associated with systemic 
exposure (210). 
It has been suggested that TACE inhibition  post-UV exposure may inhibit the 
stimulation of surviving irradiated cells (187). This may have the potential of 
decreasing the incidence of skin cancer development that may occur from prolonged 
exposure to sunlight. However, it is unclear whether the increase seen in TACE 
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activity in UV-irradiated skin cells is due to an increase in numbers, or whether it is 
due to a higher level of activity (187).  
Furin is known to activate TACE as well as matrix metalloproteases (MMP) (187), 
and as such the effect that UV radiation may have on this proprotein convertase also 
needs to be investigated. 
 
1.5.8 Furin 
The biological activity to many precursor enzymes, such as TACE (187, 207, 211, 
212) and MMP (187, 213, 214), is conferred by proprotein convertases (PCs) via 
endo-proteolytic cleavage at the C-terminal side of paired basic amino acids. Several 
mammalian proprotein convertases have been identified including PC1-PC7 and 
furin (215-217).  
PCs have been distributed according to their involvement in a variety of 
physiological and pathological processes. Furin, PACE-4, PC5/PC6, and PC7 are 
expressed in a broad range of tissues and cell lines; whereas particular members, 
such as PC1, PC2, and PC4, exhibit a tissue-specific distribution (215-217). 
Because furin plays a role in various diseases, considerable energy has been directed 
towards conceiving specific inhibitors that may have therapeutic applications. 
Although several inhibitors have been developed, none are completely furin-specific 
(218). The first synthesised furin inhibitors were peptidyl chloromethyl ketones 
(187, 219). 
The maturation of both TACE and MMP within skin cells is carried out by furin and 
other PCs. Furin and PC7 process ProTACE to its mature form – which increases its 
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proteolytic activity (187, 207, 211). As TACE travels through the Golgi 
compartment, its maturation occurs in which the prodomain is removed by furin 
(187, 205, 211, 220). When large amounts of mature TACE are detected in furin 
overexpressing cells, it seems that proTACE is a main substrate for this enzyme 
(187, 211). 
Crucial steps in melanoma metastasis include basement membrane degradation and 
remodeling of the extracellular matrix (ECM) by proteolytic enzymes such as 
MMPs. These enzymes have been found to interact with a wide range of non-matrix 
proteins, such as growth factors and their receptors, cell adhesion molecules, and 
apoptosis mediators (221). Furin plays a key role in tumour metastasis through their 
activation of MMPs, which play a role in this process (146, 222). 
 
1.6 Antioxidants 
It has been reported that UVR plays a role in the induction of ROS, which can cause 
cellular damage and lead to skin carcinogenesis (18, 118, 128). Exposure to ROS can 
lead to oxidative damage. Oxidative damage accumulates during the life cycle of the 
cell, and radical-related damage to DNA, proteins and lipids has been suggested to 
play an important role in the development of age-dependent diseases, for example: 
cancer, neurodegenerative disorders, arteriosclerosis, and arthritis (118, 223). 
However, the presence of the cell’s antioxidant defence system is designed to 
counteract oxidative damage from ROS (118, 223). 
Antioxidants play a role in stabilising ROS by donating an extra electron. The basic 
principle of the activity of many antioxidant compounds (AH) is through redox 
transitions (224). A redox transition involves the single electron donation from an 
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antioxidant to the free radical species (R) to stabilise it. The product of this electron 
transfer to the free radical is an antioxidant-derived radical that is seen in the 
following equation (224). 
                                              AH + R· → A· + RH 
A cellular redox imbalance can be induced by oxidative stress and has been observed 
in some types of cancer cells compared to their non-cancerous counterparts (76). The 
permanent modification of genetic material is likewise caused by oxidative stress, 
which can initiate ageing, mutagenesis and carcinogenesis (76, 118).  
UVR may generate ROS in the cell. Also, particular exogenous chemicals may cause 
redox cycle post-cell metabolism. As a consequent step, electron production can be 
transferred to molecular oxygen generating superoxide (O2
•−
). Regardless of their 
origin, ROS may interact with cellular biomolecules, for example DNA, which leads 
to modification and possibly deleterious outcomes for the cell (225). Also, it has 
been found that hydroxyl radicals interact with DNA molecules causing damage to 
both purine and pyrimidine bases (118). This damage caused by ROS in many types 
of tissues illustrates the role that free radicals play in DNA oxidation and may be one 
of the first steps in carcinogenesis (76, 118). 
It has been reported that free radical-mediated DNA damage has been involved in 
forming numerous cancers. Many products have been found from DNA oxidation 
and damage induced by ROS, including single- and double-stranded breaks, purine, 
pyrimidine or deoxyribose modifications, and cross-links between bases (118, 225, 
226). Arrest/induction of transcription, induction of signal transduction pathways, 
replication errors and genomic instability occur as a result of this damage (118, 225, 
226). 
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UV radiation induces two of the most abundant mutagenic and cytotoxic DNA 
lesions such as cyclobutane–pyrimidine dimers (CPDs) and 6–4 photoproducts      
(6–4PPs) (73, 74, 227). The adverse effects of solar radiation on living systems are 
mostly attributed to the small amount of UVB that is absorbed by cellular DNA. 
UVA wavelengths are less efficient in inducing such damage because they are not 
absorbed by native DNA. However, they can still produce secondary photoreactions 
of existing DNA photoproducts or cause damage via indirect photosensitizing 
reactions (227) as described above (Section 1.5.1). 
Antioxidants play a key role in the regulation of the effect of ROS by direct removal 
of the free radicals (pro-oxidants) to maintain and protect cells from their damage 
(118). The main features of antioxidants include: reducing free radicals, interactions 
between the antioxidants in an ‘antioxidant network’, direct effects on gene 
expression, easy and quick absorption, and effectiveness in different environments, 
such as aqueous and membrane domains (118). In addition, antioxidants can 
modulate cell signalling pathways and such modulations can help to avoid cancer 
formation (76, 228). These can occur by: (a) controlling the regulation of normal cell 
cycle; (b) increasing the activity of phase II detoxification enzymes; (c) inducing 
apoptosis and inhibiting proliferation; and (d) inhibiting tumour metastasis (76). 
Antioxidants fall into two main types, enzymatic and non-enzymatic. Enzymatic 
antioxidants include catalase (CAT), glutathione peroxidase (GPx), and superoxide 
dismutase (SOD). Some well-known non-enzymatic antioxidants are α-tocopherol 
(vitamin E), ascorbic acid (vitamin C), glutathione (GSH) and flavonoids (76, 118). 
Antioxidants tend to act in hydrophilic or hydrophobic environments, while some 
can act in both regions of the cell. For example, vitamin C interacts with superoxide 
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in aqueous environments, while Vitamin E reduces it in lipophilic environments, 
such as the plasma membrane (118). 
 
1.6.1 Vitamin C 
Vitamin C (ascorbic acid or ascorbate) is a water-soluble non-enzymatic antioxidant 
(229) – its structure is seen Figure 1.7. The role of vitamin C donating an electron to 
stabilise molecules with an unpaired electron is well known (230). Ascorbate, known 
as AscH−, reacts with free radicals, producing the stabilised form of tricarbonyl 
ascorbate radical (AscH•). ROS reacting with vitamin C can also form the semi-
dehydroascorbate radical (Asc•−), a weakly reactive radical which causes acceptable 
levels of oxidative stress in the cell (118). It may be able to decrease DNA damage 
through either directly reducing radical species, which directly affects DNA bases, or 
by protecting the proteins responsible for DNA repair (230). 
 
 
Figure ‎1.7 Ascorbic acid structure (231) 
 
Vitamin C does not absorb UV light but exerts an UV-protective effect by 
neutralizing free radicals, while this effect is not seen with sunscreens (232, 233). 
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Under laboratory conditions, it has been shown that application of 10% topical 
Vitamin C reduced UVB-induced erythema by 52% and sunburn cell formation by 
40-60% in porcine skin (232, 233). 
It was shown that when vitamin C was administered in vivo it reduced oxidative 
DNA markers while regulating cellular functions, such as gene expression and 
apoptosis in human lymphocytes (118, 234). Moreover, it has been shown that there 
is a link between the antioxidant activity of vitamin C and its role in preventing cell 
death (118).  In many studies, vitamin C has been shown to protect against cell death 
triggered by various stimuli, and a major proportion of this protection has been 
linked with its antioxidant ability (118, 235). Also, it was reported that the anti-
apoptotic activity of vitamin C has revealed its role in modulating immune system 
function (118). Several studies reported the mechanisms by which vitamin C 
regulates the AP-1 complex, including the Fos and Jun superfamilies (118). 
Ascorbate-treated cells exposed to UVB irradiation led to a 50% decrease in JNK 
phosphorylation (which activated AP-1), therefore inhibiting signalling via this 
pathway (118). 
According to Telang (2013), the efficacy of vitamin C was increased eight-fold when 
used in combination with ferulic acid (a potent antioxidant of plant origin) and 
vitamin E. Ferulic acid enhanced the stability of vitamin C and E, and it was 
observed that using this combination can confer a protection from acute and chronic 
photodamage. This combination of antioxidants inhibited thymine dimer formation 
and apoptosis.  It has therefore been suggested that this combination can be used for 
skin cancer prevention (232, 233).  
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1.6.2 Vitamin E 
Vitamin E is known as a non-enzymatic antioxidant that is fat-soluble. It exists in 
eight different forms and α-tocopherol is  known  to  be  the  most  active  form  of  
this  vitamin. α-Tocopherol is a potent antioxidant and is thought to be the main 
membrane-bound antioxidant in the cell (118, 236, 237), and its main role is to 
protect against lipid peroxidation (118, 238). 
Vitamin E is a peroxyl radical scavenger, and can terminate the chain reaction of 
lipid damage caused when free radicals attack membranes (239, 240). This vitamin is 
found at high levels in the stratum corneum (239, 240). This outermost layer of the 
epidermis is often exposed to environmental stressors directly, including UVR. 
Thiele et al. (1998) found that vitamin E is highly susceptible to suberythemogenic 
UVR, resulting in its depletion before the occurrence of visible skin reactions. Thus, 
the depletion of vitamin E in the stratum corneum layer is a sensitive and early in 
vivo marker of photo-oxidation induced by sunlight (241).  
The application of vitamin E to the skin, as well as its percutaneous absorption is 
made possible due to its lipophilic nature. Krol et al. (2000) showed that the topical 
applications of vitamin E reduced the occurrence of UV-induced skin cancers in 
mice (242).  
By acting as a free radical cascade-breaking antioxidant in the skin, endogenous      
α-tocopherol can inhibit lipid peroxidation induced by UV. Moreover, the levels of 
dietary derived α-tocopherol in the skin are increased by an adaptive response to 
chronic UV effect. However, the efficiency of topical application of α-tocopherol is 
reliant on numerous factors (242). 
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Vitamin E confers protection against UV-induced skin photodamage by reducing the 
formation of cyclobutane-pyrimidine photoproducts (242-244). However, topically 
applied  α-tocopherol, when applied to mouse skin was quickly reduced by UVB in a 
dose-dependent manner (242).  
Roshchupkin et al. (1979) found that UVR increased the erythemal response of skin 
to UV light. However, when the skin was pre-treated with topical vitamin E, the 
erythemal response of skin post-UVR was significantly reduced (245).  
Lopez-Torres et al. (1998) observed that α-tocopherol conferred protection to 
hairless mice against UV-induced oxidative damage, by reducing the formation of 
epidermal lipid hydroperoxides (236). Ichihashi et al. (1999) suggested that 
melanomagenesis may be suppressed by α-tocopherol if used as a skin whitening 
agent, perhaps via inhibiting tyrosine hydroxylase activity in an indirect way. α-
Tocopherol decreased the levels of 8-hydroxydeoxyguanosine (8-OHdG) produced 
indirectly in guinea pig skin exposed to 2 MED UVB (246). As it did not suppress 
the formation of cyclobutane pyrimidine dimers and (6-4) photoproducts,                
α-tocopherol may have reduced oxidative DNA damage, thereby retarding the 
development of skin cancer (246). 
Kuchide et al. (2003) found that UVB induced 8-OHdG levels in the epidermal cells 
of hairless mice, which were reduced when these mice were given dietary                
α-tocopherol – highlighting their scavenging activity against ROS (243). 
A more water soluble analog of vitamin E is trolox whose structure can be seen in 
Figure 1.8. Peus et al. (2001) showed that in primary keratinocytes, trolox reduced 
the level of UVB-induced intracellular hydrogen peroxide (128). Trolox was also 
shown to modulate the UVB-induced phosphorylation of EGFR, ERK-1/2 and p38 
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in these cells. The authors explained that these effects were only partly due to the 
inhibition of trolox on UVB-induced intracellular H2O2 generation (128). The results 
demonstrated that the increased pre-treatment of the cells with trolox was a 
significant factor affecting signal transduction and cellular outcomes (128). 
 
 
Figure ‎1.8 Structure of  trolox (247) 
  
Muthusamy et al. (2011) found that pre-treating HEM and MM96L melanoma cells 
with α-tocopherol prior UV exposure decreased UVB-induced TNF-α secretion by 
53% in melanocytes, but not in melanoma cells. α-Tocopherol did not affect UVB-
induced p38 MAPK pathway activation in these cells and suggests that its effects 
were unrelated to signalling via this pathway (196). However, it was not clear if      
α-tocopherol could exert its effects via other signalling pathways. 
Therefore in summary, UVR is known to increase ROS levels in the skin, which may 
lead to oxidative damage (248). Similarly, antioxidants have been shown to 
moderate the deleterious effect of ROS (248). Vitamin C and E are considered to be 
the main antioxidants found in the skin, and they prevent or decrease oxidative stress 
by neutralising ROS in the cells (240, 248).  It has been found that the amount of 
vitamins reaching the skin from daily nutrient intake is insufficient for 
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photoprotection, so it has been suggested that the use of topically applied vitamin C 
and E may confer photoprotection (240, 248). As vitamin C levels in the skin are 
depleted by UV exposure, and through topical application its levels may be restored 
(248). It has been observed that the oral and topical application of antioxidants in 
conjunction with sunscreens enhance photoprotection in the skin (248, 249). 
 
1.7 Summary 
UVR has been shown to play a role in the activation of different signalling pathways 
through the generation of ROS especially ERK-1/2. The hyperactivation of these 
signalling pathways plays a role in melanoma development. The p16 tumour 
suppressor gene plays a key role in suppressing tumorigenesis and melanomagenesis, 
possibly by controlling intracellular ROS levels. UVR is involved in the activation of 
cytokines that include TNF-α, which is regulated by MAPK signalling pathways. 
TNF-α plays a role in the UVR-induced immune response, and is released in its 
mature form by the action of TACE, which regulates its release. Furin is a proprotein 
convertase enzyme that is involved in the maturation and activation of TACE. UVR 
has been suggested to play a role in the activation of these key genes in melanocytes. 
B-RAF is a member of RAF family upstream of the MAPK signalling pathways, and 
is involved in the activation of pathway intermediates such as ERK, while p38 and 
JNK can be activated by UVR, or by cross-talk of these cell signals. These signalling 
pathways are involved in different cellular functions including cell survival, cell 
proliferation and cell death. Antioxidants are known to play an important role in the 
protection of the cells from oxidative damage by scavenging free radicals.  
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We hypothesised that cells with higher melanin levels will produce less ROS than 
those with lower levels and that exogenously added antioxidants will confer a 
protective effect to these cells when they are exposed to UV radiation. The 
mechanism of ROS production and of the signalling pathways activated by UV 
radiation will be different in melanoma cells compared to those in melanocytes, and 
these differences may be a means by which treatment regimens may be devised that 
could protect those untransformed skin cells from the deleterious effects of UV 
radiation.  
Therefore, the role antioxidants play in primary epidermal melanocytes and 
differently pigmented melanoma cells (MM418-C1 and MM418-C5) will be 
examined in this project, to see whether these molecules confer a protective effect on 
irradiated melanocytes – if so, then they may be added to the skin to enhance the 
protective effect of sunscreens.  
 
1.8 Aims of the project 
I investigated the effect antioxidants have on the functions of UV-irradiated 
melanocytes and melanoma cells. As part of this study, I propose to investigate if: 
1. Antioxidants confer protection to melanocytes exposed to UV-radiation.  
2. Antioxidants alter the activity of B-RAF and other MAPK signalling pathways in 
UV-irradiated melanocytes. 
3. Antioxidants reduce the release of TNF-α from UV-irradiated melanocytes.  
4. Antioxidants affect the expression of furin and TACE in UV-irradiated 
melanocytes.  
51 | P a g e  
 
 
 5. Antioxidants alter the formation of melanin in cells following exposure to UV 
radiation. 
6. The UV-induced responses seen in melanoma cells differ to that observed in 
melanocytes.  
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CHAPTER 2 
MATERIALS AND METHODS 
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Chapter 2. Materials and Methods 
2.1 Materials 
2.1.1 Cell lines 
Lightly pigmented (MM418-C1) and darkly pigmented human melanoma (MM418-
C5) cell lines were kindly donated by Drs Peter Parsons and Glen Boyle from the 
Queensland Institute of Medical Research (QIMR) (Brisbane, Australia), these two 
cell lines were grown from the same primary tumour and possess the following 
genetic mutations: BRAF
V600E
, NRAS
WT
 and PTEN
WT
 (250). The human epidermal 
melanocytes (HEM) were purchased from Promo Cell (Melbourne, Australia) and 
did not contain any genetic mutations (Figure 2.1). All solutions used in the series of 
experiments described in this thesis were kept at 37°C for MM418-C1 and MM418-
C5 cells, while those for HEM cells were kept at room temperature (RT 20°C) unless 
specified otherwise. 
 
 
Figure ‎2.1 The cell lines used in this thesis 
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2.1.2 Chemicals and biochemicals 
The chemicals and biochemicals used in this project were: Roswell Park Memorial 
Institute (RPMI) 1640 medium, (1%) Penicillin-Streptomycin-Glutamine, 0.5% 
Trypsin-EDTA, Inactivated Foetal Bovine Serum (FBS), Medium 254 for 
melanocytes, and Human Melanocyte Growth Supplement (HMGS) were purchased 
from Gibco (Melbourne, Australia). Phosphate-Buffered Saline (PBS), phenol red-
free Hank’s Buffered-Salt Solution (HBSS), 0.4% (w/v) Trypan Blue solution, 
Mercaptoethanol, Phosphatase inhibitor, Tris, Tetramethylethylenediamine 
(TEMED), Ammonium Persulfate (APS), Ponceau S, Acetic acid, Tween 20, Human 
recombinant IL-1α, Neutral red, Ascorbic acid, Ethylaminediaminetetraacetic acid 
(EDTA) 2′, 7′-Dichlorofluorescin diacetate (DCF-DA) and Melanin, were purchased 
from Sigma (Sydney, Australia); CellTiter 96® AQueous Non-Radioactive Cell 
Proliferation Assay (MTS) was obtained from Promega; MitoSOX™ Red 
Mitochondrial Superoxide Indicator was purchased from Invitrogen; Bovine Serum 
Albumin (BSA)  was obtained  from Bovogen (Melbourne, Australia); Glycine, 
Sodium Dodecyl Sulfate (SDS) and NaCl were from Astral Scientific (Sydney, 
Australia); Furin rabbit polyclonal antibody, TACE (ADAM 17) rabbit polyclonal 
antibody, Tyrosinase rabbit polyclonal antibody and GAPDH antibody  were 
obtained from Abcam (Sapphire Bioscience, Sydney, Australia); Complete Protease 
inhibitor cocktail tablets were purchased  from Roche (Sydney, Australia); 40% 
Acrylamide-Bis solution and Kaleidoscope Prestained Standards were obtained from 
BioRad (Sydney, Australia); ECL Select western blotting detection reagent was 
purchased from GE Healthcare (Australia); Pierce BCA protein assay kit was 
obtained from ThermoFisher Scientific (Melbourne, Australia); Phospho-p38 rabbit 
polyclonal antibody, phospho-JNK rabbit polyclonal antibody and phospho-B-RAF 
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rabbit polyclonal antibody were purchased from Cell Signaling  (Genesearch, 
Brisbane, Australia); Human TNFα ELISA Kit was from Scientifix (Melbourne, 
Australia) and Nitrocellulose Membrane was obtained from Amersham Biosciences 
(Sydney, Australia). 
 
2.1.3 Labware used in the project 
The 75 cm² tissue culture flasks, 60 mm × 15 mm petri dishes as well as 6-well, 24-
well and 96-well tissue culture plates were purchased from Greiner Bio-one 
(Interpath Services, Melbourne, Australia); Microcon YM-10 micro-concentrators 
(10 kDa) were from Millipore (Sydney, Australia); 1.5 ml microcentrifuge tubes 
were obtained from All-Lab Scientific (Sydney, Australia); 15 and 50 ml centrifuge 
tubes were from Biotix (Melbourne, Australia); while 200 and 1000 μl pipette tips 
were purchased from ThermoFisher Scientific (Melbourne, Australia). 
 
2.2 Techniques 
2.2.1 Cell culture 
2.2.1.1 HEM cells 
HEM cells were cultured with Medium 254 supplemented with 1% (v/v) Human 
Melanocyte Growth Supplement and 1% (v/v) Penicillin-Streptomycin-Glutamine. 
The spent culture media was discarded and replaced with fresh media every three to 
four days. The cells were grown in 75 cm² tissue culture flasks, which were placed in 
a 5% CO₂ cell incubator that was maintained at 37°C. 
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2.2.1.2 MM418-C1 and MM418-C5 melanoma cell lines 
RPMI medium 1640 containing 10% (v/v) heat-inactivated Foetal Bovine Serum 
(FBS) plus 1% (v/v) Penicillin-Streptomycin-Glutamine, was used to culture both 
melanoma cells lines. The media was changed and replaced with fresh tissue culture 
media every two to three days. The 75 cm
2
 tissue culture flasks were used for cell 
subculturing and were placed in a 5% CO₂ incubator maintained at 37°C. 
 
2.2.2 Subculture 
2.2.2.1 HEM cells 
HEM cultures normally reached confluency between seven to ten days. Confluence 
was monitored visually using an inverted light microscope (Olympus CK2, 
Australia). 
Once confluent, the spent culture media was aspirated and the cells washed twice 
with sterile Trypsin-EDTA solution. After the second wash, the cells were incubated 
with 2 ml of sterile Trypsin-EDTA solution for 45 to 60 sec. Cells were dissociated 
by gentle tapping of the flask. The trypsinised cell suspension was collected in a 15 
ml centrifuge tube containing 4 ml of 1% (v/v) Trypsin Neutraliser and centrifuged 
(400 g for 5 min at 20°C) in a Universal 16 R centrifuge (HD Scientific, Melbourne, 
Australia). The supernatant was discarded and the cell pellet resuspended in 1 ml of 
tissue culture media. Approximately 250 μl of the cell suspension was added to a 75 
cm
2
 tissue culture flask containing 20 ml tissue culture media. Then the flask was 
capped and sprayed with 70% (v/v) ethanol before being placed in the CO2 incubator 
as described previously. In setting up for an experiment, when the cultures in the 
flask reached 80% confluency, the cells were trypsinised and added to 20 ml of 
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tissue culture media. To each 60 mm petri dish, 4 ml of cell suspension was added 
using a sterile pipette. 
 
2.2.2.2 MM418-C1 and MM418-C5 melanoma cell lines 
MM418-C1 and MM418-C5 cell cultures took between five to six days to reach 
confluency. Confluence was monitored visually using an inverted light microscope. 
When confluency reached 80%, the media in the flask was aspirated and the cells 
were washed twice with pre-warmed (37°C) sterile PBS. Then, the cells were 
washed with pre-warmed sterile Trypsin-EDTA solution. After this, 2 ml of sterile 
Trypsin-EDTA was added into the flask and the cells incubated for 1-2 min in the 
CO2 incubator. Gentle tapping of the flask from the side was used to detach the cells 
in each flask. An aliquot (0.5 ml) of the cell suspension was added to 20 ml of RPMI 
1640 medium containing 10% (v/v) FBS, 1% (v/v) penicillin-streptomycin-
glutamine in a 75 cm
2
 tissue culture flasks, as described previously (Section 2.2.1.2). 
When the cultures reached 80% confluency the cells were trypsinised. 
 
2.3 UV-irradiation 
2.3.1 UV lamp output 
The solar simulator BioSun (Vilber Lourmat, France) was the source of UVA and 
UVB radiation used to irradiate the cells. As specified by the manufacturers (Vilber 
Lourmat), the BioSun contained UVA fluorescent tubes (T-40.L) with a maximal 
output at 365 nm, and UVB fluorescent tubes (T-40.M) with a maximal output at 
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312 nm. The computer connected to the solar simulator monitored the UV radiation 
and the temperature, as seen in Table 2.1. 
Table ‎2.1 UV type, dose and exposure times used in the experiments in this thesis 
UV type 
UV Dose (J/cm
2
) 
MM418-C1 MM418-C5 HEM 
UVA 
Acute = 0.6 Acute = 0.4 Acute = 3.2 
Chronic = 0.3 Chronic = 0.2 Chronic = 1.6 
UVB 
Acute = 0.03 Acute = 0.02 Acute = 0.16 
Chronic = 0.015 Chronic = 0.01 Chronic = 0.08 
UVAB 
Acute = 0.6+0.03 Acute = 0.4+0.02 Acute = 3.2+0.16 
Chronic = 
0.3+0.015 
Chronic = 
0.2+0.015 
Chronic = 1.6+0.08 
 
2.3.2 UV type and dose  
Cells were exposed to different doses of UVA and/or UVB radiation as mentioned in 
the results section. The outputs of the UV lamps were checked regularly and the 
following UV doses and their exposure times were controlled by computer software. 
UVAB refers to cells exposed to UVA plus UVB radiation. Reference is made 
throughout the thesis to cells irradiated with UVAB radiation, and in this situation 
the cells were exposed to UVA prior to being exposed to UVB.  
The UV doses that the cells were exposed to were based on the UVB dose that was 
found to cause 50% cell death 24 h post-exposure (See Section 3). As the UVB 
component of sunlight which reaches the Earth’s surface is approximately 1/20th that 
of UVA radiation (251), the latter dose was 20x that of the UVB component. Cell 
viability was determined using the MTS assay (Section 2.4). Furthermore, according 
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to Samanek et al. (2006), the doses indicated above for melanocytes equate to 8 min 
of solar UV exposure in the city of Melbourne (Australia) at midday on a summer’s 
day (January). The authors calculated that 10 min of solar exposure, under the above 
mentioned conditions, was equivalent to 1 MED (252). 
The cell lines used in this study differed with respect to their melanin content; hence 
as a result the UV doses given to each cell line was different. 
 
2.3.3 UV-irradiation of cells 
The cells were grown in 24 well plates and were used in experiments investigating 
the effect of UV radiation on cell viability (Section 2.4), melanin content (Section 
2.5) and cellular ROS levels (Section 2.6). Cells cultured in 60 mm petri dishes 
(Section 2.7) were used to study the expression of signalling pathway intermediates 
(Section 2.7), TACE and Furin (Section 2.8) and for the secretion of TNF-α by the 
cells (Section 2.9).  Once the cultures in the plates or petri dishes reached ~ 80% 
confluency, the spent tissue culture media was discarded and the cells were gently 
washed twice with pre-warmed sterile PBS. Then, the PBS was removed and 1 ml of 
pre-warmed sterile phenol red-free HBSS was gently added to the side of the well in 
a 24 well plate, while 3 ml was added to a 60 mm petri dish. The tissue culture plate 
or petri dish was placed in the middle of the shelf in the UV cabinet and was exposed 
to UV-irradiation without the lid. The cells were exposed to the type and dose of UV 
radiation as mentioned in Table 2.1. In the case of UVA, the plate and petri dishes 
were covered with a glass (10 mm thick) to avoid UVB radiation.  
Immediately following UV irradiation, the HBSS was gently aspirated from the 
tissue culture plate or petri dish, after which 1 ml of fresh tissue culture media was 
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gently added to the side of the plate or 3 ml to a petri dish. The tissue culture plates 
or Petri dishes were returned to the cell incubator for various time points as 
mentioned in the results section. 
 
2.4 Antioxidant treatments 
In those cells grown in 24 well plates, these were treated with vitamin C, where 10 
µl of a stock solution (100 mM vitamin C) was then added to 990 µl of media in a 
well of the tissue culture plate. The final concentration of vitamin C in the tissue 
culture media was 1 mM. 
For cultures treated with trolox, a stock solution of trolox (10 mM dissolved in 10% 
(v/v) DMSO) was prepared. Then, 10 µl of stock solution was added to 990 µl of 
tissue culture media in the well of a tissue culture plate. The final concentration of 
trolox in the tissue culture media was 0.1 mM. As trolox was suspended in DMSO, 
the effect of this solvent on cell viability was also examined. To 990 µl of fresh 
tissue culture media, 10 µl of the DMSO stock solution (10% (v/v) DMSO) in tissue 
culture media was added to each well of a tissue culture plate. The plates were 
placed in a 5% CO2 incubator for 24 h at 37°C before and after UV exposure. 
Cells cultured in 60 mm petri dishes were used to study the expression of signalling 
pathway intermediates, as well as that of TACE and furin. In those cultures in 60 
mm petri dish treated with vitamin C, 30 µl of a vitamin C stock solution (100 mM) 
was then added to 2970 µl of media in the dish. The final concentration of vitamin C 
in tissue culture media was 1 mM. 
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For cultures treated with trolox, a stock solution of trolox (10 mM dissolved in 10 % 
(v/v) DMSO) was prepared. Then, 30 µl of stock solution was added to 2970 µl of 
tissue culture media in the dish. The final concentration of trolox in the tissue culture 
media was 0.1 mM. As trolox was suspended in DMSO, the effect of this solvent on 
cell viability was also examined. In 2970 µl of fresh media, 30 µl of the DMSO 
stock solution (10% (v/v) DMSO) in tissue culture media was added to each dish. 
The petri dishes were placed in a 5% CO2 incubator for 24 h at 37°C before and after 
UV exposure for TACE and furin levels (Section 2.8), and for the secretion of TNF-
α by the cells (Section 2.9). For cell signalling experiments, the petri dishes were 
incubated for 24 h with the antioxidants prior to being exposed to UV radiation 
(Section 2.8). 
 
2.5 Cell viability assay 
Cell viability was determined 24 h post-UV exposure using the MTS assay. In these 
experiments, the cells were seeded into wells of a 24 well tissue culture plates in 
triplicate. The plates were incubated overnight to allow for cell attachment. On the 
next day, the tissue culture media was aspirated and the cells washed twice with pre-
warmed sterile PBS. After which, pre-warmed sterile HBSS (500 µl) was added to 
each well. Then, the cells were irradiated with different doses of UV (A and/or B) 
radiation as described in Table 2.1. Immediately post UV-radiation, the HBSS 
solution was discarded and 1 ml fresh tissue culture media was added to the sham- 
and UV- irradiated cells. 
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2.5.1 Antioxidant effects on cell viability 
At 23 h post-irradiation (see Section 2.3.2), the tissue culture media was removed 
and the UV-irradiated cells washed twice with pre-warmed sterile PBS. Then 300 µl 
of fresh tissue culture media was added to the cells followed by 60 µl of MTS 
reagent. In a blank well, 300 µl of fresh tissue culture media, along with 60 µl of 
MTS reagent, was added.  The plates were placed in the CO2 incubator (37
o
C) for 60 
min before being read at 490 nm on a CLARIOstar® plate reader (BMG LABTECH, 
Mornington, Australia). Cell viability was calculated as the percentage of treated 
viable cells compared to the sham-irradiated (control) cells – which were shown as 
100% viability. 
 
2.6 Melanin measurements 
2.6.1 Protein concentration determination 
The amount of protein in the cell cultures was measured using the Bicinchoninic 
Acid (BCA) kit as described in the manufacturer’s instructions using Bovine serum 
albumin (BSA) as the protein standard. Briefly, in a 96 well plate 10 µl of protein 
standards (0-20 µg) in duplicate and 10 µl of cell lysate were added in duplicate to 
the wells.  After which 200 μl of BCA solution was added to each well. The plates 
were incubated for 1 h at 37°C and read at 560 nm on a CLARIOstar® plate reader.  
The standards on the plate were used to establish a protein standard curve. 
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2.6.2 Melanin level 
Cells were treated with antioxidants and UV-radiation as described in section 2.4. 
After 24 h or 48 h post-exposure, the cells were washed twice with pre-warmed 
sterile PBS. After which 100 µl of 1 M NaOH was added to each well. The plates 
were agitated on a platform shaker for 30 min before 400 µl of H2O was added to 
each well. On a 96 well plate, 100 µl of melanin standards (0-10 µg) were added in 
duplicate, as well as 100 µl of cell extract were added to the wells in duplicate. The 
plates were read at 475 nm on a CLARIOstar® plate reader. The standards on the 
plates were used to establish a melanin standards curve.  
 
2.7 Formation of Intracellular ROS  
Intracellular ROS formation in the irradiated cells was detected using two different 
flow cytometry-based fluorescent assays to measure intracellular peroxide, as well as 
mitochondrial superoxide levels. 
 
2.7.1 Intracellular peroxide formation 
In order to measure the peroxide formation in the treated melanocytes and melanoma 
cells post-UV exposure, 2′,7′-Dichlorofluorescin diacetate (DCFDA) was used (253).   
A 100 μM working solution was prepared by diluting the DCFDA stock solution in 
HBSS. In 24 well plates, melanocyte and melanoma cells were grown as described in 
section 2.4.1. Prior to the cells being exposed to UV-radiation they were washed 
with 0.5 ml of sterile PBS, after which 250 µl of DCFDA solution (100 µM in 
HBSS) was added to each well. The plates were incubated for 30 min in a humidified 
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and dark incubator at 37°C and 5% CO2. This step is necessary to allow the cells to 
first take up the indicator. 
At the end of this period, the cells were washed twice with 0.5 ml of sterile PBS. 
After which the cells were exposed to UV-radiation and then treated with 
antioxidants, as previously described (Section 2.4.1). A positive control was used on 
the same plate to generate a consistent amount of peroxide. The positive control well 
in this experiment was exposed to UVB as it is known to generate peroxide (254). 
After that, the plate was incubated in the incubator for 24 h. 
At the end of the 24 h incubation period, the cells in plates were trypsinised before 
being resuspended and placed into flow cytometry tubes and centrifuged for 5 min at 
400 g. After centrifugation, the supernatant was discarded and the cell pellet 
suspended in 300 µl of PBS. The tubes were then assayed by flow cytometry 
(Section 2.7.2). 
 
2.7.2 Flow cytometry of intracellular peroxide formation 
The effect of antioxidants on the level of peroxide in UV-irradiated melanocytes and 
melanoma cells was measured by flow cytometry. For this, either 10,000 events or 
the number of events after 3 min per tube were recorded. The reason for the latter 
was because cells that were exposed to UVB and UVAB radiation generally had 
lower cell numbers and viability compared to UVA- or sham-irradiated cells and, as 
such, 10,000 events may not be achieved by the flow cytometer for these samples. In 
these experiments, each treatment was performed in triplicate and the mean 
fluorescence intensity used to measure the amount of peroxide generated in the cell. 
The BD FACSDiva™ software (Becton Dickinson, Sydney, Australia) was used to 
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import the data set to Excel Microsoft files (Excel Microsoft 2010, Redmond, 
California) for the analysis. The mean±SEM of three samples were determined and 
were represented as the fold of increase compared to untreated sham-irradiated 
controls, which was given the value of unity (1). 
 
2.7.3 Mitochondrial superoxide formation 
In order to measure superoxide production in treated melanocytes and melanoma 
cells post UV-exposure, MitoSOX™ Red mitochondrial superoxide indicator for 
live-cell imaging (Invitrogen, USA) was used (255).   A 2.5 μM working solution 
was prepared by diluting the stock solution in HBSS. Melanocyte and melanoma 
cells were grown in 24 well plates as described in section 2.4.1. Prior to the cells 
being exposed to UV-radiation, they were washed with 0.5 mL of sterile PBS, after 
which 250 µl of 2.5 µM MitoSOX Red in HBSS was added to each well. The plates 
were incubated for 30 min in a humidified and dark incubator at 37°C and 5% CO2. 
This step is necessary to allow the cells to first take up this indicator. 
At the end of this period, the cells were washed twice with 0.5 ml of sterile PBS. 
After which, the cells were exposed to UV-radiation and then treated with 
antioxidants, as previously described (Section 2.4.1). A positive control was used on 
the same plate to ensure a consistent generation of superoxide radicals. The positive 
control well in this experiment contained 3.33 mM xanthine, 1 mM EDTA, 10 mM 
potassium phosphate buffer, phenol red-free media and xanthine oxidase (4 U/ml). 
After that the plate was incubated in the incubator for 24 h. 
At the end of 24 h incubation period, the cells in the plates were added into flow 
cytometry tubes and centrifuged for 5 min at 300 g. After centrifugation, the 
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supernatant was discarded and the cell pellet suspended in 300 µl of PBS. The tubes 
were then read by flow cytometry (Section 2.7.2). 
 
2.7.4 Flow cytometry of mitochondrial superoxide formation 
The effect of antioxidants on mitochondrial superoxide levels in UV-irradiated 
melanocyte and melanoma cells was measured by flow cytometry. Here either 
10,000 events or the number of events after 3 min per tube were recorded. As stated 
in Section 2.7.2, the reason for the latter was because cells exposed to UVB and 
UVAB radiation generally had lower cell numbers and viability compared to UVA- 
or sham-irradiated cells. In these experiments, each treatment was performed in 
triplicate and the mean fluorescence intensity used to measure the amount of 
mitochondrial superoxide generated in the cell. The BD FACSDiva™ software was 
used to import the data set to Excel files for the analysis. The mean±SEM of three 
samples were determined and were represented as the fold of increase compared to 
untreated sham-irradiated controls, which was given the value of unity (1). 
 
2.8 Western blotting 
2.8.1 Preparation of cell lysates 
Following exposure to UV radiation, the cells grown in 60 mm Petri dishes were 
harvested at different time points, as described in the results section. The cells in the 
petri dishes were washed twice with ice-cold PBS (4°C) before 100 μl of ice-cold 
Lysis buffer (Appendix 1) was added. The attached cells were scraped vigorously 
using a cell scraper and the lysate was placed in a 1.5 ml microfuge tube that was 
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kept on a shaker for 20 min at 4°C. After this, the lysate was centrifuged (10,000 g 
for 5 min at 4°C), an 80 µl aliquot of the supernatant was placed in a fresh microfuge 
tube. Duplicate aliquots (5 µl) of the supernatant were used for protein 
determination, as described previously (Section 2.5.1). 
To the tubes containing the cell lysates, 20 μl of Laemmli buffer (Appendix 2) was 
added (256) and were then boiled for 5 min in a water-bath at 95°C. After which the 
samples were stored at -80°C until the proteins were resolved by SDS PAGE gel 
electrophoresis (Section 2.7.2). 
 
2.8.2 SDS PAGE gels 
SDS PAGE running gels (10%) were prepared (Appendix 3) and set in Mini Protean 
III Multicasting Chambers (BioRad, Sydney, Australia). In order to get a straight 
edge on the gel, 0.1% (w/v) SDS was carefully layered on the top of the running gel. 
Once the running gel had set, the SDS was removed and, a stacking gel (Appendix 4) 
was added along with a 10 lane comb.  
Once the stacking gel had set, the comb was removed and the whole gel placed in a 
western blot tank containing running buffer [25 mM Tris, 192 mM Glycine, 3.5 mM 
SDS, (pH8.8)]. Using a gel loading pipette tip, 5 µl of the protein markers 
[Kaleidoscope Prestained Standards (BioRad)] was placed in the first well of each 
gel while the cell protein lysates (30 µg) were added to subsequent wells. After all 
the cell lysates had been added to the gel, it was run at a constant voltage of 120 V 
for 90 min. 
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2.8.3 Immunoblotting 
Following electrophoresis, the proteins on the SDS page gel were electro-transferred 
onto a pre-wet nitrocellulose membrane, which had been pre-soaked in ice-cold 
(4°C) transfer buffer [25 mM Tris, 192 mM Glycine, 20% (v/v) Methanol] for 10 
min, using a wet transfer unit (BioRad) at a constant voltage of 105 V for 80 min. 
Once the transfer was completed, the efficiency of wet transfer was determined by 
observing the bands on the membrane, which had been soaked in Ponceau S solution 
[0.1% (w/v) Ponceau S in 0.05% (v/v) acetic acid] for 2-3 min. The stained 
membranes were either rinsed with Tris-buffered Saline Tween-20 (TBST) [20 mM 
Tris, 138 mM NaCl, 0.05% (v/v) Tween 20, pH 7.6] or water at room temperature 
(RT).  
The nitrocellulose membrane was blocked in Blocking buffer using [2.5% (w/v) 
BSA in TBST] and left on an orbital shaker for 1 h at room temperature. After that, 
the membrane was incubated in a container with 5 ml of 5% (w/v) BSA (in TBST) 
containing the primary antibody [1:1000 phospho-p38 rabbit polyclonal antibody, 
1:1000 phospho-JNK rabbit polyclonal antibody, 1:2000 phospho-ERK rabbit 
polyclonal antibody, 1:1000 furin rabbit polyclonal antibody, 1:1000 TACE (ADAM 
17) rabbit polyclonal antibody or 1:1000 tyrosinase rabbit polyclonal antibody] 
overnight with gentle agitation on a rocker at 4°C. The next day, the membrane was 
washed thrice (10 min / wash) with TBST. After which, it was placed in a container 
containing 5 ml of 2.5% (w/v) BSA (in TBST) containing the secondary antibody 
(1:2000 Goat HRP conjugated anti-Rabbit Ig) and incubated on an orbital rocker for 
1 h at RT. After which the membranes were washed thrice (10 min / wash) with 
TBST at RT. 
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After the final wash, the membrane was exposed to 1 ml Chemilucent solution 
[prepared as per the manufacturer’s instructions] for 5-20 sec (GE Healthcare, 
Brisbane, Australia)]; after which the proteins were detected using a Chemidox XRS 
system (Bio-Rad). The membrane was positioned in the Chemidox XRS unit and 
digital images were taken by CCD high-resolution camera. These images were 
analysed using Bio-Rad’s Quantity One Digital Imaging Software (Version 4.5.1). 
After a blot had been imaged on the Chemidox XRS unit, it was stripped using 
stripping buffer for 15 min at RT. Then the blot was washed thrice with TBST (5 
min/wash) at RT. After the last wash, the blot was blocked with Blocking buffer for 
1 h on the rocker at RT. Then it was washed with TBST, before being incubated in 5 
ml of 2.5% (w/v) BSA (in TBST) containing the GAPDH antibody 1:4000 with 
gentle agitation on a shaker for 1 h at RT. The GAPDH antibody was used as a 
loading control to ensure that an equal amount of cell lysate was loaded into each 
lane.  
 
2.8.4 Quantifying protein expression 
The levels of protein expression on the western blots were calculated using the 
values of pixels for the bands as detected on the images. The pixels for the protein 
and GAPDH bands were first corrected by removing the background values for the 
gel (i.e. the region of the blot which had no visible band was used to correct the 
number or pixels for the protein band of interest). The expression of the protein band 
was corrected for by its corresponding loading control. In the untreated sham-
irradiated controls, this was given the value of unity (1). The change in the level of 
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protein expression due to treatment was expressed as folds of the corresponding 
untreated control sample. 
In the case of JNK-1/2, ERK-1/2 and pTACE/mTACE expression, the fold level of 
both bands were combined when calculating total JNK, ERK or TACE expression. 
The individual contribution of isoforms in the treated cells was then calculated (See 
Appendix 4). 
 
2.9 ELISA 
The levels of TNF-α in the media of treated cells was measured 24 h post UV-
irradiation using a Human TNFα ELISA Kit (BD Biosciences) as per the 
manufacturer’s protocol. Immediately after UV exposure, 1.5 ml of fresh tissue 
culture media was added to the cells in 60 mm petri dish. In some cases, directly 
after UV exposure, 10 ng/ml of IL-1α was also added to the media, as it has been 
shown to stimulate TNFα release from UV-irradiated cells (177, 202). After 24 h, the 
media was placed in a 10 ml centrifuge tube and centrifuged (400 g) for 5 min. 
Aliquots (1 ml) were placed into a 1.5 ml microfuge tube and stored at -80°C until 
assayed, usually within 14 days. The media samples were thawed and were 
concentrated using Microcon YM-10 microconcentrators (10 kDa filter) as per the 
manufacturer‘s protocol. Briefly, 0.5 ml of media was centrifuged (4°C for 30 min at 
10,000 g) and the concentrate placed in a well of a 96 well plate and assayed for 
TNF-α as per the manufacturer’s protocol. 
Prior to the addition of the concentrated media samples, wells in a 96 well plate were 
coated with 100 μl of capture antibody solution and the plate incubated overnight at 
4°C. Then, the plate was washed thrice with Washing Buffer [PBS containing 0.05% 
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(v/v) Tween 20], before the wells were blocked by adding 300 μl of Assay Buffer 
[PBS containing 1% (w/v) BSA] for 60 min at 37°C. Then the wells were washed 
thrice with Washing Buffer. At this stage the plates were ready to be used for the 
ELISA assay. 
To duplicate wells of a prepared 96 well plate, 100 μl of TNF-α standards (0-2000 
pg/ml) were added. At the same time, the microconcentrated samples (as described 
above) were added to duplicate wells and the plate incubated at 37°C for 60 min. 
After which, the wells were washed thrice with Washing Buffer. After this step, the 
Detection Antibody (100 μl) was added to each well and the plate incubated at 37°C 
for 60 min. Next, the plate was washed thrice with Washing Buffer. After which, 100 
μl of pre-diluted Streptavidin-(HRP) was added to each well and the plate placed in 
the dark for 20 min at RT. Then, the plate was washed thrice with Washing Buffer, 
before 100 μl of substrate solution was added to each well. Next, 50 μl of stop 
solution was added to each well and the plate incubated at RT for 30 min. The plates 
were then read at 450 nm within 30 min with λ correction at 570 nm, using the 
FlexStation 3 microplate reader. The levels of TNF-α present in the media were 
determined by comparison to the standard curve. 
 
2.10 Statistical method analysis 
In this project, the GraphPad Prism program (Version 6.0, GraphPad Software,      
La Jolla, USA) was used for statistical analysis. The results of experiments in this 
project were represented as the mean ± the Standard Error of the Mean (SEM) from 
three independent experiments. The statistical significance was calculated by one-
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way ANOVA followed by Bonferroni’s multiple comparisons post-test. The results 
were measured significant if p<0.05. 
In the case of some experiments, which include the measurement of superoxide, 
tyrosinase expression, TACE and furin expression, the results of these experiments 
were represented as the mean ± Standard Deviation (SD) from one-two independent 
experiments. In these experiments, no statistical analysis were performed due to the 
low number of replicates.  
  
73 | P a g e  
 
 
 
 
 
CHAPTER 3 
THE EFFECT OF 
ANTIOXIDANTS ON 
MELANOCYTE-DERIVED 
CELLS 
  
74 | P a g e  
 
 
Chapter 3. The Effect of Antioxidants on Melanocyte-Derived Cells 
3.1 Introduction 
Human skin tissue comprises three main layers; these include (from the outside): the 
epidermis, the dermis, and the hypodermis. In the epidermis, the main cell types are 
keratinocytes and melanocytes (19). About 90-95% of the cells found in the 
epidermis are keratinocytes while the rest consist of melanocytes, Langerhans cells 
and Merkel cells (19). Melanocytes produce melanin, which is the natural pigment in 
the skin (19).  It has been found that vitamin D, which is a hormone that is 
synthesised in the skin post-UVB exposure, also plays a role in skin pigmentation. 
Alghamdi et al. (2013) observed low vitamin D levels in vitiligo and in patients who 
had autoimmune diseases (257). It has been suggested that vitamin D supplements 
may help in preventing damage of melanocytes that can cause vitiligo and 
autoimmune diseases (257). Sunlight emits different types of UV radiation of which 
UVB is involved in the production of vitamin D3 in the skin (130, 196).  
A high dose of UVR is an environmental carcinogen; because it can cause damage to 
the skin and may induce skin cancer (130, 196). Melanocytes can be transformed to 
melanomas, which in general are highly metastatic cancers (258, 259). They can 
metastasise to different organs in the human body, such as the brain, liver and lungs 
(258, 260). UVR is known as the main cause of the development of melanoma; 
however the type of UV, including UVA versus UVB, period of UV exposure, the 
presence of melanocytic nevi, family history of melanoma and hereditary genetic 
mutations, can all contribute to melanoma formation (258, 260). UVR can also 
mediate different immunological and inflammatory reactions by activating receptors, 
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damaging DNA/RNA, as well as producing reactive oxygen species (ROS) (16, 
196). 
The different types of ROS produced in the skin as a result of exposure to UVR 
include superoxide anions, singlet oxygen, hydrogen peroxide and hydroxyl radicals 
(261). These ROS are short-lived molecules which may cause oxidative damage in 
DNA, cellular proteins and lipids (141). This damage can lead to the activation of 
signal transduction pathways and genetic changes which initiate carcinogenesis in 
UV-irradiated skin cells (141). It has been shown that lipid peroxidation products 
and antioxidant enzyme levels are increased in melanomas compared to benign nevi 
(55, 261). In addition to that, it was found that melanoma progression was correlated 
to the dysregulation of oxidative stress in a mouse model (55, 261). These findings 
indicate that oxidative stress/damage induced by UVR can contribute to the 
pathogenesis of melanoma (55, 261), and that antioxidants may be used as 
preventative therapy. Antioxidants have been known to reduce ROS levels in the 
skin that were induced by UVR (248).  
Cotter et al. (2007) showed that exposing the immortalised mouse melanocyte cell 
line (Melan-A) to 960 J/m
2
 UVR increased endogenous peroxide levels by 3–5 fold 
at 48 h post-irradiation, compared to unirradiated cells (261). However, pre-treating 
these cells with 1–10 mM N-acetylcysteine (NAC) significantly reduced the UV-
induced peroxide levels (261). The same UV dose also increased endogenous 
superoxide levels two-fold compared to the unirradiated cells. When the melan-A 
cells were treated with 5–10 mM of NAC, there was a modest and significant 
reduction in superoxide levels (261). 
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Vitamin C and E are considered to be the predominant antioxidants in the skin, 
which neutralize ROS before they cause oxidative stress (248, 249). However, the 
levels of vitamins that reach the skin from nutritional uptake are limited. It has been 
suggested that using topical applications of these vitamins may increase the levels of 
photoprotection in the skin. Indeed, it has been shown that topical application of 
vitamin C and E can decrease both erythema and sunburn cell formation (248, 249). 
In animal and human studies it has been shown that topical vitamin E reduced both 
sunburn and skin damage induced by chronic UVB, as well as photocarcinogenesis 
(248, 249).  
 α-Tocopherol (vitamin E) has been shown to be preventative in different conditions 
of oxidative stress (262). Treatment with α-tocopherol acetate reduced lipid 
peroxidation, oedema and erythema caused by UVB in the skin (262). In cells 
exposed to UVA radiation, α-tocopherol reduced the upregulation of IL-8 mRNA 
and protein expression along with increased the activator protein-1 (AP-1) DNA 
binding activity (262, 263).  
Muthusamy et al. (2011) found that UVB (2 kJ/m
2
) was more cytotoxic in MM96L 
melanoma cells when compared to HEM cells (196). The viability of UVB-irradiated 
MM96L cells was significantly decreased 24 h post-irradiation compared to the 
sham-irradiated controls, while no significant reduction in HEM viability post-UVB 
was observed. When both cells were treated with 0.625 µg/ml of α-tocopherol 24 h 
prior to UVB exposure, no protective effect was seen (196). 
Eberlein-Konig et al. (2005) reported that the topical application of vitamin C 
reduced the levels of free radicals and/or sunburnt cells caused by prolonged sun 
exposure (249). It has been shown that exposure to UVR can reduce vitamin levels 
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in the skin (249). Thus, it has been suggested that the application of topical vitamin 
C would confer protection to skin cells exposed to UVR (249). 
In order to maintain the normal physiologic state of the skin, ascorbic acid scavenges 
most of the ROS, resulting in the oxidation of ascorbate to dehydroascorbate. 
Despite ascorbic acid being commonly used to confer a protection and maintaining 
the physiology of the skin, it hardly penetrates the skin and its instability in 
formulations decreases its clinical ability to confer better efficacy (262, 264). 
Panich et al. (2011) found that ascorbic acid, even at high doses (120 μM), was not 
toxic to G361 human melanoma cells. These researchers found that ascorbic acid 
prevented the UVA-mediated inactivation of catalase, depletion of glutathione, and 
production of nitric acid and oxidant formation through suppression of iNOS  and 
eNOS mRNA. They concluded that UVA-dependent melanomagenesis can be 
protected by ascorbic acid, and may be due to the enhancement of the cell’s 
antioxidant defence capacity and by inhibiting nitric oxide (NO) production (265). 
As described previously, UVR plays a role in the generation of ROS, which can 
cause oxidative stress in the skin. It has been suggested that the use of antioxidants 
can reduce UV-induced ROS in skin cells (248, 249). Also, Masnec et al. (2010) 
suggested that to regulate photocarcinogenesis and photoageing in skin cells, 
adequate levels of antioxidants are essential (248). As such, the aims of this chapter 
are to investigate the effect of selected doses of UVA, UVB and UVAB on cell 
viability and ROS generation (Peroxide and Superoxide levels) in lightly pigmented 
melanoma cells (MM418-C1), darkly pigmented melanoma cells (MM418-C5) and 
human epidermal melanocytes (HEM) at 24 h post-UVR. The melanoma cells were 
chosen as they have differing melanin levels, allowing us to observe if this pigment 
78 | P a g e  
 
 
plays a protective role in reducing the effects of UV radiation on these cells. HEM 
cells were used to investigate if the effects elicited by UVR in primary melanocytes 
differed to that seen in the melanoma cells. Moreover, this study aims to look at the 
protective effect of treating these cells for 24 h before/after UVR with vitamin C and 
trolox. Consequently the effects that these antioxidants have on cell viability and 
ROS generation in UV-irradiated MM418-C1, MM418-C5 and HEM were 
investigated in this study. 
 
3.2 Results 
3.2.1 MTS optimal incubation time  
In order to be able to determine the effect of UV radiation on cell viability, the 
optimal incubation time of MTS with the cultured cells needed first to be undertaken. 
MTS measures mitochondrial activity which involves the reduction of tetrazolium 
compounds to a coloured formazan product, which can be read 
spectrophotometrically, which correlates to the number of viable cells. The 
absorbance reflects the number of metabolically active cells in the well. 
MM418-C1, MM418-C5 and HEM cell cultures were seeded (5 x 10
4
) in 24 well 
plates and incubated in a humidified atmosphere (37°C and 5% CO2) until they 
reached 80% confluency (see section 2.2.2). Then 60 µl of MTS reagent was added 
to 300 µl of fresh tissue culture media in each well and incubated at different time 
points over 4 h. The absorbance was read at 490 nm. A blank (cell-free) well was 
used to record the background and was used to correct the absorbance levels. The 
time course of the reduction of MTS by MM418-C1, MM418-C5 and HEM cells can 
be seen in Figure 3.1.  
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(B) 
 
(C) 
 
Figure ‎3.1 Time course of MTS reduction by MM418-C1, MM418-C5 and HEM cells 
MTS was added to cultures of (A) MM418-C1, (B) MM418-C5 and (C) HEM cells for different times over 4 h. 
Results represent the mean±SEM of three replicates that were performed in triplicate. 
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3.2.2 Effect of UVA on cell viability 
As the majority component (95%) of sunlight is UVA, the cells were exposed to 
different doses of UVA and/or UVB radiation in the ratio of 20:1 (251). Hence 
MM418-C1 and MM418-C5 cells were exposed to different doses of UVA (up to 2 
J/cm² for MM418-C1 and 1.2 J/cm² for MM418-C5) as seen in Figure 3.2. These 
UVA doses did not have a significant cytotoxic effect on these cells. The viability of 
MM418-C1 cells fell from 100% (control) to 89% at 2 J/cm
2
 UVA exposure. UVA 
at 1.2 J/cm
2
 did not cause any loss of viability in MM418-C5 cells when compared 
to the unirradiated controls.  
(A) 
 
(B) 
 
 
Figure ‎3.2 Effect of UVA irradiation on MM418-C1 and MM418-C5 cell viability 
The viability of (A) MM418-C1 and (B) MM418-C5 cells at 24 h post-exposure to different doses of UVA was 
determined using the MTS assay and expressed as a % of that of the unirradiated controls which were given the 
value of 100%. Results represent the mean±SEM from triplicates of three separate experiments. 
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3.2.3 Effect of UVB on cell viability 
The cytotoxic effect of UVB radiation is considerably greater than that for the same 
UVA dose (251), therefore the cells were exposed to different doses of UVB 
radiation in order to obtain a dose that caused 50% cell death at 24 h post-irradiation. 
HEM, MM418-C1 and MM418-C5 cells were exposed to a range of UVB doses and 
the cell viability determined using the MTS assay at 24 h post-irradiation.  
In Figure 3.3 it can be seen that increasing doses of UVB radiation were cytotoxic in 
the three cell types. In MM418-C1 cells a dose of 0.04 J/cm
2 
UVB caused a 50% loss 
of cell viability at 24 h-post exposure. In the more darkly pigmented MM418-C5 cell 
line, only 0.03 J/cm
2 
UVB was required to cause a 50% drop in cell viability 24 h-
post irradiation. HEM cells on the other hand, were less affected by exposure to 
UVB radiation than the two melanoma cell lines with 0.16 J/cm
2 
UVB required to 
cause approximately 50% loss of cell viability 24 h-post irradiation. In all 
subsequent experiments, the cells were exposed to this dose of UVB radiation. As 
sunlight contains both UVA and UVB light in the ratio of approximately 20:1 (251), 
the cells were also exposed to both UVA and UVB radiation in this same ratio, as 
seen in Section 3.2.4. 
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Figure ‎3.3 Effect of UVB  irradiation on  MM418-C1, MM418-C5 and HEM cell viability 
The viability of (A) MM418-C1, (B) MM418-C5 and (C) HEM cells at 24 h post-exposure to different doses of 
UVB was determined using the MTS assay and expressed as a % of that of the unirradiated controls which were 
given the value of 100%. Results represent the mean±SEM from triplicates of three separate experiments. 
Statistical significance from sham was calculated by one-way ANOVA followed by Bonferroni’s multiple 
comparisons post-test. **p ≤ 0.01; ***p ≤ 0.001 
 
 
3.2.4 Effect of UVAB on cell viability 
The UV component of sunlight consists of 90-95% UVA and 5-10% UVB, thus the 
cells were exposed to UVA and UVB radiation at a ratio of 20:1 (251). The UVB 
dose was that determined in Section 3.2.3 for each cell line. The corresponding UVA 
dose was 20x that of the UVB dose. In the experiments when the cells were exposed 
to both UVA and UVB radiation, they were exposed to UVA prior to UVB, and for 
simplicity we have termed this as UVAB radiation. These cells were exposed to 
UVAB radiation and the viability determined 24 h post-exposure using the MTS 
assay. Due to the limited availability of HEM cells these were not exposed to UVAB 
radiation.  
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Increasing doses of UVAB radiation were shown to be cytotoxic on both melanoma 
cell lines (Figure 3.4). However no significant difference was observed in the effect 
of these doses when compared to the cytotoxic effect elicited by UVB alone (Figure 
3.3). A dose of 0.8 J/cm
2
 UVA + 0.04 J/cm
2 
UVB was shown to cause 52% of cell 
death in MM418-C1 cells. Similarly, a dose of 0.06 J/cm
2
 UVA+ 0.03 J/cm
2 
UVB 
caused 52% cell death in MM418-C5 cells. These doses were similar to that seen for 
MM418-C1 and MM418-C5 cells where 0.04 J/cm
2 
and 0.03 J/cm
2 
UVB, 
respectively caused approximately 50% cell death. The UV doses used in all 
subsequent experiments for the different melanocyte-derived cell lines are 
summarised in Table 3.1. 
 
Table ‎3.1 Types and doses of UVAB, based on 50% cytotoxicity by UVB, that were tested 
 Dose (J/cm
2
) 
Cell line UVA UVB UVAB 
MM418-C1 0.8 0.04 0.8+0.04 
MM418-C5 0.6 0.03 0.6+0.03 
HEM 3.2 0.16 3.2+0.16 
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(A) 
 
(B) 
 
 
Figure ‎3.4 Effect of UVAB irradiation on MM418-C1 and MM418-C5 cell viability 
The viability of (A) MM418-C1 and (B) MM418-C5 cells at 24 h post-exposure to different doses of UVAB was 
determined using the MTS assay and expressed as a % of that of the unirradiated controls which were given the 
value of 100%. Results represent the mean±SEM from triplicates of three separate experiments. Statistical 
significance from sham was calculated by one-way ANOVA followed by Bonferroni’s multiple comparisons 
post-test. *p ≤ 0.01; ***p ≤ 0.001  
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3.2.5 Effect of vitamin C on cell viability 
The effect of different concentrations of vitamin C (ascorbic acid) on the viability of 
MM418-C1 and MM418-C5 cells at 24 h post-exposure was tested using the MTS 
assay. Vitamin C concentrations ranging from 0.01–5 mM were added to the cells 
and after 24 h the cell viability was measured as seen in Figure 3.5.  
Vitamin C was shown to be relatively non-toxic at doses between 0.01–1 mM in 
both cell lines, however when added at doses >1 mM it caused significant cell death. 
Therefore, 1 mM vitamin C was chosen as the dose to test the effect of this 
antioxidant in the studies described in this thesis. 
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(A) 
 
(B) 
 
 
Figure ‎3.5 Effect of vitamin C  on  MM418-C1 and MM418-C5 cell viability 
The viability of (A) MM418-C1 and (B) MM418-C5 cells treated with vitamin C (0–5 mM) for 24 h was 
determined using the MTS assay and expressed as a % of that of the unirradiated controls which were given the 
value of 100%. Results represent the mean±SEM from triplicates of three separate experiments. Statistical 
significance from sham was calculated by one-way ANOVA followed by Bonferroni’s multiple comparisons 
post-test. ***p ≤ 0.001  
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3.2.6 Effect of DMSO on the viability of UV-irradiated cells 
As vitamin E is poorly soluble in aqueous solution, I used its more aqueous analog 
form trolox to measure the effect of this vitamin’s antioxidant properties. As trolox 
is partially soluble in an aqueous solution, it was necessary to solubilize it in 
dimethyl sulfoxide (DMSO) in order to obtain millimolar concentrations. Therefore, 
it was important to determine what volume of this solvent (DMSO) could be added 
to the cells that was not cytotoxic. The effect of 24 h exposure to DMSO on the 
viability of UV-irradiated MM418-C1 and MM418-C5 cells was determined, as 
shown in Figure 3.6. 
It can be seen that at concentration of 0.2% (v/v) or higher DMSO was increasingly 
cytotoxic on MM418-C1 exposed to UVB or UVAB radiation; however it did not 
affect the viability of irradiated MM418-C5 cells. In UVA-irradiated MM418-C1 
cells, DMSO at 0.5% (v/v) significantly decreased cell viability; however it did not 
affect the viability of UVA-irradiated MM418-C5 cells.   
Overall, 0.1% (v/v) DMSO was shown to cause negligible cytotoxic effects, while at 
higher concentrations there was a small amount of cell death irrespective of whether 
the cells had been exposed to UV radiation. Therefore, trolox was dissolved in 
DMSO, such that the final incubation volume of the carrier solvent used in all 
experiments was 0.1% (v/v).  
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Figure ‎3.6 Effect of DMSO  on the viability of UV-irradiated  MM418-C1 and MM418-C5 cells 
The effect of DMSO (0-0.5% v/v) on the viability of UV-irradiated (A) MM418-C1 and (B) MM418-C5 cells 
was examined. The cells were exposed to UVA and/or UVB radiation as described in Table 3.1. Cell viability 
was determined 24 h post-UV exposure using the MTS assay. Results represent the mean±SEM from samples of 
three separate experiments. Statistical significance was calculated by one-way ANOVA followed by Bonferroni’s 
multiple comparisons post-test. Significant difference between sham and UVR is represented by (*). Significant 
difference between different DMSO concentrations in UVA-irradiated MM418-C1 is represented by (£), while in 
UVB-irradiated MM418-C1 it is represented by (#), and in UVAB-irradiated MM418-C1 cells it is represented 
by ($). ££ p ≤ 0.01, ***, ###, $$$ p ≤ 0.001  
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3.2.7 Effect of trolox on cell viability 
In section 3.2.6, it was shown that 0.1% (v/v) DMSO was tolerated by the cells. 
Therefore, trolox was suspended in DMSO at 100x final concentration and diluted in 
tissue culture media. The final concentration of DMSO in all incubations tested was 
0.1% (v/v). The effect of 24 h exposure to different concentrations of trolox           
(0–1 mM) on the viability of MM418-C1 and MM418-C5 cells was examined as 
seen in Figure 3.7. Trolox was shown to be well tolerated by the cells at 
concentrations below 0.1 mM, but at 1 mM it was shown to be cytotoxic. Therefore, 
0.1 mM trolox was used as the dose to test the effect of this antioxidant in all 
subsequent experiments outlined in this thesis. 
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               Trolox (mM) 
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            Trolox (mM) 
 
Figure ‎3.7 Effect of trolox  on  MM418-C1 and MM418-C5 cell viability 
The viability of (A) MM418-C1 and (B) MM418-C5 cells treated with trolox (0–1 mM) for 24 h was determined 
using the MTS assay and expressed as a % of that of the untreated controls which were given the value of 100%. 
Results represent the mean±SEM from triplicates of three separate experiments. Statistical significance from 
sham was calculated by one-way ANOVA followed by Bonferroni’s multiple comparisons post-test.              
***p ≤ 0.001  
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3.2.8 Effect of antioxidants on the viability of UV-irradiated cells 
The effect of the antioxidants Vitamin C and trolox on the viability of UV-irradiated 
(UVA, UVB and UVAB) melanocyte-derived (MM418-C1, MM418-C5 and HEM) 
cells at 24 h post-exposure was measured using the MTS assay (Section 2.4.1). The 
cells were treated with these antioxidants for 24 h before and after UV exposure. The 
aim of this experiment was to determine if these antioxidant vitamins conferred 
protective effect on the viability of these irradiated cells. Cells were treated with 
vitamin C (1 mM), trolox (0.1 mM) and DMSO (0.1% as the vehicle control for 
trolox treatment) and exposed to selected doses of UVA and/or UVB radiation (See 
Table 3.1). 
The effects of the antioxidants on the viability of UV-irradiated MM418-C1 cells are 
seen in Figure 3.8A. In the sham-irradiated controls, the addition of vitamin C, trolox 
and DMSO had no significant effect on cell viability. It was noted that trolox caused 
a slight increase in cell viability however this effect was not significant.  
While there was a slight decrease (8%) in the viability of the cells exposed to UVA 
radiation (0.8 J/cm
2
) neither vitamin C nor trolox had an effect on these cells. When 
the MM418-C1 cells were exposed to UVB, cell viability fell 52%, and by 48% 
following exposure to UVAB. In the UVB-irradiated  MM418-C1 cells, only vitamin 
C was shown to significantly enhance cell viability (14%), but trolox did not have a 
protective effect. While in the UVAB-irradiated MM418-C1 cells, neither vitamin C 
nor trolox had a significant protective effect.   
The effects of the antioxidants on the viability of UV-irradiated MM418-C5 
melanoma cells are seen in Figure 3.8B. In the sham-irradiated controls, the addition 
of vitamin C, trolox and DMSO had no significant effect on cell viability.  
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Figure ‎3.8 Effect of antioxidants on the viability of UV-irradiated MM418-C1, MM418-C5 and HEM cells 
The effect of vitamin C, DMSO and  trolox on the viability of UV-irradiated (UVA and/or UVB) (A)      
MM418-C1, (B) MM418-C5 and (C) HEM cells were measured 24 h post-exposure using the MTS assay. 
Results represent the mean±SEM from triplicate samples of three separate experiments. Statistical significance 
was calculated by one-way ANOVA followed by Bonferroni’s multiple comparisons post-test. Significant 
difference between sham and UVR is represented by (*). Significant difference between untreated and 
antioxidants in the UVB-irradiated cells is represented by (#).*,#p ≤ 0.05; ***p ≤ 0.001 
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Whereas there was a slight decrease in the viability of the cells exposed to UVA 
radiation, neither vitamin C nor trolox had an effect. When the cells were exposed to 
UVB radiation, cell viability fell 53% which was similar to that caused by UVAB 
exposure (54%). In the UVB and UVAB-irradiated MM418-C5 cells, neither 
vitamin C nor trolox conferred a protective effect on cell viability.   
The effects of the antioxidants on the viability of UV-irradiated human epidermal 
melanocytes (HEM) are seen in Figure 3.8C. In the sham-irradiated controls, vitamin 
C and DMSO had no effect on cell viability, while trolox elicited a slight protective 
effect.  
UVA radiation had no effect on HEM cell viability. Vitamin C had no effect on these 
cells. Trolox had a slight protective effect in the UVA-irradiated cells but this was 
not significantly different from the UVA-only or trolox-only values. 
When the HEM cells were exposed to either UVB or UVAB radiation, there was a 
52% loss of cell viability. Both vitamin C and trolox appeared to confer a small 
protective effect on these UV-irradiated cells. 
 
3.2.9 Effect of 60 min antioxidant pre-treatment on the viability of UV-
irradiated MM418-C1 cells 
In order to determine whether the period of antioxidant treatment used in these 
experiments were too long, the effect of a shorter exposure period of 60 min (1 h) 
was tested with respect to the viability of the most antioxidant responsive     
MM418-C1 cells exposed to UVR. In this experiment, MM418-C1 cell viability was 
measured at 24 h post-UV radiation using the MTS assay, in cells pre-exposed to 
antioxidants for either 1 or 24 h prior to exposure to UVR.  
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The effect of pre-treating the cells with the antioxidants for 1 h prior to UV exposure 
is seen in Figure 3.9A. In the sham-irradiated controls, the addition of vitamin C, 
trolox and DMSO had no significant effect on cell viability. When these cells were 
exposed to either UVA, UVB or UVAB radiation, 1 h pre-treatment with vitamin C 
or trolox did not confer any protective effect to the viability of these cells. 
The effects of prolonged treatment (24 h) with the antioxidants on the viability of 
UV-irradiated MM418-C1 cells are seen in Figure 3.9B. In the sham-irradiated 
controls, vitamin C, trolox and DMSO had no significant effect on cell viability. 
When the cells were exposed to either UVA or UVAB radiation, 24 h pre-treatment 
with vitamin C or trolox did not confer protection to these cells. In the UVB-
irradiated cells, only vitamin C given to the cells 24 h prior irradiation increased cell 
viability (14%); while trolox did not confer any protective effect. 
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Figure ‎3.9 Effect of antioxidant pre-treatment times on the viability of UV-irradiated MM418-C1 cells 
Vitamin C, DMSO and trolox were added to MM418-C1 cells for either (A) 1 h or (B) 24 h prior to exposure to 
UV (A and/or B) radiation. Cell viability was measured 24 h post-irradiation using the MTS assay. Results 
represent the mean±SEM from samples for three separate experiments. Statistical significance was calculated by 
one-way ANOVA followed by Bonferroni’s multiple comparisons post-test. Significant difference between sham 
and UVR is represented by (*). Significant difference between untreated and antioxidants in the UVB-irradiated 
cells is represented by (#). #p ≤ 0.05; ***p ≤ 0.001 
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3.2.10 Effect of antioxidants on peroxide levels in UV-irradiated cells 
Intracellular ROS levels specifically that of peroxides (O2
2-
), were quantified using 
DCFDA by flow cytometry (See Section 2.7).  The cells were treated with the 
antioxidants 24 h before and/or after being exposed to UV radiation (UVA and/or 
UVB). The antioxidants were then re-added to the cells and cellular peroxide levels 
measured 24 h post-irradiation. The cellular levels of peroxide were expressed as a 
percentage of that seen in the untreated sham-irradiated cells, which were given a 
value of 100%. 
In MM418-C1 cells treatment with vitamin C, DMSO and trolox had no effect on the 
peroxide levels in the sham-irradiated cells (Figure 3.10A). UVA radiation alone 
caused a non-significant 1.75-fold increase in peroxide levels in these cells. 
However, treatment with the antioxidants (vitamin C and trolox) had no effect on the 
peroxide levels in these irradiated cells. When the cells were exposed to UVB 
radiation, there was a significant 3.70-fold increase in peroxide levels compared to 
the sham-irradiated controls. Pre-treatment with the antioxidants caused a slight 
decrease in cellular peroxide levels but these were not statistically significant. 
UVAB radiation also significantly increased peroxide levels by 5.29-fold in these 
cells compared to sham-irradiated controls. As with that seen for the UVB-irradiated 
cells, pre-treatment with the antioxidants caused a slight decrease in peroxide levels 
but these were not statistically significant.  
In the MM418-C5 cells, treatment with vitamin C and trolox on the sham-irradiated 
cells had no effect on cellular peroxide levels (Figure 3.10B). 
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Figure ‎3.10 Effect of antioxidants on peroxide levels in UV-irradiated MM418-C1, MM418-C5 and HEM 
cells 
The effect of vitamin C, DMSO and trolox on the peroxide levels of UV-irradiated (UVA and/or UVB) (A) 
MM418-C1, (B) MM418-C5 and (C) HEM cells were measured 24 h post-exposure. Results represent the 
mean±SEM from triplicate samples for three separate experiments. Statistical significance from sham was 
calculated by one-way ANOVA followed by Bonferroni’s multiple comparisons post-test. **p ≤ 0.01,           
***p ≤ 0.001   
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UVA radiation alone increased peroxide levels by 1.20-fold in the MM418-C5 cells. 
This increase was not significant. However, the addition of the antioxidants had no 
effect on these peroxide levels. When the cells were exposed to UVB radiation, there 
was a significant increase (2.13-fold) in peroxide levels in these cells compared to 
the sham-irradiated controls. Treatment of the UVB-irradiated cells with antioxidants 
slightly increased cellular peroxide levels but this was not statistically significant. 
UVAB radiation significantly increased (2.62-fold) peroxide levels in the MM418-
C5 cells compared to the sham-irradiated controls. Antioxidant treatment (vitamin C 
and trolox) had no effect on the peroxide levels in these irradiated cells. 
In the HEM cells, treatment with vitamin C, DMSO and trolox on the sham-
irradiated cells had no effect on cellular peroxide levels (Figure 3.10C). Exposure to 
UVA radiation slightly increased peroxide levels in these cells, however, this 
increase was not significant.  However, the addition of the antioxidants had no effect 
on these levels. When the cells were exposed to UVB radiation there was a 
significant increase (3.72-fold) in cellular peroxide levels compared to sham-
irradiated controls. Treatment of these irradiated cells with the antioxidants caused a 
slight decrease in peroxide levels in these cells. UVAB radiation also significantly 
increased (4.01-fold) peroxide levels in these cells when compared to sham-
irradiated controls. In agreement to that seen for UVB-irradiated cells, pre-treatment 
with the antioxidant slightly decreased the peroxide levels in these cells but this was 
not statistically significant. 
Overall, it can be seen that pre-treatment with antioxidants did not cause any 
significant reduction in peroxide levels after these cells (MM418-C1, MM418-C5 
and HEM) were exposed to UVR.  
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3.2.11 Effect of antioxidants on superoxide levels in UV-irradiated cells 
Intracellular superoxide levels were measured on MM418-C1, MM418-C5 and HEM 
cells treated with antioxidants 24 h before and after exposure to UVR. Immediately 
post-irradiation, the antioxidants were added to the cells and after 24 h the 
superoxide levels were measured using MitSOX Red mitochondrial superoxide 
indicator by flow cytometry. The cellular levels of superoxide were expressed as a 
percentage of that seen in the untreated sham-irradiated cells, which were given a 
value of 100%. 
In the MM418-C1 cells, vitamin C, DMSO and trolox had no effect on the 
superoxide levels in the sham-irradiated cells (Figure 3.11A). UVA radiation did not 
change the superoxide levels in these cells. Treatment with vitamin C caused a slight 
decrease in superoxide levels but increasing number of experiments is needed to do 
statistical analysis for these results; unlike that of DMSO and trolox which had no 
effect. When the cells were exposed to UVB or UVAB radiation, there were no 
changes in the superoxide levels in these cells compared to that seen in the sham-
irradiated controls. Treatment with vitamin C caused a slight decrease in superoxide 
levels, while trolox had no effect. 
In the MM418-C5 cells, treatment with vitamin C, DMSO and trolox had no effect 
on the mitochondrial superoxide levels in the sham-irradiated cells (Figure 3.11B). 
UVA radiation had no effect on the mitochondrial superoxide levels. Antioxidant 
treatment had no effect on the superoxide levels in the UVA-irradiated cells. When 
the cells were exposed to UVB or UVAB radiation, there was a slight increase in 
mitochondrial superoxide levels, but these were not significant. Treatment of either 
of these irradiated cells with vitamin C caused a slight decrease in the superoxide 
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levels, but these were not significant. Trolox treatment had no effect on the 
mitochondrial superoxide levels in either of these irradiated melanoma cells. 
(A) 
 
(B) 
 
(C) 
 
 
Figure ‎3.11 Effect of antioxidants on superoxide levels in UV-irradiated MM418-C1, MM418-C5 and HEM 
cells 
The effect of vitamin C, DMSO and trolox on the superoxide levels of UV-irradiated (UVA and/or UVB) (A) 
MM418-C1, (B) MM418-C5 and (C) HEM cells were measured 24 h post-exposure. Results represent the 
mean±SEM from triplicate samples for two separate experiments. 
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When vitamin C was added to the sham-irradiated HEM cells, a slight increase in 
superoxide levels was observed. Treating the cells with DMSO and trolox had no 
effect on these levels (Figure 3.11C). 
Exposure to UVA radiation had no effect on the mitochondrial superoxide levels. 
Vitamin C slightly increased superoxide levels in these irradiated cells, while trolox 
treatment had no effect. When the cells were exposed to UVB and UVAB radiation, 
no changes of mitochondrial superoxide levels were observed. Vitamin C treatment 
slightly increased superoxide levels in these irradiated cells, while trolox had no 
effect.  
Overall, it can be seen that UVR radiation did not affect mitochondrial superoxide 
levels in these cells. In addition, treatment with any of the antioxidants did not 
significantly reduce superoxide levels after these cells (MM418-C1, MM418-C5 and 
HEM) were exposed to UVR. 
 
3.3 Discussion 
Sunlight plays a role in the ROS formation in the skin (132, 266), which has been 
known to be a major player in the development of skin cancers (132, 266). 
Moreover, exposing the skin to UVA and/or UVB radiation that are emitted by 
sunlight can induce ROS production, as well as impairing the natural defences of 
antioxidants in the skin. Also, while there are many etiological factors that can cause 
melanomagenesis, acute exposure of UVR is one of the main factors involved in this 
process (132). 
In this study, MM418-C1, MM418-C5 and HEM cells were exposed to different 
doses of UVB in order to find a dose which caused ~50% cell death (Figure 3.3). 
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These doses were chosen to study the effect of antioxidants on UV-irradiated cells 
for one important reason – if cell killing was less than 50%, then the effects elicited 
by the antioxidants on UV-irradiated cells may have been too small to detect a 
difference, while on the other hand, killing more than 50% of cells may have resulted 
in insufficient cells left alive to adequately measure the antioxidant effect. In order to 
obtain the UV doses used in this study, both melanoma cell lines were exposed to a 
wide range of UVA and UVAB doses to obtain a dose-response profile on cell 
viability (Figures 3.2 & 3.4). According to a study carried out by Samanek et al. 
(2006), 10 min of solar UV exposure in the city of Melbourne (Australia) at midday 
on a summer’s day (January) causes 1 MED on the skin of a person with type II skin 
(252). As such, the doses selected in this project equates to 8 min of solar UV 
exposure for melanocytes. 
Both MM418-C1 and MM418-C5 cells were shown to be more sensitive to UVB 
radiation than were HEM cells. Of particular interest was the observation that the 
lightly pigmented MM418-C1 cells had a similar sensitivity to UVR than did the 
darkly pigmented MM418-C5 cells. Muthusamy et al. (2011) found that UVB 
radiation was more cytotoxic on MM96L melanoma cells compared to HEM. They 
suggested that the MM96L cells either had lower melanin content or a less efficient 
repair mechanism for damaged DNA than did the HEM cells (196). 
Melanin is believed to confer a photoprotective effect to the human skin, however it 
can also exhibit phototoxic properties (265, 267). It has been assumed UV-induced 
melanin overproduction can be biologically harmful and may be involved in the 
initiation of melanoma (265, 267). 
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Jenkins et al. (2013) found that melanin in the skin generated different responses to 
UV radiation. It has a protective role in melanocytes and keratinocytes via absorbing 
UV radiation. However, the synthesis of melanin by melanocytes when exposed to 
UVR enhanced the production of intracellular ROS, which may in turn play a role in 
melanoma formation (116). 
Kvam et al. (2003) investigated membrane damage in the melanocytes of both 
pigmented and unpigmented albino mice post UVA-radiation. This UVA-induced 
damage has been shown to initiate melanoma (267). Also, they found that pigmented 
cells were less susceptible to UVA-induced membrane permeability and 
peroxidation compared to that seen in the unpigmented albino mice (267).  
De Leeuw et al. (2001) examined the effect of different levels of melanin in 
melanocytes exposed to UVA and UVB radiation. A higher melanin level was 
shown to confer a greater protection to those cells exposed to UVB, while no 
differences were observed in cells exposed to UVA radiation (268). While the effect 
of UVA on the cell lines tested had no effect on cell viability, there were differences 
in the effect elicited by UVB exposure.  
In this study, we have shown that MM418-C5 cells have more melanin than do 
MM418-C1 cells (Chapter 4). Despite having more melanin, MM418-C5 were more 
sensitive to UVB radiation than were MM418-C1 cells. This is in contrast with De 
Leeuw et al.’s (2001) study, which showed that higher levels of melanin conferred 
better protection from UVB than lower levels of melanin (268). However, as many 
studies have suggested (116, 265, 267, 269), higher doses of UVB can be more 
cytotoxic in the presence of melanin due to its double-edged effect as being photo-
protective or phototoxic post-UV exposure. On the other hand, similar to                
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De Leeuw et al.’s (2001) study, our results showed that UVA at the doses tested did 
not have a significant effect on cell viability in MM418-C1, MM418-C5 and HEM 
cells compared to that elicited by UVB radiation (Figures 3.2, 3.3 & 3.4). The results 
from the present study suggest that higher levels of melanin have photo-toxic 
properties post exposure to high doses of UVB or UVAB.  
Antioxidants in the skin, including vitamins C and E, play a vital role in the 
protection of epidermal cells from the deleterious effect of UVR (240). Vitamin C 
protects the aqueous environment, while vitamin E confers protection to the 
membranes (240). 
Doses of vitamin C up to 1 mM were shown to be well tolerated in the sham-
irradiated melanocytes and melanoma cells (Figure 3.5). However at higher 
concentrations (2–5 mM) it was shown to be cytotoxic to both melanoma cell lines, 
with MM418-C1 being more sensitive than MM418-C5 cells. 
In addition to vitamin C, the cytotoxic effect of the water soluble form of vitamin E 
(trolox) was also tested. DMSO was used as a solvent vehicle for trolox in this study 
and, as such, its effect on cell viability was also determined. In the sham-irradiated 
cells, DMSO doses as high as 0.5% (v/v) were reasonably well tolerated, however 
when applied to UV-irradiated MM418-C1 cells, a significant decrease in cell 
viability was observed (Figure 3.6). This was not observed in MM418-C5 cells 
(Figure 3.6). Therefore, a dose of 0.1% (v/v) DMSO was used in all experiments as 
it was shown to be nontoxic at this concentration. Similar to that seen for vitamin C, 
trolox at low doses was not cytotoxic, while at higher doses (1 mM) it was shown to 
cause significant levels of cell death (Figure 3.7). As with that seen for vitamin C, 
trolox was more cytotoxic against MM418-C1 cells and this could relate to the lower 
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melanin levels within these cells. Further experiments would need to be performed to 
confirm if melanin itself confers protection against very high levels of antioxidants 
in these pigmented cells.  
In this study, neither vitamin C (1 mM) nor trolox (0.1 mM) treatment had any effect 
on the viability of UV-irradiated MM418-C1, MM418-C5 and HEM cells. In the 
MM418-C1 cells, vitamin C significantly increased the viability of the cells post-
UVB exposure, while trolox had no effect on these cells. Moreover, none of the 
antioxidants conferred a protective effect to MM418-C5 cells post-UVB and-UVAB 
exposure. In the HEM cells, both antioxidants caused a slight increase in cell 
viability post-UVB and-UVAB exposure but these were not significant (Figure 3.8). 
Vitamin E   has  eight  naturally  occurring  compounds  of  which  α-tocopherol is 
the most abundant form and has the highest biological activity (243). It confers a 
protection to the lipophilic cellular structures from the damage caused by oxygen 
free radicals. However, some studies have shown α-tocopherol’s cellular functions 
are independent of its antioxidant/radical scavenging ability (243, 270). These have 
suggested that trolox may have less of an effect on cell viability or free radicals 
generated from high doses of UVR. 
Peus et al. (2000) found that pre-treating keratinocytes for 24 h with 20 μg/ml of 
trolox enhanced the survival of cells exposed to 0.4 kJ/m
2 
of UVB (128). They also 
found that the protective effect of this form of vitamin E on keratinocytes was 
reduced by increasing the pre-treatment time before UVB exposure (128). The 
results of this study may help explain why the 1 h pre-treatment did not enhance the 
viability of the UV-irradiated MM418-C1 cells (Figure 3.9). Muthusamy et al. 
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(2011) found that pre-treating melanocytes and MM96L for 24 h with α-tocopherol 
(0.625 μg/ml) did not confer protection to these cells from UVB radiation (196). 
Thus, these findings together suggest that these antioxidants do not directly protect 
these cells from the cytotoxic effects of high UVR doses. The effect of pre-
incubation of the antioxidants on cell survival post-UV should be examined to 
determine the optimal time and dose which confers maximal protection to the 
irradiated cells. 
It has been found that, UVB exposure can generate ROS, which can cause 
carcinogenesis through DNA damage and activation of cytokines (243).  It has been 
suggested that antioxidants may play a role in reducing the oxidative damage caused 
by UVB that may lead to the induction of skin cancer in mice (243). 
UV irradiation has been shown to induce ROS formation in the skin including 
hydrogen peroxide, superoxide, hydroxyl radicals and singlet oxygen (261, 271). 
Redmond et al. (2014) studied the direct effects of UVA on human fibroblasts, 
keratinocytes and melanocytes, and found that toxicity was lower in the pigmented 
melanocytes compared to the other cells (272). In agreement with cell viability 
findings, UVA (10 J/cm
2
) generated less ROS in melanocytes compared with other 
cell types – and this may be due to the presence of melanin. Redmond et al. (2014) 
suggested that melanin conferred protection against UVA irradiation by its ability to 
absorb these UV photons (272). 
In this study, the selected UVA doses did not increase peroxide levels in UV-
irradiated melanocyte and melanoma cells, which is in contrast with the study by 
Redmond et al. (2014). The difference observed in the results may be due to UVA 
doses and cell lines used in this study. In my study, the UVA doses were about       
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3–10-fold lower than those used in the study by Redmond et al. (272). Furthermore, 
both of the antioxidants used in this study had no effect on peroxide levels. 
However, UVB and UVAB significantly induced peroxide levels in these cells, with 
the lowest increase in peroxide levels being observed in MM418-C5 cells, which 
suggests that melanin may prevent or maintain the formation of these ROS (Figure 
3.10). 
Peus et al. (2000) observed that trolox inhibited H2O2 levels in UVB-irradiated 
keratinocytes in a concentration-dependent manner. This reduction of H2O2 levels by 
trolox led to modulated phosphorylation levels of EGFR, ERK and p38 in these 
irradiated cells (128). However, in the irradiated melanocyte-derived cells these 
antioxidants did not have a modulatory effect on ROS production. Thus, in 
comparison with previous studies, my findings suggest that prolonged of pre-
treatment with antioxidants (ascorbic acid and trolox) may confer a photo-protective 
effect, as it may help in quenching the generated peroxide levels generated as a result 
of UV exposure. 
Cotter et al. (2007) showed that different concentrations of the antioxidant NAC   
(1–10mM) decreased peroxide levels generated in UV-irradiated mouse primary 
melanocytes. While, there was an increase in superoxide levels at 24 h post-UV 
exposure, the authors found that the protective effect of NAC on peroxide levels was 
greater (261). They suggested that there may be a direct interaction between the UV 
and melanin, which induces superoxide formation but this is not modulated by 
cellular GSH levels (261, 273). In this study, cellular GSH levels were not examined, 
however in future studies a study of the protective effect of GSH antioxidants is 
recommended. 
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It was shown that when endogenous sensitizers absorb UV light, and in that process 
become excited, they can generate ROS. These ROS can interact with DNA, 
proteins, and fatty acids causing oxidative damage (7, 274). Tada et al. (2010) 
showed that melanin has an ability to scavenge ROS, especially O2
•−
 and 
1
O2 (275). 
Melanin also has a photoprotective effect, with two proposed underlying 
mechanisms as follows: (i) an efficient UV filter, and (ii) as a scavenger of ROS (7). 
In addition, the interaction between melanin and the superoxide anion (O2
•−
) has 
been suggested to be involved in the pivotal photoprotective mechanism of this 
cellular pigment (276, 277). As this study confirmed, melanin has a scavenging or 
quenching activity against O2
•−
 and 
1
O2 (275). In contrast to its photoprotective 
function, it was recently reported that melanin – especially pheomelanin – also acts 
as a potent UVB photosensitizer that generates ROS upon UV irradiation (110). 
Thus, it has been suggested that melanin sometimes behaves like a double-edged 
sword and can be either beneficial or deleterious  (278). 
The results observed in this study suggest that the doses of UVA, UVB and UVAB 
used are not directly involved in the production of superoxide in MM418-C1, 
MM418-C5 and HEM cells (Figure 3.11). These results are in agreement with Cotter 
et al. (2007) who showed that in melanocytes, UVR generated more peroxide levels 
than superoxide levels in melanocytes (261). 
Vitamin C was shown to only confer protection on the viability of less-pigmented      
MM418-C1 cells post-UVB exposure, but not in MM418-C5 and HEM cells. Trolox 
had no protective effect on any of the cell lines tested. Moreover, UVB and UVAB 
significantly increased the peroxide levels in all cells, with the highest levels 
observed in MM418-C1 cells and the lowest in MM418-C5 cells. This suggests that 
UVB can generate peroxide in melanocytes and melanoma cells. Furthermore, 
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melanin can maintain and reduce peroxide levels in these cells following exposure to 
UVB and UVAB radiation. However, as no significant changes were detected with 
antioxidant treatment, this suggests that either the sampling times or doses used were 
insufficient to quench the peroxide levels generated by UV exposure. These findings 
also suggest that the protective effect of vitamin C in UVB-irradiated MM418-C1 
cells was not from its scavenging effect on ROS, but may be due to a different 
mechanism or pathway. It may be possible that the weak photo-protective effect of 
these vitamins on HEM and melanoma cells could be improved by prolonging the 
time of pre-treatment with antioxidants, or by exposing the cells to less cytotoxic UV 
doses. Furthermore, as no significant changes in superoxide levels were measured 
with or without UV, and in the presence or absence of antioxidants, it suggested that 
the doses used in this study did not generate superoxide levels in these cells.  
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Chapter 4. The effect of antioxidants on tyrosinase expression and 
melanin content 
4.1 Introduction 
Epidermal melanocytes produce melanin, which is a pigment responsible for giving 
skin its colour and for conferring protection from the deleterious effects of UV 
radiation (279). Abnormalities in melanomagenesis have been observed in many skin 
diseases, including melanoma (280). 
In melanocytes, melanin synthesis is induced by the binding of α-melanocyte 
stimulating hormone (α-MSH) to the melanocortin-1 receptor (MC1R). This binding 
process upregulates the cyclic adenosine monophosphate (cAMP) pathway (280). 
Upregulated cAMP activates microphthalmia-associated transcription factor (MITF), 
which is the master gene responsible for melanocyte differentiation. MITF activates 
at least three enzymes which are necessary for the synthesis of melanin, these 
enzymes include tyrosinase-related protein 1 (TRP1), tyrosinase-related protein 2 
(TRP2) and tyrosinase (280).   
Tyrosinase is a copper-containing metalloglycoprotein and it is the rate-limiting 
enzyme in melanin synthesis. It has several substrates, including L-tyrosine, 
dihydroxyphenylalanine  (L-DOPA) and 5,6-dihydroxyindole (90). Synthesis of 
melanin depends on the amino acid tyrosine (95, 279). Briefly, L-tyrosine is 
hydroxylated to form L-DOPA, which is oxidized to form L-DOPA quinone, which 
in turn is processed and forms either pheomelanin (reddish pigment) or eumelanin 
(brownish-black pigment) (91, 279). Two important events result in cutaneous 
pigmentation: firstly, melanin synthesis by melanocytes and secondly, the 
transmission of melanin-containing melanosomes to neighbouring keratinocytes. 
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However, in all types (I-VI) of human skin the number of melanocytes per area of 
skin is constant, while within keratinocytes the size, number and distribution of 
melanosomes can vary  (281).  
Melanin has been shown to have a photoprotective role from investigations reporting 
the correlation between the incidence of sun-induced skin cancer and skin 
pigmentation levels (281, 282). Moreover, people with fair skin are about 70 times 
more likely to develop skin cancer than are people who have dark skin (281, 283). 
The melanin shielding effect results from the ability of eumelanin to act as a physical 
barrier to UVR, which reduces its ability to penetrate through the epidermis (281). 
Moreover, much more eumelanin is present in dark skin compared to fair skin, which 
confers greater protection against UV-induced damage in the former. Also, the 
photoprotective properties of eumelanin are well documented to be superior to 
pheomelanin. Gloster et al. (2006) and Halder et al. (1995) mentioned that the 
melanin of people with dark skin has double the protective effect to that seen in fair 
skinned people in preventing UVB in penetrating the epidermis (111, 281, 284). 
Only 55% of UVA and 24% of UVB from UVR exposure penetrated the epidermis 
of fair skinned individuals, while in dark skin only 17.5% of UVA and 7.4% of UVB 
penetrated the same region (281, 284). 
It is well known that melanin confers protection in the skin against UV-induced 
photo-damage. Melanin itself can also be toxic post-UVR exposure (281, 285). For 
example, Kvam et al. (1999) observed that induced melanin synthesis in human and 
mice melanoma cell lines did not confer protection against UVA-induced oxidative 
DNA base damage. UVA irradiation was shown to double 8-OHdG levels in human 
melanoma cells that had a high melanin content compared to those with low melanin 
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levels (285). They suggested that the induction of premutagenic UVA-induced 
oxidative DNA base damage was due to melanin synthesis and not its level (285).  
A study conducted in vivo suggested that melanin – mainly pheomelanin – can cause 
cell death because it works as a sensitizer for UVA and UVB radiation (110, 281). In 
UVA-irradiated skin cells, melanin has been shown to act as a photosensitizer, 
producing ROS that induced single strand DNA breaks (281, 286, 287). 
Pheomelanin is prone to photodegradation, resulting in the production of superoxide 
anions and hydrogen peroxide, which could cause DNA mutations in melanocytes or 
other cell types (281). Melanocytes containing pheomelanin have a higher rate of 
apoptotic cell death post-UVR than do cells containing eumelanin (281, 288). In 
addition to this, pheomelanin induces histamine release, which contributes to oedema 
and erythema induced by sun exposure in fair skinned individuals (281, 289).  
Hill et al. (2000) observed that in mouse cell lines possessing different melanin 
content, UVB exposure induced pigment production which was shown to be photo-
protective (288). Induced pigment levels were shown to act as a photosensitizer for 
cell survival post-UVA exposure (288). Moreover, in pigmented mouse melanocytes 
(melan-A and melan-B) UVB caused more DNA damage and the cells were more 
sensitive to killing compared to albino melanocytes (melan-C) (288). However, 
melanin conferred protection to these cells from killing by UVA (288). UVA caused 
more DNA damage in the heavily-pigmented cells compared to the lightly-
pigmented cells (288). However, these heavily-pigmented cells were resistant to 
killing by UV. It was found that increased DNA damage in the lightly-pigmented 
cells post-UVA was due to pheomelanin acting as a photosensitizer (288). Noonan et 
al. (2012) showed that UVA can initiate melanomas and involves melanin, and 
occurs in association with oxidative DNA damage in melanocytes (290). However, 
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DNA damage induced directly by UVB initiated melanoma formation in a pigment-
independent manner (290).  
Melanocytes may be protected by endogenous melanin that directly absorbs UV-
generated photons and oxygen radicals, however at higher UV doses melanin can be 
oxidized, leading to the generation of ROS (291). In the absence of UV exposure, the 
pro-oxidative nature of melanin production is directly associated with higher 
melanocyte basal levels of intracellular ROS, which increase significantly following 
p16 depletion (116). Jenkins et al. (2013) stated that the existence of melanin in the 
skin appears to be double-sided; on the one hand, melanin protects melanocytes and 
proximate keratinocytes in the skin via its ability to absorb UV radiation, but on the 
other hand, melanin synthesis in melanocytes causes higher levels of intracellular 
ROS that may increase an individual’s tendency to develop melanoma (116). 
It has been found that the melanocytes were exposed to high levels of oxidative 
stress by hydrogen peroxide and other types of ROS that were generated  through  
melanogenesis (279, 292). It has been shown that ROS play an important role in 
regulating melanin synthesis, as inhibitors or scavengers of ROS generation were 
found to reduce UV-induced melanogenesis (279, 293). Thus, it has been suggested 
that using antioxidants may reduce UV-induced melanomagenesis. Chakraborty et 
al. (1996) showed that the expression of proopiomelanocortin (POMC), which is 
complemented by α-MSH production and release, was induced by UVB in 
keratinocytes and melanocytes. This increased expression of POMC was reduced by 
the intracellular sulfhydryl free radical scavenger NAC. They suggested that UVB-
induced POMC expression might include a cellular response to oxidative stress (279, 
294). Endogenous antioxidant stimulation by metallothionein reduced melanin 
synthesis in melanocytes (279, 295). Consequently, using antioxidants to confer a 
115 | P a g e  
 
 
protection to human skin from the deleterious effects of UVR is considered a trend 
and has, in recent years, received increasing attention in the fields of dermatology 
and new skin care product development (279, 296). 
Thus, the aims of this study are firstly, to observe the effect of acute or chronic dose 
of UV radiation on tyrosinase levels in the MM418-C1, MM418-C5 and HEM cells.  
In other words, does a single large UV dose induced expression of tyrosinase to a 
greater extent than does two smaller doses? The second aim of this study is to 
observe the effect of an acute or chronic dose of UV radiation on melanin levels, in 
order to see if a single large UV dose enhanced production more than did two 
smaller doses. The third aim of this study is to investigate if vitamin C and trolox 
have an effect on melanin levels in melanocyte and pigmented melanoma cells post 
UV-irradiation. 
 
4.2 Results 
4.2.1 Effect of acute and chronic doses of UV on tyrosinase expression in 
melanocyte- derived cells 
The effect of an acute or chronic dose of UVR on tyrosinase levels in the 
melanocyte-derived cells were examined in order to see if a large single UV dose 
induced greater expression of tyrosinase than did two smaller doses (0.5 single dose 
each exposure) given 24 h apart. The aim of these experiments was to observe if 
tyrosinase expression (Figure 4.1) was increased by (a) single acute UV exposure or 
(b) chronic exposure of UV radiation in MM418-C1, MM418-C5 and melanocytes. 
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MM418-C1 cells were exposed to a single dose UVA (0.8 J/cm
2
) and/or UVB (0.04 
J/cm
2
) or two chronic doses (0.4 J/cm
2
 UVA and/or 0.02 J/cm
2
 UVB) given 24 h 
apart, the results of which are shown in Figure 4.2. 
 
(A) 
 
 
(B) 
 
 
(C) 
 
 
Figure ‎4.1 A representative Western blot showing changes in tyrosinase expression in acute/chronic UV-
irradiated (A) MM418-C1, (B) MM418-C5 and (C) HEM cells 
MM418-C1 cells were exposed to either a single dose UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) or two chronic 
doses (0.4 J/cm2 UVA and/or 0.02 J/cm2 UVB) given 24 h apart. MM418-C5 cells were exposed to a single dose 
UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) or two chronic doses (0.3 J/cm2 UVA and/or 0.015 J/cm2 UVB) given 
24 h apart. HEM cells were exposed to a single dose UVA (3.2 J/cm2) and/or UVB (0.16 J/cm2) or two chronic 
doses (1.6 J/cm2 UVA and/or 0.08 J/cm2 UVB) given 24 h apart. Cell lysates were run on western blots. The 
blots were probed with an anti-tyrosinase and an anti-GAPDH antibody (see section 2.8). 
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It can be seen from Figure 4.2A that exposure to either acute or chronic UVA 
radiation did not increase tyrosinase expression in MM418-C1 cells. Exposure to 
UVB did not alter tyrosinase expression in these cells. However, while an acute dose 
of UVAB radiation increased the expression of tyrosinase, this was not significant 
(Figure 4.2A). 
MM418-C5 cells were exposed to a single dose UVA (0.6 J/cm
2
) and/or UVB (0.03 
J/cm
2
) or two chronic doses (0.3 J/cm
2
 UVA and/or 0.015 J/cm
2
 UVB) given 24 h 
apart, the results of which are shown in Figure 4.2B. It can be seen that exposure to 
either acute or chronic UVA radiation did not change tyrosinase expression in 
MM418-C5 cells. Of interest was the observation that tyrosinase expression was 
decreased in these cells exposed to either acute UVB or UVAB radiation. Chronic 
exposure to UVAB also reduced tyrosinase expression in these cells, but this differed 
to that seen for chronic UVB exposure, however the latter effect was not significant 
(Figure 4.2B).  
HEM cells were exposed to a single dose UVA (3.2 J/cm
2
) and/or UVB (0.16 J/cm
2
) 
or two chronic doses (1.6 J/cm
2
 UVA and/or 0.08 J/cm
2
 UVB) given 24 h apart, the 
results of which are shown in Figure 4.2C. It can be seen that either acute or chronic 
exposure to UVA radiation did not alter tyrosinase expression in these cells. The 
same observation was also made in the cells exposed to both forms of UVB 
radiation, as well as an acute dose of UVAB radiation. Of interest was that chronic 
UVB radiation increased tyrosinase expression, but this was not significant (Figure 
4.2C). 
Tyrosinase levels were calculated from the images of the western blots as described 
in Section 2.8.4. Changes in the expression of tyrosinase were expressed as a fold 
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change to that level seen in unirradiated controls. Tyrosinase levels in the 
unirradiated controls were expressed as value of unity (1).   
(A) 
 
(B) 
 
(C) 
 
 
Figure ‎4.2 The effect of acute and chronic UV doses on tyrosinase levels in melanocyte-derived cells  
Tyrosinase activity was measured in (A) MM418-C1 (B) MM418-C5 (C) HEM following exposure to acute or 
chronic doses of UVA and/or UVB radiation. Tyrosinase levels were expressed as a ratio to that seen in sham-
irradiated controls, which was given a value of 1. Data is represented as the mean±SD from two separate 
experiments. Due to the low number of replicate samples no statistical comparisons were made.   
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4.2.2 The effect of antioxidants on melanin levels in melanoma cells 
4.2.2.1 The effect of antioxidants on melanin levels in MM418-C1 cells 
The effect of antioxidants (vitamin C, DMSO or trolox) on the melanin levels in 
lightly-pigmented MM418-C1 cells exposed to an acute or chronic doses of UV 
radiation, were examined in order to see if a large single UV dose (acute) enhanced 
more melanin production than did two smaller doses (0.5 single dose each exposure) 
(chronic) given 24 h apart. These cells were exposed to a single dose (UVA 0.8 
J/cm
2
) and/or UVB 0.04 J/cm
2
) or two chronic doses (0.4 J/cm
2
 UVA and/or 0.02 
J/cm
2
 UVB) given 24 h apart. The melanin levels were measured 48 h after the initial 
exposure to UV radiation, the results of which are shown in Figure 4.3. 
It can be seen that exposure to UVA radiation, be it acute (Figure 4.3A) or chronic 
(Figure 4.3B), did not enhance melanin formation in these cells. The addition of 
antioxidants had no effect on melanin formation in these irradiated cells. Melanin 
levels were higher in these cells following exposure to either acute or chronic UVB 
or UVAB radiation dose (Figure 4.3). Exposure to an acute UVB or UVAB dose 
caused a significant increase (2.0 and 2.3-fold, respectively) in melanin levels 
(Figure 4.3A), but not in cells exposed to chronic UV exposure (Figure 4.3B). When 
the MM418-C1 cells were treated with the antioxidants (vitamin C, DMSO or 
trolox), no reduction in melanin levels were observed even if these cells were 
exposed to an acute or chronic dose of UVB or UVAB radiation. This suggests that 
the antioxidants do not influence melanin production in these UV-irradiated cells. 
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(A) 
 
(B) 
 
 
Figure ‎4.3 Effect of antioxidants on melanin levels in MM418-C1 cells exposed to acute and chronic doses of 
UV radiation 
Melanin levels were measured in MM418-C1 exposed to (A) an acute dose of UVA and/or UVB or (B) a chronic 
doses of UVA and/or UVB in the presence or absence of 1 mM of vitamin C, 0.1% (v/v) DMSO and 0.1 mM 
trolox. These antioxidants were added 24 h prior and post exposure to UVR. Data is represented as the 
mean±SEM from triplicate samples from three separate experiments. Statistical significance from sham was 
calculated by one-way ANOVA followed by Bonferroni’s multiple comparisons post-test. *p ≤ 0.05 
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4.2.2.2 The effect of antioxidants on melanin levels in MM418-C5 cells 
MM418-C5 cells are darkly-pigmented melanoma cells and contain 1.43 μg 
melanin/mg cell protein, which was 2.3-fold higher than that seen in the lightly 
pigmented MM418-C1 cells. 
The effect of antioxidants on acute or chronic dose of UV radiation on melanin 
levels in these cells were examined in order to see if a large single UV dose (acute) 
enhanced more melanin production than did two smaller doses (0.5 single dose each 
exposure) (chronic) given 24 h apart. MM418-C5 cells were exposed to a single dose 
UVA (0.6 J/cm
2
) and/or UVB (0.03 J/cm
2
) or two chronic doses (0.3 J/cm
2
 UVA 
and/or 0.015 J/cm
2
 UVB) given 24 h apart. The melanin levels were measured 48 h 
after the initial exposure to UV radiation, the results of which are shown in Figure 
4.4. 
It can be seen that exposure to UVA radiation, be it acute (Figure 4.4A) or chronic 
(Figure 4.4B) did not enhance melanin formation in these cells. The addition of 
antioxidants had no effect on melanin formation in these cells exposed to UVA 
radiation. Similarly, melanin levels were unchanged in cells exposed to either acute 
or chronic UVB or UVAB exposure (Figure 4.4). When these UV-irradiated (UVB 
and UVAB) cells were treated with antioxidants (vitamin C or trolox), no change in 
melanin levels were observed in those cells exposed to acute or chronic radiation 
dose. This suggests that the antioxidants do not influence melanin production in 
these cells following exposure to UV radiation. 
When comparing Figure 4.3A and Figure 4.4A together, it appears that lightly-
pigmented cells (MM418-C1) were induced by UVB and UVAB radiation to have 
similar melanin levels to that seen in untreated darkly-pigmented cells (MM418-C5). 
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This suggests that only lightly-pigmented cells are responsive to these UV doses, 
whereas darkly-pigmented cells are already at that level of melanin and are therefore 
unresponsive. 
 
(A) 
 
(B) 
 
Figure ‎4.4 Effect of antioxidants on melanin levels in MM418-C5 cells exposed to acute and chronic doses of 
UV radiation 
Melanin levels were measured in MM418-C5 exposed to (A) an acute dose of UVA and/or UVB or (B) a chronic 
doses of UVA and/or UVB in the presence or absence of 1 mM of vitamin C, 0.1% (v/v) DMSO and 0.1 mM 
trolox. These antioxidants were added 24 h prior and post exposure to UVR. Data is represented as the 
mean±SEM from triplicate samples from three separate experiments. 
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4.2.2.3 The effect of antioxidants on melanin levels in HEM cells 
Experiments performed using MM418-C1 and MM418-C5 cells (Sections 4.2.2.1 
and 4.2.2.2) were repeated using HEM cell cultures. However, in the HEM cells, 
melanin was not detected in either the sham-irradiated controls or in those cells 
exposed to acute and chronic doses of UVR. As a result, changes were made to the 
experimental protocol in order to detect melanin levels in the HEM cells. Whereas 
the melanoma cells were grown in 24 well plates, HEM were grown in 60 mm petri 
dishes. The cells were trypsinised and the cell pellet dissolved in 250 μl of 0.2 M 
NaOH instead of 1 ml of 0.2 M NaOH. Neither of these changes resulted in melanin 
being detected in the HEM cells.  
Other numerous possible changes to the protocol were also identified. These 
included treating the cells with a melanin precursor, such as tyrosine or 3-isobuty-1-
methxlzanthine (IBMX) to enhance melanin production (267, 297). However, due to 
time limitations, these experiments were not performed (for further discussion please 
see Chapter 7). 
 
4.3 Discussion 
The effect of an acute or chronic dose of UVR on tyrosinase expression and melanin 
levels in MM418-C1, MM418-C5 and HEM were examined in order to see if a large 
single UV dose induced higher tyrosinase expression and melanin levels in the cells 
than did two smaller doses (0.5 single dose each exposure) given 24 h apart. 
MM418-C1, MM418-C5 and HEM cells were exposed to a single dose of either 
UVA and/or UVB or two chronic doses given  24 h apart. The results from this study 
may help our understanding of the role played by UVR in melanogenesis. Moreover, 
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the effect of antioxidants (vitamin C or trolox) on the melanin content was compared 
in order to investigate the role these molecules may play in this process.  
It can be seen that acute and chronic doses of UVA did not have an effect on the 
expression of tyrosinase in the cell lines examined. It was also observed that neither 
UVB nor UVAB radiation had any effect on tyrosinase expression in these cells 
(Figure 4.2).  
Panich et al. (2011) found that UVA may play a role in melanogenesis due to 
oxidative stress. They found that irradiating G361 melanoma cells with (8 J/cm
2
) of 
UVA significantly increased the cellular tyrosinase activity (265), however the UVA 
doses used in this study were 0.8 J/cm
2
 for MM418-C1, 0.6 J/cm
2
 for MM418-C5 
and 3.2 J/cm
2
 for HEM, which suggests that UVA has different effects depending on 
the doses and the type of cells exposed. However, more experiments will need to be 
performed to confirm that this is the case. 
Gu et al. (2014) looked at the effect of UVB on melanogenesis in melanocytes, cell 
differentiation and phosphorylation of MAPK.  They found that exposing 
melanocytes from skin type III to 0.02 J/cm
2
 UVB once a day for 5 days led to an 
increase in the melanin formation and the activation of c-jun N-terminal kinases 
(JNK)/p38/MITF/tyrosinase in these cells (298). In the current study, the UVB doses 
used did not induce tyrosinase activity in both pigmented melanoma cells and 
melanocytes. It should be noted that UVAB radiation also elicited a similar effect to 
that of UVB radiation with respect to tyrosinase expression.  
The doses used in this experiment were those which caused ~50% cell killing. These 
UV doses did not change the levels of tyrosinase expression in these cells. The UVB 
doses used did not enhance melanin synthesis in the cells while causing 50% cell 
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death. If the cells were exposed to smaller doses of UVR over longer periods of time, 
this may enhance tyrosinase expression, however further experiments would help 
confirm this suggestion.  
Moreover, tyrosinase is considered to be the main target of melanogenesis inhibitors 
(279) and these compounds have been used to treat abnormal skin pigmentation 
diseases (279, 299). However, microphthalmia-associated transcription factor 
(MITF), tyrosinase-related protein-1 (TRP-1) and tyrosinase-related protein-2 (TRP-
2), also contribute in the synthesis of melanin (279).  
Microphthalmia-associated transcription factor (MITF) is a key transcription factor 
for tyrosinase. When upregulated, it enhanced tyrosinase expression. MITF has also 
been shown to be closely related with melanocyte survival (300). Nishioka et al. 
(1999) investigated the effect of tyrosinase, tyrosinase related protein TRP-1 and 
TRP-2 on cell growth, differentiation and cell death in melanocytic cells. They found 
that low doses of UVB upregulated the expression of tyrosinase and TRP-1, as well 
as melanin content in these cells. The expression and activity of TRP-2 was not 
linked with pigmentation, but only with cell proliferation (301). 
Nishioka et al. (1999) observed significant suppression of cell proliferation in a 
melanoma cell line exposed to low or high doses of UVB-irradiation. They observed 
that TRP-2 expression was decreased in UVB-irradiated cells, and transfection of 
this protein was able to confer protection to these cells against the apoptotic effect of 
UVB radiation. These results suggest that the regulation of cell survival/growth of 
melanocytes irradiated with UVB is correlated to that of TRP-2 expression (301).  
These results suggest that the doses of UV used in this study were too high to have 
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an effect on tyrosinase, but may have had an effect on MITF, TRP-1 and TRP-2 with 
regards to cell survival.  
UVA can cause indirect damage to DNA through generation of ROS, while UVB 
causes direct DNA damage (299). It has been suggested that melanin confers 
protection to the cell’s DNA against the effect of UVR through either working as a 
scavenger of ROS or as a UV filter (302). In this study, the chosen dose of acute 
UVB and UVAB radiation significantly increased the melanin levels in MM418-C1, 
but not MM418-C5 cells; whereas the acute dose of UVA did not alter the melanin 
level in either cell line. Our findings suggest that the increase in melanin in MM418-
C1 induced by an acute UVB dose was not due to the activation of tyrosinase but 
due to other enzymes involved in this pathway, such as TRP-1. Nishioka et al. 
(1999) found that chronic exposure to low doses of UVB induced melanin content in 
melanocytic cells. They found that an increase in melanin content was associated 
with upregulated tyrosinase and TRP-1 expression (301).  
Moreover, the doses used here of UVB caused ~50% cell death, but had no effect on 
melanin levels in the darkly pigmented cells.  This finding suggests that UVB at the 
doses used did not affect cells with high melanin levels. 
When looking at the effect of chronic doses of UVB on both cell lines, it can be seen 
that they enhanced melanin levels. Neither UVA nor UVAB had any effect on the 
melanin levels in both cell lines. These results suggest that repeated exposure to 
lower doses of UVB radiation over a period of time will increase melanin formation. 
Panich et al. (2011) found that exposing the G361 cells to (8 J/cm
2
) of UVA 
increased tyrosinase levels but not melanin. When the UVA dose was increased to  
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16 J/cm
2
, melanin levels were significantly induced (265). The authors suggested 
that increasing the UVA doses may enhance melanin levels in the cell. 
Panich et al. (2011) also found that by pre-treating G361 cells with 120 µM of 
ascorbic acid, melanin levels fell while tyrosinase activity (or its mRNA levels) were 
unaffected post-UVA exposure (265). Additionally, they found that ascorbic acid 
conferred protection against UVA-dependent melanin synthesis. This may be due to 
improvements in the defence capacity of antioxidants and suppression in the 
production of nitric oxide in the irradiated cells (265). Recently, Panich et al. (2013) 
found that a single dose of UVA (16 J/cm
2
) significantly induced tyrosinase activity 
and the formation of melanin in G361 melanoma cells. However, a single dose of 
UVA (8 J/cm
2
) only significantly induced tyrosinase expression, but not melanin 
formation, in the same cells. They also found that pre-treating cells with Thai herb 
extracts (AVS073) for 30 min prior to UVA exposure suppressed UVA-augmented 
tyrosinase activity and inhibited melanin formation. Pre-treatment with AVS073 
suppressed cellular oxidative stress, GSH depletion and GST inactivation in G361 
melanoma cells exposed to UVA radiation. The authors concluded that the AVS073 
formula had anti-melanogenic effects, possibly through improving the cell’s redox 
state by upregulating GSH and GST levels (303). 
Yoko et al. (2004) found that treating B16 melanoma cells with 50 μg/ml of α-
tocopherol for four days significantly reduced its level of melanin. Furthermore, the 
simultaneous treatment of α-tocopherol inhibited tyrosinase activity in these cells 
(304). In this study, I observed that neither vitamin C nor trolox had a significant 
effect on melanin levels in the melanocytic cells post-UV radiation. In this 
experiment, I was unable to detect melanin levels in the irradiated HEM cells. 
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Kvam et al. (2003) found that tyrosine treatment modulated melanin synthesis in 
melanocytes post-UVA exposure. In their experiments, three types of immortalized 
mouse melanocytes were used: black mouse melanocytes (melan-A), brown mouse 
melanocytes (melan-B) and unpigmented albino mouse melanocytes (melan-C). 
When these cells were cultured in media containing tyrosine, there was an increase 
in melanin levels found in the cells (267).  
The experiments using HEM cells should be repeated and the cells could be grown in 
media containing tyrosine, which may enhance melanin synthesis. Also, it has been 
shown that IBMX can induce melanin synthesis in melanocytic-derived cells, and 
HEM cells could be treated with this compound to enhance melanin production 
(305). 
In future studies these experiments should be performed to see if they can enhance 
melanin synthesis in HEM cells. And if so, it will allow for the effect of UVR and 
antioxidants to be examined (see Chapter 7). 
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CHAPTER 5 
THE EFFECT OF 
ANTIOXIDANTS ON TNF-α, 
TACE AND FURIN IN  
UV-IRRADIATED MELANOMA 
CELLS 
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Chapter 5. The effect of antioxidants on TNF-α, TACE and furin in 
UV-irradiated melanoma cells  
5.1 Introduction 
Inflammation is a notable feature observed in many types of epithelial cancers, and 
plays a vital role in the initiation and progression of these tumours. Recently, many 
studies have shown the role that cytokines play in forming a connection between 
inflammation and cancer (306-308). Tumour necrosis factor-α (TNF-α) is a cytokine 
that plays an important role in many inflammatory and malignant diseases (306, 
309). It is a member of the TNF ligand superfamily and is a type II transmembrane 
glycoprotein of 234 amino acids (187). TNF-α exists in either a membrane-bound 
(mTNF-α) or soluble form (sTNF-α) (187). Many different types of cells can 
produce TNF-α; for example, macrophages, dendritic cells, leucocytes, fibroblasts, 
keratinocytes and melanocytes (187). TNF-α plays an important role in different 
processes including: inflammation, cellular proliferation, differentiation,  
tumorigenesis and apoptosis (187). It has been found that the soluble form of TNF-α 
is involved in most of these cellular processes, but there is increasing evidence 
showing that mTNF-α is also biologically active (187). 
It has been demonstrated in numerous studies that TNF-α induces chemokines in the 
skin (203, 310-312). In dermal endothelial cells, UVB induces nitric oxide synthase 
(iNOS) activity, which plays a vital role in UVB-induced inflammation of human 
skin (203, 313-316). 
It has been shown that UVR can stimulate both TNF-α mRNA and protein 
production in the skin (146, 196, 202, 317). The addition of IL-α to keratinocytes 
and fibroblasts has been shown to significantly enhance TNF-α secretion post-UVB 
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exposure (203). UVB, but not UVA, was shown to induce TNF-α production in 
keratinocytes and fibroblasts (146, 202).  Muthusamy et al. (2011) revealed that at 
24 h post-UV exposure, TNF-α levels were induced in human epidermal 
melanocytes (HEM) and MM96L melanoma cells treated with IL-1α   (10 ng/ml) 
and then exposed to UVB (2 kJ/m
2
) (196). When pre-treated with antioxidants         
[α-tocopherol, CO2-supercritical fluid extract of green-lipped mussels (CO2-SFE) 
and 5β-scymnol] 24 h prior to UVB exposure, levels of TNF-α secreted by HEM 
cells, but not in MM96L cells, were reduced (196).  
Cytokines may also be involved in anti- or pro-tumorigenic activities in the 
development of melanoma (318, 319). For example, it has been found that CREB-
associated proteins and ATF2 transcription factors are involved in altering the 
resistance of melanoma to UV-irradiation (318). Also, it has been reported that in 
melanoma cells, ATF2 conferred resistance to radiation through elevated 
transcription and TNF-α expression. This elevation may cause an anti-apoptotic 
signal in some melanoma cell lines (318). On the other hand, RelA was shown to 
inhibit the expression of the TNF-related apoptosis-inducing ligand receptors (319). 
Therefore, an investigation on the effect of UV radiation on TNF-α release in 
melanocyte-derived cells is warranted. Exogenous TNF-α was shown to inhibit 
apoptosis in melanoma cells with abrogated B-RAF signalling (320). Cell cycle 
arrest and apoptosis were induced by the inhibition of mutated B-RAF
V600E
 
signalling in these cells (320). However, the activation of the NF-κB pathway by the 
addition of external TNF-α, reduced apoptosis and led to melanoma cell survival 
(320). TNFα-mediated cell survival was also inhibited by the depletion of NF-κB 
subunits (p50 and p65). Together, these findings suggest that the presence of TNFα 
in the tumour microenvironment may help in melanoma progression (320). 
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Through the action of tumour necrosis factor-α converting enzyme (TACE), sTNF-α 
is cleaved from its membrane-bound precursor (189, 321). TACE is known also as 
ADAM 17 (A Disintegrin and Metalloproteinase Domain 17), which is a member of 
ADAM family of proteases (187). TACE has two forms in the mammalian cells. 
Pro-TACE is located in the endoplasmic reticulum and proximal Golgi body, while 
the mature form of TACE is found in the cytoplasm and on the plasma membrane 
(187). It was found that some metalloproteases are activated post-UV exposure in 
epidermal cells (146, 208). Skiba et al. (2005) found that the induction of TACE 
mRNA in HaCaT cells was upregulated significantly by both UVA and UVB 
irradiation (209). Additionally, they also showed that UVA increased the levels of 
TACE mRNA more than UVB did. However, the induction of TNF-α mRNA was 
not related to the time course of TACE mRNA induction in these cells (209). 
The proprotein convertase furin is localized to the constitutive secretory pathway 
(322-324), and plays an important role in the activation of many enzymes, including 
TACE and matrix metalloproteases (MMP) from their respective preproforms (209, 
325, 326). Furin is found in most cells and the phosphorylation of basic amino acid 
sites is responsible for its activation (323, 327). Recently, it has been shown that the 
enhancement of metastatic spread and the proliferation of tumour cells are linked to 
the increase of furin expression in head, neck, breast and lung cancer cells (213, 328, 
329). This could be a result of extracellular matrix degradation by the activation of 
MMPs, which in turn were activated by furin (329, 330). Skiba et al. (2005) reported 
that UVA and UVB induced furin mRNA expression in HaCaT cells (209). Huynh et 
al. (2009) found that UV type and doses had different effects on furin expression in 
keratinocyte-derived cell lines (322). They observed that UVA (20 kJ/m
2
) and/or 
UVB (2 kJ/m
2
)  irradiation downregulated furin expression in the keratinocyte cell 
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line (HaCaT cell) at 24 post-UV exposure, while UVB and UVAB induced furin 
expression in the squamous cell carcinoma cell line (Colo16) at 24 h post-UV 
exposure (146). 
The effect of UVR on the production of TNF-α and the expression of TACE and 
furin in melanocytes and melanoma cell is poorly understood. Thus, the aim of this 
study was divided into two parts. The first part was to investigate the effect that 
acute doses of UVA and/or UVB (Table 2.1), in the presence and absence of IL-1α, 
had on the production of TNF-α, and the expression of TACE and furin in both light- 
and dark-pigmented melanoma cells (MM418-C1 and MM418-C5). The second part 
was to look at the effect of vitamin C and trolox (which is the analog form of vitamin 
E) on the production of TNF-α and the expression of TACE and furin at 24 h post-
UV exposure in both cell lines. 
 
5.2 Results 
5.2.1 Effect of antioxidants on TNF-α release from UV-irradiated melanoma 
cells 
The effects of UV-radiation on TNF-α release in MM418-C1 and MM418-C5 were 
measured 24 h post-exposure in the presence or absence of antioxidants [vitamin C 
(1 mM) and trolox (0.1 mM) with DMSO (0.1% v/v)] using an ELSIA assay. IL-1α 
has been shown to enhance the production of TNF-α in melanocytes and melanoma 
cells post-UV exposure (196). The purpose of these experiments was to observe the 
effect of UV radiation on TNF-α release from melanocyte-derived cells and whether 
IL-1α enhanced its production. The effect of antioxidants on the release of TNF-α 
from these irradiated melanoma cells were also investigated.  
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5.2.1.1 Effect of antioxidants on TNF-α release from UV-irradiated      
MM418-C1 cells 
In the presence of IL-1α, TNF-α levels released from sham-irradiated controls were 
similar to that seen in the untreated cells (63.4±7.7 pg/ml vs 57.1±9.0 pg/ml) (Figure 
5.1A). When the cells were treated with vitamin C, DMSO and trolox, there was no 
change in TNF-α levels released from the cells, compared to untreated sham-
irradiated controls. In the sham-irradiated cells treated with IL-1α, the antioxidants 
slightly increased TNF-α released from these cells when compared to those cells not 
treated with this cytokine; however, this difference was not significant. 
When the cells were exposed to UVA radiation, there was a slight increase in the 
release of TNF-α compared to sham-irradiated controls (81.2±11.8 pg/ml vs 
57.1±9.0 pg/ml) (Figure 5.1B). When the UVA-irradiated cells were treated with 
vitamin C, there was a 22% reduction in TNF-α level released from the cells. Trolox 
addition also reduced TNF-α levels, while DMSO alone had no effect (Figure 5.1B). 
The addition of IL-1α to the UVA-irradiated cells resulted in a 23% reduction in 
TNF-α secreted from these cells. Treatment with vitamin C caused a 54% increase in 
TNF-α levels secreted from UVA-irradiated cells treated with IL-1α, while DMSO 
and trolox treatment were shown to have no effect. However, these changes were not 
significant. 
When the cells were exposed to UVB radiation, the level of TNF-α released from 
these cells (161.2±25.6 pg/ml vs 57.1±9.0 pg/ml) was greater than that seen in the 
sham-irradiated controls (Figure 5.1C). When the antioxidants were added to the 
UVB-irradiated cells, vitamin C increased TNF-α levels released from the cells by 
165%, however neither trolox nor DMSO had any effect. 
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(B) 
 
(C) 
 
(D) 
 
Figure ‎5.1 Effect of antioxidants on TNF-α‎release‎from‎UV-irradiated MM418-C1 cells 
TNF-α levels were measured in the cells exposed to (A) sham-irradiation, (B) UVA radiation, (C) UVB radiation 
and (D) UVAB radiation. The cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 
mM) 24 h prior to being exposed to UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation. The antioxidants were 
added to the irradiated cells and TNF-α levels measured 24 h post-irradiation. Cells were also treated with IL-1α 
(10 ng/ml) to observe its effect on TNF-α secretion (denoted as “α” in the 𝑥-axis labels). Data is represented 
asthe mean±SEM for three separate experiments. For statistical analysis, one-way ANOVA followed by 
Bonferroni’s multiple comparisons post-test was carried out.  
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When IL-1α was added to the UVB-irradiated cells there was a 137% increase in 
TNF-α levels secreted by the cells, compared to those only exposed to UVB 
radiation. Treating the cells with vitamin C and trolox resulted in a further increase 
in the already elevated TNF-α levels (85% and 54%, respectively). DMSO treatment 
had no effect on TNF-α secretion, however, these differences were not significant. 
Following exposure to UVAB radiation, there was a two-fold increase in the level of 
TNF-α released from the cells, when compared to sham-irradiated controls 
(167.8±42.9 pg/ml vs 81.2±11.8 pg/ml) (Figure 5.1D). When the antioxidants were 
added to these irradiated cells, no effects on the levels of secreted TNF-α were seen.  
When IL-1α was added to the UVAB-irradiated cells, there was a 249% increase in 
the levels of TNF-α secreted by the cells compared to those only exposed to UVAB 
radiation. When these irradiated cells were treated with vitamin C, there was a 
further 20% increase in the level of TNF-α secreted by the cells; however treatment 
with DMSO or trolox had no effect, however, these differences were not significant. 
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5.2.1.2 Effect of antioxidants on TNF-α release from UV-irradiated MM418-
C5 cells 
The levels of endogenous TNF-α released from MM418-C5 cells were less than that 
released from MM418-C1 cells (13.41±4.5 pg/ml vs 57.1±9 pg/ml). In the presence 
of IL-1α, TNF-α levels released from sham-irradiated controls (MM418-C5 cells) 
were 49% higher than that seen in the untreated cells (Figure 5.2A). Vitamin C 
treatment in the unirradiated untreated cells reduced the levels of secreted TNF-α by 
62%; while trolox caused a slight increase by 55%. Neither of these differences were 
significant. 
 When the MM418-C5 cells were treated with IL-1α, the addition of antioxidants had 
no effect on the release of TNF-α from these cells (Figure 5.2A). In the UVA-
irradiated MM418-C5 cells, the levels of TNF-α released from these cells were 
similar to that seen in the sham-irradiated controls (Figure 5.2B). Treatment of these 
irradiated cells with vitamin C, DMSO and trolox had no effect on the secretion of 
TNF-α.  
The addition of IL-1α to the UVA-irradiated cells had no effect on TNF-α secretion. 
When these cells were treated with the antioxidants (vitamin C and trolox) or DMSO 
alone, no effects were observed. 
In the UVB-irradiated cells, the levels of TNF-α released from the cells were three 
times than that seen in the sham-irradiated controls (42.0±4.2 pg/ml vs 13.4±4.5 
pg/ml) (Figure 5.2C). The addition of vitamin C and trolox reduced the level of 
TNF-α released from the cells by 69% and 35%, respectively. Neither of these 
differences were significant. 
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Figure ‎5.2 Effect of antioxidants on TNF- α‎release‎from‎UV-irradiated MM418-C5 cells 
TNF-α levels were measured in the cells exposed to (A) sham-irradiation, (B) UVA radiation, (C) UVB radiation 
and (D) UVAB radiation. The cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 
mM) 24 h prior to being exposed to UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation. The antioxidants were 
added to the irradiated cells and TNF-α levels measured 24 h post-irradiation. Cells were also treated with IL-1α 
(10 ng/ml) to observe its effect on TNF-α secretion (denoted as “α” in the 𝑥-axis labels). Data is represented as 
the mean±SEM for triplicate samples from three separate experiments. For statistical analysis, one-way ANOVA 
followed by Bonferroni’s multiple comparisons post-test was carried out. 
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The addition of IL-1α to the UVB-irradiated MM418-C5 cells did not enhance the 
secretion of TNF-α by these irradiated cells. When the antioxidants were added to 
the IL-1α treated UVB irradiated cells, only vitamin C treatment caused a 26% 
reduction in the levels of TNF-α secreted from the cells, however this was not 
significant. 
In the UVAB-irradiated cells, TNF-α levels were nearly five-fold higher than that 
seen in the sham-irradiated controls (64.1±5.9 pg/ml vs 13.4±4.5 pg/ml) (Figure 
5.2D). When these cells were treated with vitamin C or trolox, there was a reduction 
in TNF-α levels by 54% and 48%, respectively.  
When the UVAB-irradiated cells were treated with IL-1α, TNF-α levels fell by 35% 
compared to the untreated irradiated cells. Further treatment with vitamin C and 
DMSO had no effect on the levels of TNF-α secreted from these cells, while trolox 
increased these levels by 39%.  The effect of trolox was shown to be not significant. 
In summary, the levels of TNF-α released from MM418-C1 cells were about four-
fold higher than those released from the MM418-C5 under all experimental 
conditions. The addition of IL-1α also caused a greater stimulation of TNF-α release 
in the MM418-C1 cells than compared to MM418-C5 cells that had been exposed to 
UVR. These results suggest that melanin may play a role in suppressing the release 
of TNF-α, especially when the cells are exposed to high UV doses.   
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5.2.2 Effect of antioxidants on TACE expression from UV-irradiated 
melanoma cells 
The effect of antioxidants on the expression of TACE in both melanoma cells were 
examined, in the presence or absence of IL-1α (10 ng/ml), at 24 h post-UV exposure. 
The cells were treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 
mM) 24 h prior to being exposed to either UVA and/or UVB radiation. Following 
UV exposure, the antioxidants were re-added to the cells and at 24 h post-irradiation 
the expression of TACE (pTACE and mTACE) was detected using western blots. 
 
5.2.2.1 Effect of antioxidants on TACE expression from MM418-C1 UV-
irradiated cells 
The rabbit polyclonal TACE antibody used in this study detected both pTACE (120 
kDa) and mTACE (80 kDa) as seen in Figure 5.3. Changes in the expression of the 
two isoforms of TACE were expressed as a fold change to the total level (pTACE 
and mTACE) seen in the unirradiated controls. The expression of UV-induced 
pTACE and mTACE were calculated as a fraction of total TACE levels. Total TACE 
levels in sham-irradiated control were expressed as unity (1). 
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Figure ‎5.3 A representative western blot probed for TACE in MM418-C1 cells 
Changes in the level of TACE expression were observed in UV-irradiated MM418-C1 cells treated with 
antioxidants [vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM)] in the presence or absence of IL-1α. 
The cells were exposed to either sham or UVA radiation (0.8 J/cm2) in the (A) absence or (B) presence of IL-1α. 
Cells were exposed to either UVB (0.04 J/cm2) or UVAB (0.8 J/cm2 UVA + 0.04 J/cm2 UVB) in the (C) absence 
or (D) presence of IL-1α. 
 
In the sham-irradiated MM418-C1 cells, the majority (89±6%) of TACE is in the 
mature form, with the rest being pTACE (Figure 5.4A). Antioxidant treatment 
(vitamin C and trolox) or DMSO had little or no effect on the expression of TACE in 
these cells. When IL-1α was added to the sham-irradiated cells, no changes in the 
total amount of TACE was seen, although there was a slight decrease in pTACE 
levels (Figure 5.4A). When these cells (sham-irradiated + IL-1α) were treated with 
the antioxidants, only vitamin C enhanced TACE expression (1.9±0.9-fold vs 
1.2±0.6-fold). This change was due to increased mTACE levels, while those of 
pTACE were lower. Treatment with DMSO and trolox had no effect on TACE levels 
in these cells. 
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UVA radiation had no effect on TACE expression (Figure 5.4B). Treatment with 
trolox resulted in a 46% decrease in TACE levels, which was mainly due to mTACE. 
When these cells were treated with vitamin C and DMSO, no changes in TACE 
expression were observed.  In the UVA-irradiated cells treated with IL-1α, no 
changes in TACE expression were observed. A similar result was also observed 
when these cells were treated with antioxidants. 
Exposure to UVB radiation did not alter TACE levels in the MM418-C1 cells 
(Figure 5.4C). Treatment with vitamin C and DMSO had no effect on TACE 
expression in these cells, while trolox increased total TACE levels by 169%. When 
IL-1α was added to the UVB-irradiated cells, no effect on TACE levels was 
observed (Figure 5.4C). When these irradiated cells were treated with the 
antioxidants (vitamin C and trolox), no changes in the levels of TACE expression 
were seen. However, when DMSO was added to these cells, an unexpected increase 
was observed in TACE expression.  
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Figure ‎5.4 Effect of antioxidants on the expression of TACE in UV-irradiated MM418-C1 cells 
TACE (mTACE and pTACE) levels were measured in (A) sham- (B) UVA- (0.8 J/cm2), (C) UVB- (0.04 J/cm2), 
and (D) UVAB-irradiated (0.8 J/cm2 UVA+ 0.04 J/cm2 UVB) MM418-C1 cells, 24 h post-irradiation cultured in 
the presence or absence of IL-1α (10 ng/ml), and treated with either vitamin C (1 mM), DMSO (0.1% v/v), trolox 
(0.1 mM) or nothing (Controls). Data represents the mean±SD from samples for two separate experiments. No 
statistical comparisons were made due to the low number of replicate samples. 
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TACE levels were elevated (2.7±1.0-fold) in UVAB-irradiated cells mainly due to 
increased mTACE levels (Figure 5.4D). When these UVAB-irradiated cells were 
treated with vitamin C, DMSO and trolox, a slight increase in TACE levels were 
seen which was due to elevated mTACE levels. When the UVAB-irradiated cells 
were treated with IL-1α, no further increase in TACE expression was observed. 
Treatment with antioxidants caused a slight decrease in TACE expression in these 
cells. 
 
5.2.2.2 Effect of antioxidants on TACE expression from MM418-C5  
UV-irradiated cells 
As mentioned earlier (5.2.2.1), the effects of UV radiation, IL-1α and antioxidants on 
the expression of TACE in MM418-C5 cells were determined using western blots. 
The effects of these agents on the expression of pTACE and mTACE were compared 
to the level of total TACE (pTACE + mTACE) seen in the unirradiated controls, 
which was expressed as unity (1). 
In the MM418-C5 sham-irradiated controls, the majority (81±1%) of TACE was in 
the mature form, the rest being pTACE (Figure 5.6A). Treatment with antioxidants 
(vitamin C and trolox), or DMSO alone had little or no effect on TACE expression 
in these cells. When IL-1α was added to the sham-irradiated cells, no increase in 
TACE levels was seen (Figure 5.6A). When these cells (sham-irradiated + IL-1α) 
were treated with vitamin C and trolox, a slight increase of mTACE levels was 
observed. 
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Figure ‎5.5 A representative western blot probed for TACE in MM418-C5 cells 
Changes in the level of TACE expression were observed in UV-irradiated MM418-C5 cells treated with 
antioxidants [vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM)] in the presence or absence of IL-1α. In 
(A) cells were exposed to either sham or UVA radiation (0.6 J/cm2) in the (A) absence or (B) presence of IL-1α. 
Cells were exposed to either UVB (0.03 J/cm2) or UVAB (0.6 J/cm2 UVA + 0.03 J/cm2 UVB) in the (C) absence 
or (D) presence of IL-1α. 
 
UVA radiation had no effect on TACE expression (Figure 5.6B). When these cells 
were treated with vitamin C and trolox, a slight increase in TACE expression was 
seen. In the UVA-irradiated cells treated with IL-1α, TACE expression was not 
changed. Also, a slight elevation in TACE expression was observed when these 
irradiated cells were treated with vitamin C and trolox. 
Exposure to UVB radiation increased TACE levels in MM418-C5 cells (Figure 
5.6C). In addition, when these cells were treated with vitamin C, DMSO and trolox, 
there was an increase in TACE levels. When IL-1α was added to the UVB-irradiated 
cells, TACE levels were reduced compared to that seen in the irradiated cells alone 
(Figure 5.6C). Moreover, when these cells were treated with antioxidants, there was 
a reduction in the expression of TACE in these cells, which were similar to that seen 
in the untreated UVB-irradiated cells treated with IL-1α. 
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TACE levels were not changed when the cells were exposed to UVAB radiation 
(Figure 5.6D). Treating these cells with vitamin C, DMSO or trolox had no effect on 
TACE levels. When the UVAB-irradiated cells were treated with IL-1α, no change 
in TACE expression was observed. Treatment with vitamin C caused a decrease in 
TACE expression, which was unexpected and this experiment would to be repeated 
to confirm the observed result, while DMSO and trolox had no effect. 
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Figure ‎5.6 Effect of antioxidants on the expression of TACE in UV-irradiated MM418-5 cells 
TACE (mTACE and pTACE) levels were measured in (A) sham- (B) UVA- (0.6 J/cm2), (C) UVB- (0.03 J/cm2), 
and (D) UVAB-irradiated (0.6 J/cm2 UVA+ 0.03 J/cm2 UVB) MM418-C5 cells, 24 h post-irradiation cultured in 
the presence or absence of IL-1α (10 ng/ml), and treated with either vitamin C (1 mM), DMSO (0.1% v/v), trolox 
(0.1 mM) or nothing (Controls). Data represents the mean±SD from samples for one-two separate experiments. 
No statistical comparisons were made due to the low number of replicate samples. 
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5.2.3 Effect of antioxidants on Furin expression in UV-irradiated melanoma 
cells 
The effect of antioxidants on the expression of furin in both melanoma cell lines 
were examined, in the presence or absence of IL-1α (10 ng/ml), at 24 h post-UV 
exposure. The cells were treated with vitamin C (1 mM), DMSO (0.1% v/v) and 
trolox (0.1 mM) 24 h prior to being exposed to either UVA and/or UVB radiation. 
Following UV exposure, the antioxidants were re-added to the cells and at 24 h post-
irradiation the expression of furin was detected using western blots. 
 
5.2.3.1 Effect of antioxidants on Furin expression from UV-irradiated 
MM418-C1 cells 
Changes in the expression of furin were expressed as a fold change to the level seen 
in unirradiated controls. Furin levels in the unirradiated controls were expressed as 
unity (1). 
In the sham-irradiated cells, vitamin C, DMSO and trolox had no effect on furin 
levels in the MM418-C1 cells (Figure 5.8A). Furthermore, IL-1α reduced furin 
expression by 30% in these cells. When these cells were treated with DMSO or 
trolox, no changes in furin expression were observed, while vitamin C caused a 60% 
reduction. 
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Figure ‎5.7 A representative western blot probed for furin in MM418-C1 cells 
Changes in the level of furin expression were observed in UV-irradiated MM418-C1 cells treated with 
antioxidants [vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM)] in the presence or absence of IL-1α. 
The cells were exposed to either sham or UVA radiation (0.8 J/cm2) in the (A) absence or (B) presence of IL-1α. 
Cells were exposed to either UVB (0.04 J/cm2) or UVAB (0.8 J/cm2 UVA + 0.04 J/cm2 UVB) in the (C) absence 
or (D) presence of IL-1α. 
 
UVA radiation had no effect on furin expression in MM418-C1 cells (Figure 5.8B). 
Antioxidant treatment slightly decreased in furin levels. In the UVA-irradiated cells 
treated with IL-1α, furin levels were 10% higher compared to the untreated irradiated 
cells. Neither DMSO nor trolox treatment had an effect on furin expression, while 
vitamin C caused a 70% drop in expression, compared to cells not treated with      
IL-1α. 
Exposure to UVB radiation slightly reduced furin levels (Figure 5.8C). Trolox 
treatment increased furin levels by 48%, while that of vitamin C and DMSO caused 
no effect in these cells. In the UVB-irradiated cells treated with IL-1α, furin levels 
decreased by 32% in comparison to the untreated irradiated cells. When these cells 
were treated with the antioxidants, there was a slight reduction in furin levels, but in 
cells given DMSO there was a slight increase. 
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UVAB radiation caused a slight increase in furin levels when compared to the sham-
irradiated controls (Figure 5.8D). Trolox treatment increased furin levels by 34%, 
while vitamin C and DMSO had no effect in these cells. The addition of IL-1α to the 
UVAB-irradiated cells had no effect on furin expression (Figure 5.8D). When the 
antioxidants were added to these treated cells, vitamin C enhanced furin expression 
by 87% while trolox decreased levels by 66%.  
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Figure ‎5.8 Effect of antioxidants on the furin expression from UV-irradiated MM418-C1 cells 
Furin levels were measured in the cells exposed to (A) sham-irradiation, (B) UVA radiation, (C) UVB radiation 
and (D) UVAB radiation. The cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 
mM) 24 h prior to being exposed to UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation. The antioxidants were 
added to the irradiated cells and furin levels measured 24 h post-irradiation. Cells were also treated with IL-1α 
(10 ng/ml) to observe its effect on furin secretion. Data is represented as the mean±SD for samples from two 
separate experiments. No statistical comparisons were made due to the low number of replicate samples. 
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5.2.3.2 Effect of antioxidants on Furin expression from UV-irradiated 
MM418-C5 cells 
When comparing the effect of UV radiation, IL-1α and antioxidants on the 
expression of furin in this cell line, changes in the expression of furin were expressed 
as a fold change to the level seen in unirradiated controls. Furin levels in the 
unirradiated controls were expressed as unity (1). 
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Figure ‎5.9 A representative western blot probed for furin in MM418-C5 cells 
Changes in the level of furin expression were observed in UV-irradiated MM418-C5 cells treated with 
antioxidants [vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM)] in the presence or absence of IL-1α. 
The cells were exposed to either sham or UVA radiation (0.6 J/cm2) in the (A) absence or (B) presence of IL-1α. 
Cells were exposed to either UVB (0.03 J/cm2) or UVAB (0.6 J/cm2 UVA + 0.03 J/cm2 UVB) in the (C) absence 
or (D) presence of IL-1α. 
 
In the sham-irradiated cells, vitamin C treatment decreased furin expression by 80%, 
while trolox increased levels by 190% (Figure 5.10A). When IL-1α was added to the 
sham-irradiated cells, a slight increase in furin expression was observed. Trolox 
slightly increased furin levels of IL-1α treated cells, while treatment with vitamin C 
and DMSO did not have an effect. 
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Exposure to UVA radiation resulted in a 2.5±1.1-fold increase in furin levels (Figure 
5.10B). When these cells were treated with antioxidants, there was a slight decrease 
in furin levels. When the UVA-irradiated cells were treated with IL-1α, furin levels 
fell by 48% compared to the untreated irradiated cells. Treatment with trolox 
increased furin levels by 123%. However, neither vitamin C nor DMSO had any 
effect.  
UVB radiation enhanced the expression of furin in the cells by 60% when compared 
to the unirradiated controls (Figure 5.10C). Treating the cells with antioxidants 
slightly increased furin levels. In the UVB-irradiated cells treated with IL-1α, furin 
levels were elevated in comparison to the untreated irradiated cells, however due to a 
large degree of experimental error more data points are needed before a definitive 
statement on the effect of UVB and antioxidants have on furin expression can be 
made. When these cells were treated with the antioxidants, trolox increased furin 
expression by 18%, while neither vitamin C nor DMSO had an effect.   
UVAB radiation slightly increased furin levels when compared to the sham-
irradiated controls (Figure 5.10D). Treatment with vitamin C, DMSO or trolox had 
no effect in these cells. In the UVAB-irradiated cells treated with IL-1α, furin levels 
increased by 420% compared to that observed in the untreated irradiated cells. 
Antioxidant treatment was shown to have no effect on furin expression in these cells. 
Due to the large variation in the levels of furin detected in the UVB- and UVAB-
irradiated cells treated with IL-1α, further replicates need to be tested to confirm the 
extent by which IL-1α modulates the expression of this protein in these irradiated 
cells.  
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Figure ‎5.10 Effect of antioxidants on the expression of furin in UV-irradiated MM418-C5 cells 
Furin levels were measured in the cells exposed to (A) sham-irradiation, (B) UVA radiation, (C) UVB radiation 
and (D) UVAB radiation. The cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 
mM) 24 h prior to being exposed to UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation. The antioxidants were 
added to the irradiated cells and furin levels measured 24 h post-irradiation. Cells were also treated with IL-1α 
(10 ng/ml) to observe its effect on furin secretion. Data is represented as the mean±SD for samples from two 
separate experiments. No statistical comparisons were made due to the low number of replicate samples. 
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5.3 Discussion 
 To the best of my knowledge, there are only a few studies that have looked at the 
effect UVR has on the secretion of TNF-α from keratinocytes, melanocytes and their 
tumour cell derivatives. While Skiba et al. (2005), Hynh et al. (2009) and Ravi 
(2010) have investigated the effect of different UVR types on TACE and furin 
mRNA and protein expression in keratinocytes (146, 209, 322), no one has done so 
using melanocytes or melanoma cells. In this study, I have investigated the effect of 
different types of UVR on TNF-α secretion, TACE and furin expression in lightly-
pigmented MM418-C1 and darkly-pigmented  MM418-C5 melanoma cells. The cell 
lines were chosen in order to enhance our understanding of the role melanin may 
play with regards to the effect UVR has on these proteins. 
While there are studies that looked at the effect of antioxidants on TNF-α post UV-
irradiated cells (196), no studies have been performed investigating the effect of 
antioxidants on UV-irradiated melanocytes or melanoma cells on TACE and furin. In 
this study, I investigated the effect of non-enzymatic antioxidants (vitamin C and 
trolox) on TNF-α, TACE and furin in UV-irradiated melanoma cells. 
Unfortunately due to time constraints, it was not possible to investigate HEM 
(Human Epidermal Melanocytes) as part of this study. I have made suggestions in 
section 7.3 about what experiments could be performed if these cells were available.   
 
5.3.1 The effect of antioxidants on TNF-α release from UV-irradiated 
melanoma cells 
UVR has been shown to play a role in cytokine gene expression and the induction of 
TNF-α, which in turn has been shown to regulate cell signalling in keratinocytes (39, 
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196, 209) and cause a myriad of pro-inflammatory effects in the skin (203). IL-1α is 
a member of the IL-1 cytokine family, which is involved in the regulation of many 
cellular responses to injury and infection (146, 331). IL-1α is produced following 
UV radiation of keratinocytes, fibroblasts and skin equivalents under in vitro 
conditions (196-198). On neighbouring cells like melanocytes, which express IL-1 
receptors, IL-1α can initiate cell signalling in a paracrine/autocrine fashion (196, 
199, 200). Bashir et al. (2009) found that the synergistic effect of IL-1α and UVB 
enhanced the formation of TNF-α in human keratinocytes and fibroblasts (203). 
They also observed that the secretion of TNF-α was enhanced following exposure to 
UVB, but not by UVA radiation (203). In addition, Ravi (2010) found that exposure 
to the synergistic effect of IL-1α and UVAB [UVA (40 kJ/m2) followed by (2 kJ/m2) 
UVB] resulted in a significant increase in TNF-α in HEK, HaCaT and Colo 16 cells  
(146). Ravi (2010) also found that UVAB increased TNF-α formation/release from 
HEK cells (33-fold) followed by HaCaT cells (4.2-fold), with the lowest increase 
seen in Colo 16 cells (SCC cell line)(3.5-fold) when compared to their respective 
untreated UVAB-irradiated cells (146). Also, they showed that TNF-α levels fell 
80% post-UVA radiation in Colo 16 compared to sham-irradiated controls. However, 
treating the cells with IL-1α increased TNF-α secretion from UVA-irradiated cells 
compared to unirradiated controls (146). 
In this present study, IL-1α enhanced the release of TNF-α from both sham- and UV-
irradiated MM418-C1 cells. While these increases were not significant, the greatest 
increase was observed in the UVAB-irradiated cells, while the lowest increase was 
observed in UVA-irradiated cells (Figure 5.1). These results were similar to a study 
on the SCC cell line Colo 16 cells (146). In the presence of IL-1α there was an 
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increase in TNF-α levels secreted from the UV-irradiated Colo 16 cells, which was 
only statistically significant in UVAB-irradiated cells (146). 
Muthusamy et al. (2011) found that TNF-α levels were not induced by UVB in HEM 
and MM96L melanoma cells in the absence of IL-1α (196). However, when IL-1α 
was added to UVB-irradiated cells there was a significant increase in TNF-α release 
in HEM (120-fold) and MM96L melanoma cells (101-fold), compared to the sham-
irradiated untreated cells (196).  
The results obtained here show similar results to Ravi (2010) and Muthusamy et al. 
(2011) in that UVR increased the TNF-α released from cancerous epidermal cells, 
however the responses differed depending on the cell type, type of UV and the 
radiation doses used (146, 196). 
The level of TNF-α secreted from MM418-C1 cells were 4.5-fold that seen in 
MM418-C5 cells (Figures 5.1 and 5.2). The reduced levels seen in MM418-C5 cells 
may be related to the increased levels of melanin present in these cells. Exposure to 
UVA radiation did not increase TNF-α levels, even if IL-1α was present. In UVB-
irradiated cells, there was a slight increase in TNF-α levels, but IL-1α addition had 
no effect. In the UVAB-irradiated cells there was a non-significant increase in   
TNF-α levels, although IL-1α addition appeared to have a suppressive effect. The 
difference between MM418-C1 and MM418-C5 cells shows that higher melanin 
levels in the latter cells reduced the production of TNF-α in those cells exposed to 
UVR, even if IL-1α was present.   
The addition of antioxidants to the MM418-C1 cells did not have a significant effect 
on TNF-α secreted from the UV-irradiated cells, even if they were treated with      
IL-1α. In the MM418-C5 cells, vitamin C reduced TNF-α secreted from sham-
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irradiated cells, as well as in those cells exposed to UVB or UVAB radiation that 
were supplemented with IL-1α. Trolox only reduced TNF-α levels in UVAB-
irradiated cells that were not supplemented with IL-1α. Overall, it was observed that 
treatment with the antioxidants did not significantly modulate the release of TNF-α 
from the UV-irradiated melanoma cell lines. 
Muthusamy et al. (2011) found that α-tocopherol did not significantly affect the 
secretion of TNF-α from UVB-irradiated MM96L cells (196), which was similar to 
that observed in this study. Pupe et al. (2003) looked at the effect of different 
antioxidants on TNF-α mRNA levels released from UVB-irradiated keratinocytes 
(332).  When these UVB-irradiated cells were treated with 3 mM NAC, increased 
levels of TNF-α mRNA were observed. When the cells were treated with vitamin C 
(1 mM) and vitamin E (50 μM), minimal effects on TNF-α mRNA levels were 
observed. These results suggested that vitamin C and E had a weak effect on the 
levels of TNF-α mRNA released from UVB-irradiated keratinocytes (332). While 
TNF-α mRNA expression levels were not examined in this study, one can speculate 
that the antioxidants had minimal effects on these levels. 
The lower levels of TNF-α produced in the UV-irradiated darkly-pigmented 
MM418-C5 cells suggests that, due to its ability to absorb higher levels of UVB-
photons, this may have moderated the secretion of TNF-α when compared to that 
seen in melanoma cells containing less melanin. Further studies on the role that 
melanin plays in modulating UV cellular responses are warranted. Similarly, the 
effect of other antioxidants, such as NAC, has on modulating the secretion of TNF-α 
from the UV-irradiated cells, should also be investigated.   
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5.3.2 The effect of antioxidants on TACE expression in UV-irradiated 
melanoma cells 
Recently, numerous studies have focused on the importance of cytokines as a 
connection between inflammation and cancer, as TNF-α has been shown to be 
involved in many inflammatory diseases including Crohn’s disease, as well as 
ulcerative and rheumatoid arthritis (306-308). While TNF-α may play a role in 
tumour growth and metastasis by acting as an endogenous tumour promoter 
contributing to tissue remodelling and stromal development (306, 333), in another 
study it was shown to have a conflicting role in malignant diseases – where high 
doses of TNF-α damaged tumour blood vessels and was shown to be a powerful anti-
cancer agent (306, 308). Therefore, it is important to know how this cytokine is 
activated in tumour cells. 
TNF-α converting enzyme (TACE), also called metalloproteinase ADAM-17, 
cleaves membrane pre pro form mTNF-α to its soluble mature form (sTNF-α) (189, 
306, 334). TACE itself exists as two forms within the cell: an inactive pre pro form 
(pTACE) and a mature form (mTACE). Furin is one enzyme which is responsible for 
the activation of TACE in the cell (146, 187, 211).  
In this current study, the expressions of both forms of TACE were investigated at 24 
h post-irradiation in the presence or absence of IL-1α in both melanoma cell lines. 
To the best of my knowledge, no other studies have shown the effect antioxidants 
may play a role in this process in these tumour cells. 
Individual pTACE and mTACE levels were expressed as a ratio of the sum of both 
TACE forms detected in sham-irradiated controls. Ge et al. (2009) found that both 
higher levels of TACE activity and protein were present in the tumour cells and 
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tissue of the head and neck region, compared to that found in normal keratinocytes 
or oral mucosa (335). They suggested that the increase in TACE expression could 
have biological and clinical relevance which can be used as biomarkers in the 
prognosis of cancer (335). Sjarma et al. (2014) found that preventing skin 
tumorigenesis in mice can be achieved by the blocking of inflammatory events 
facilitated through the inhibition of TACE activation (306). Ravi (2010) observed 
that UVR reduced the expression of pTACE in HEK and HaCaT at 24 h post-UV 
exposure, while that of mTACE was higher in HEK, HaCaT and Colo 16 cells. Ravi 
also found that UVR increased the expression of both forms of TACE in Colo 16 
cells, however, it reduced expression in both HEK and HaCaT cells (146). In this 
study, UVR had no effect on the total expression of TACE post-UVA or UVB in 
both melanoma cells; while UVAB increased levels in these cells. This increase was 
due to higher levels of mTACE. Treating the cells with antioxidants did not affect 
the expression of pTACE or mTACE in the irradiated cells, except that trolox 
enhanced mTACE levels in the UVB-irradiated cells. The addition of IL-1α to the 
MM418-C1 cells caused no change in total TACE expression post-UV radiation, and 
treatment with the antioxidants (vitamin C and trolox) had no effect on these levels. 
Furthermore, in UVB-irradiated cells treated with IL-1α DMSO increased total 
TACE expression. Exposure of MM418-C1 cells to UVAB elevated total TACE 
expression. Treating these UVAB-irradiated cells with antioxidants caused a slight 
increase in TACE levels.  
In the MM418-C1 cells, TACE levels were not increased in the cells post-UVR. The 
addition of IL-1α did not enhance the expression of TACE in the irradiated cells. 
This differed to the results of Ravi (2010), which showed that IL-1α reduced the 
levels of both forms of TACE in HEK, HaCaT and Colo 16 cells post-UVA and -
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UVB exposure (146). In the UVAB-irradiated cells, IL-1α enhanced pTACE and 
mTACE levels in HEK and HaCaT cells, but not in Colo 16 cells. Thus, my results 
suggest that IL-1α may not have a synergistic effect with UV-radiation in both 
pigmented melanoma cells. Similar to MM418-C1, treating MM418-C5 cells with 
antioxidants did not change TACE expression either in sham-irradiated cells or post-
UV exposure. This result may not be unexpected, as both MM418-C1 and    
MM418-C5 cells are derived from the same tumour, and therefore they would be 
expected to have similar levels of TACE and furin expression. It may be beneficial 
to investigate the effect IL-1α and UVR may have on TACE and for furin expression 
in melanoma cells, by comparing cells derived from both primary and secondary 
tumours. It would be expected that the expression of both enzymes would be higher 
in cells obtained from the secondary tumour, as they undergo metastasis their levels 
of enzymes (e.g. MMPs), which degrade the extracellular matrix, would be higher to 
that seen in both benign and primary tumours.  
Overall UVR did not change the TACE levels in both melanoma cell lines and these 
results are in agreement with that seen in the SCC Colo 16 cells (146, 335). The 
addition of antioxidants did not affect the expression of TACE which suggests that 
they do not play a role in modulating its synthesis.  
The addition of IL-1α, which stimulated TNF-α production in the irradiated  
MM418-C1 cells but not MM418-C5, did not influence the expression of TACE in 
either cell. This suggests that the activation of TACE is unrelated to that of TNF-α 
production in these cells. However, further experiments are required to confirm this 
observation. 
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5.3.3 The effect on antioxidants on furin expression in UV-irradiated 
melanoma cells 
Furin is a proprotein convertase (PC) that is expressed in different tissues at low 
levels (335). It plays an important role in the process of many diseases including 
cancer metastasis (146, 220, 336, 337). UVR has been shown to induce the activity 
of many proteases in the skin (322). One of these proteases is furin, which is 
expressed in epidermal cells. As UVR is the main environmental cause of skin 
cancers, the effect it plays on furin expression in both melanocytes and melanoma 
cell lines is important but still unknown. Likewise, the effect antioxidants have on 
furin levels in melanocytic cells post-UVR is not well understood.  
Bassi et al. (2001) looked at the furin expression in a number of SCC cell lines and 
found that the most invasive cells had the highest furin expression (338). Huynh et 
al. (2009) observed that furin expression in HaCaT cells was reduced post-UV 
exposure, but it increased in Colo 16 cells exposed to UVB or UVAB radiation 
(322). Ravi (2010) found that while furin expression was induced by UVR in HaCaT 
and Colo 16 cells, it was not in HEK cells (146). Endogenous levels of furin were 
less in Colo 16 cells compared to that seen in HaCaT cells (146). Exposure to UVAB 
radiation enhanced furin expression in HaCaT, while UVB elicited a similar effect in 
Colo 16 cells. Ravi (2010) suggested that the difference observed in her results may 
be due to the fact that Huynh et al. (2009) used both attached and detached cells in 
their experiments, while Ravi (2010) only used attached cells in her study. In my 
study, I found that UVR did not change the expression of furin in both MM418-C1 
and MM418-C5 cell lines, which differed to that seen in irradiated keratinocytic cells 
(146, 322). This suggests that UVR does not influence the expression of furin in the 
melanoma cells compared to that seen in SCC cells. The difference in melanin levels 
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of the two melanoma cell lines also did not have an effect on furin levels in the UV-
irradiated cells. 
 Ravi (2010) also found that the addition of IL-1α to the keratinocyte-derived cells 
had minimal effects on furin expression, and suggested that this cytokine does not 
play a role in regulating the expression of this enzyme. 
In this study, IL-1α did not alter furin expression in UV-irradiated MM418-C1 cells, 
which agreed with that seen in keratinocyte-derived cells (146). In the darkly-
pigmented      MM418-C5 cells, IL-1α addition also did not significantly affect furin 
levels in the UV-irradiated cells, however, further experiments are needed to confirm 
this is correct.  
None of the antioxidants studies in this chapter had an effect on furin expression in 
either of the UV-irradiated melanoma cells, irrespective of whether they had been 
treated with IL-1α or not.  
The mechanism by which furin is regulated in the melanoma cells is not clear, and 
other factors may be involved in this mechanism. Further studies on the regulation of 
furin levels in melanocytic cells are warranted, and would form the basis for further 
studies in understanding melanoma metastasis. The MM418 cell lines are derived 
from primary human melanoma, so the regulation of furin in secondary human 
melanoma cell lines can also be examined in order to see if there is a difference in 
furin levels post-UVR between primary and secondary melanoma cell lines as it may 
implicate in the tumour cell invasive process.  
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CHAPTER 6 
EFFECT OF ANTIOXIDANTS 
ON UV-ACTIVATED CELL 
SIGNALLING PATHWAY 
ACTIVITY IN MELANOCYTE-
DERIVED CELLS 
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Chapter 6. Effect of antioxidants on UV-activated cell signalling 
pathway activity in melanocyte-derived cells 
6.1 Introduction 
UVR is one of the main carcinogens that can transform melanocytes to melanoma 
(65, 258). UVR can initiate molecular interactions which differ depending on 
whether they are initiated by UVA and/or UVB radiation. Furthermore, these 
interactions can give rise to abnormal cellular processes including: genetic alteration, 
cell signalling and causing either the upregulation or downregulation of cytokine 
release (258). Moreover, UVR plays an important role in melanomagenesis by 
inducing the alteration of genetic/epigenetic changes in melanocyte chromosomes 
(339). The RAS/RAF/MEK/ERK (MAPK) and PI3K/PTEN/AKT pathways are the 
two main signalling pathways observed in human melanomas (339), and are 
constitutively activated via genetic alterations (339). It was found that the mutations 
of RAF, RAS and PTEN contribute to abnormal proliferation and tissue invasion for 
melanoma development and progression (339). 
The B-RAF/ERK (extracellular-regulated kinase) signalling pathway in melanoma 
cells has been extensively studied (258, 340). However, the link between p38, JNK 
and nuclear factor-κB (NFκB), which are the other mitogen-activated protein kinases 
(MAPK), has not been fully associated with the incidence of melanoma (258). On 
the other hand, it has been suggested that the synergistic effect between 
activation/inhibition of these signalling pathways and the use of chemotheraptic 
agents can cause cytotoxicity in melanoma cells (341, 342). Moreover, it has been 
suggested that these signalling pathways maybe involved in the malignant 
transformation of melanocytes (343, 344).  
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It has been suggested that p38 and JNK play a role in apoptosis, the development of 
melanoma and chemoresistance, and as such, they need to be examined more 
thoroughly as this interaction appears to differ with different types of UVR and cell 
types  (258). 
Also, Muthusamy and Piva (2013) found that p38 MAPK and JNK pathways are 
activated differently in UV-irradiated melanocytes and melanoma cells (MM96L) 
(177). They suggested  that the UV response in these cells was cell type-dependant 
(177). Thus, it has been suggested that the other MAPK pathways may play a role in 
the development and progression of melanoma on their own, or in connection with, 
ERK (340).  Thus, the usage of topical applications containing antioxidants may 
regulate the activation of these signalling pathways, as well as decrease the 
deleterious effects elicited by these pathways. 
Vitamin C (ascorbic acid) is an antioxidant that has numerous physiological and 
pharmacological functions in different processes including: antioxidation and 
cardiovascular disease (345, 346). It was found that topical applications containing 
vitamin C restored the depleted levels of this antioxidant in the skin caused by UV 
exposure (248). Moreover, some studies observed that photoprotection was enhanced 
in human and animal skin by using topical applications of antioxidants (such as 
vitamin C) (248, 249). Vitamin C and/or E have also been shown to reduce chronic 
UVB-induced photodamage and photocarcinogenesis in animal skin (248, 249). 
Lee et al. (2011) found that the phosphorylation of p38 was induced by ascorbic 
acid, while no effect was found on p-ERK levels in B16F10 melanoma cells (347). 
They also found that the inhibition of p38 MAPK pathways resulted in the reduction 
of tyrosinase expression mediated by ascorbic acid in B16F10 melanoma cells (347). 
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These results showed that the activation of p38 MAPK signalling pathways and 
subsequent up-regulation of Microphthalmia-associated transcription factor (MITF), 
tyrosinase and tyrosinase-related protein (TRP) expression was increased by the 
addition of ascorbic acid in melanoma cells (347).    
Peus et al. (2001) have shown that trolox – which is a water-soluble analog of 
vitamin E (α-tocopherol) – is an antioxidant with preventative and protective 
potential against the harmful effects of UV radiation on human skin (128). They also 
showed that a physiological UVB dose activated epidermal growth factor receptor 
(EGFR)/(ERK-1/2) and p38 signalling pathways though ROS, and this activation 
was modulated by pre-treatment with trolox (128).  Trolox strongly inhibited the 
activation of ERK-1/2 at a lower concentration, and p38 activation at a higher 
concentration, when it was added to keratinocytes prior to exposure to UV radiation 
(128). However, no significant reduction was observed in UVB-induced EGFR 
phosphorylation in these cells (128). Of interest was the finding that, the longer 
trolox was added to the cells pre-UVB exposure, the greater was the survival rate 
(128). A study by Muthusamy et al. (2011) showed that the lipophilic antioxidants α-
tocopherol, CO2-supercritical fluid extract (CO2-SFE) of green-lipped mussel oil and 
5β scymnol reduced the production of TNF-α in melanocytes, but not in MM96L 
melanoma cells, that were treated with IL-1α and exposed to UVB radiation (196). 
This reduction was not due to the intracellular p38 signalling pathway inhibition, 
instead it appeared that these antioxidants mediated their effects through different 
signalling pathways (196). 
Recently, it has been suggested that MAPK (p38, MAPK and JNK) pathways play a 
role in the malignant transformation of melanocytes and the progression of 
melanoma (318, 343). For example, Alexaki et al. (2008) found that JNK, especially 
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JNK-1, supported the growth of melanoma growth cells. This process occurred 
through either regulating the progression of the cell cycle or apoptosis (343). Also, 
p38 was found to play a role in sensitising melanoma cells to UV-induced 
programmed cell death – this happened in response to aberrant TRAF2 signalling 
pathways (318). 
In this study, I have investigated the effect of different types of UV on MAPK 
signalling pathways in cultured MM418-C1, MM418-C5 and HEM cells. These cell 
lines have been selected in order to observe the effect of UVR in normal 
melanocytes and in oncogenic processes (e.g. melanoma cells). The different 
pigmented melanoma cell lines were chosen to observe the effect that melanin may 
play in the cells following exposure to UV radiation. 
This study investigated the effect of UVR on the phosphorylation of B-RAF, ERK, 
JNK and p-38 in melanocytes and pigmented melanoma cell lines, and the effect that 
vitamin C and trolox had on these signalling intermediates.  
 
6.2 Results 
6.2.1 Effect of antioxidants on UV-activated cell signalling pathway activity 
Changes in the levels of B-RAF, ERK, p38 and JNK in the UV-irradiated cells were 
observed over the first 2 h post UV-exposure. B-RAF is located upstream of the 
MAPK kinase family which regulates ERK, while p38 and JNK respond to stress 
stimuli such as UV radiation. MM418-C1 and MM418-C5 cells were exposed to 
either UVA and/or UVB radiation as seen in Table 2.1. In this investigation, the 
reason for conducting a time course experiment was to identify the maximal 
expression time point for these proteins and to look at the effect that antioxidants 
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may have on their expression levels post-UV exposure. When investigating HEM 
cells, the effects that antioxidants had on the expression of these proteins post-UV 
exposure were examined at the same time points as for the melanoma cell lines. 
Western blots were run using cell lysates and the respective proteins were resolved 
using relevant antibodies, as described in Section 2.8. GAPDH levels were also 
measured for each cell lysate and were used as a loading control for the expression 
of each signal pathway intermediate, as described in Section 2.8.  
 
6.2.1.1 Effect of UV radiation on cell signalling pathway activity in MM418-C1 
cells 
6.2.1.1.1 Effect of UV radiation on B-RAF activity  
B-RAF is found upstream of the MAPK kinase family and it is mutated in up to 50% 
of melanomas (65, 66). Due to its importance in melanomas, the levels of 
phosphorylated B-RAF (p-B-RAF) were observed at different time points post-UV 
exposure of MM418-C1 cells, as seen in Figure 6.1. 
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Figure ‎6.1 A representative western blot showing changes in p-B-RAF levels in UV-irradiated MM418-C1 
cells during the first 120 min post-exposure  
MM418-C1 cells were exposed to either UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation. At different time 
points post-irradiation (0, 5, 15, 30, 60 and 120 min), cell lysates were run on western blots. The blots were 
probed with an anti-p-B-RAF antibody and an anti-GAPDH antibody, which was used to monitor protein levels 
in the cell lysates (See Section 2.8).  
 
In the MM418-C1 cells, levels of p-B-RAF did not change during the first 120 min 
post-UVA exposure (Figure 6.2). A similar observation was also noted for p-B-RAF 
levels in cells exposed to UVB or UVAB over the same time period. As intracellular 
p-B-RAF levels do not change post-UV radiation it suggests that UV does not 
activate this signalling pathway intermediate. This finding is in agreement with that 
seen previously as B-RAF
V600E
 is not a UV-signature mutation in melanomas. 
Thomas et al. (2006) suggested that B-RAF mutations could still increase from error 
replication of DNA damage caused by UVR. 
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Figure ‎6.2 Time course of p-B-RAF expression in UV-irradiated MM418-C1 cells 
The effect of UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation on the expression of p-B-RAF was measured at 
different time points (0-120 min). Data is represented as the mean±SEM from three separate experiments. 
 
 
6.2.1.1.2 Effect of UV radiation on ERK-1/2 activity 
ERK is a member of MAPK kinase family occurring downstream from RAF (157). 
In this experiment, the levels of phosphorylated ERK-1/2 (p-ERK-1/2) were 
observed at different time points up to 120 min post-UV exposure of MM418-C1 
cells, as seen in Figure 6.3. 
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Figure ‎6.3 A representative Western blot showing changes in p-ERK-1/2 levels in UV-irradiated MM418-C1 
cells during the first 120 min post-exposure 
MM418-C1 cells were exposed to either UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation. At different time 
points post-irradiation (0, 5, 15, 30, 60 and 120 min), cell lysates were run on western blots. The blots were 
probed with an anti-p-ERK-1/2 and an anti-GAPDH antibody to monitor the level of protein present in the cell 
lysate (See Section 2.8).  
 
B-RAF plays an important role in activating the ERK signalling pathway. As two 
isoforms of ERK exist (37, 158), each of the levels of phosphorylated ERK-1 and 
ERK-2 were monitored over the first 120 min post-UV exposure. A polyclonal 
phosphorylated ERK-1 and ERK-2 antibody was used in western blots in order to 
observe the expression of these proteins     post-UV (A and/or B) exposure. The 
phosphorylation levels of ERK-1 (44 kDa) and ERK-2 (42 kDa) following UV 
exposure were calculated as a percentage of the total ERK-1 and ERK-2, when 
normalised to that of the protein loading control GAPDH. 
Exposure to UVA had no effect on p-ERK-1 levels over the first 120 min, which 
remained at control levels (0.48-fold). Similar to that seen for ERK-1, p-ERK-2 
levels were not changed post-UVA in the first 30 min; after this time, they reached a 
peak (0.68-fold) at 60 min before falling back to that of sham-irradiated control 
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levels (0.51-fold) at 120 min (Figure 6.4A and B), but this was not statistically 
significant.  
Following UVB exposure, p-ERK-1 levels decreased gradually from 0.48-fold at 0 
min reaching a minimum at 15 min (0.33-fold). p-ERK-1 levels then gradually rose 
and reached 0.55-fold at 120 min. Following exposure to UVB, p-ERK-2 levels rose 
in the first 5 min (0.61-fold) compared to unirradiated controls at 0 min (0.51-fold). 
After this, the levels gradually decreased to a minimum at 30 min (0.55-fold) before 
rising to 0.83-fold at 120 min (Figure 6.4A and B). 
When exposed to UVAB radiation, p-ERK-1 levels rose from that at 0 min to a peak 
at 60 min (0.65-fold) before falling to 0.51-fold by 120 min. Exposure to UVAB 
radiation saw an initial decrease in p-ERK-2 levels to 0.48-fold at 15 min. After 
which p-ERK-2 levels increased to a maximum of 0.79-fold at 60 min before 
returning to baseline levels (0.59-fold) at 120 min. 
In summary, exposure to UV-radiation had a minimal effect on p-ERK levels within  
MM418-C1 cells, and suggests that UV does not directly signal via this intermediate 
of the MAPK pathway.  
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Figure ‎6.4 Time course of p-ERK 1/2 expression in UV-irradiated MM418-C1 cells 
The effect of UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation on the expression of (A) p-ERK-1 and (B)     
p-ERK-2 proteins at different time points (0-120 min) were determined by western blots. Expression of p-ERK-1 
and p-ERK-2 was calculated as the relative component of the total level of p-ERK (1+2) found in the sham-
irradiated controls. Data is represented as the mean±SEM from three separate experiments.  
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6.2.1.1.3 The effect of UV radiation on JNK-1/2 activity 
JNK is a member of MAPK family, which is known to be activated by UV and other 
stressors (142, 145). In this experiment, the levels of phosphorylated JNK-1/2        
(p-JNK-1/2) were observed at different time points post-UV exposure. A polyclonal 
antibody was used to probe for p-JNK-1/2 protein (46/54 kDa) using western blots, 
as seen in Figure 6.5. 
 
 
 
Figure ‎6.5 A representative western blot showing changes in p-JNK-1/2 levels in UV-irradiated MM418-C1 
cells during the first 120 min post-exposure 
MM418-C1 cells were exposed to either UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation. At different time 
points post-irradiation (0, 5, 15, 30, 60 and 120 min), cell lysates were run on western blots. The blots were 
probed with an anti-p-JNK-1/2 and an anti-GAPDH antibody which was used to monitor protein levels in the cell 
lysates (see Section 2.8).  
 
Similar to that of ERK, two isoforms of JNK exist in the cell (181). In this 
experiment, the expression levels of p-JNK-1 and p-JNK-2 were measured in the 
first 120 min post-UV (A and/or B) exposure. A polyclonal p-JNK-1 and p-JNK-2 
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antibody was used in western blots in order to observe the effect of UV radiation on 
the expression of these proteins. The phosphorylation levels of JNK-1 (46-48 kDa) 
and JNK-2 (56 kDa) following UV exposure were calculated as a percentage of the 
total JNK-1 and JNK-2 in control (sham-irradiated controls). The value of the total 
level of JNK (1+2) in the sham-irradiated control was given the value of unity (1). 
Due to the high variability in the data, statistically significant changes were not seen, 
however an overview of the observed trends are described below. 
In MM418-C1 cells, UVA exposure sharply raised the levels of p-JNK-1 from 
0.8±0.1-fold at 0 min, to 3.2±2.9-fold in the first 5 min post-UV exposure, as seen in 
Figure 6.6A. These levels slowly increased, reaching a peak of 4.4±4.1-fold at 60 
min, after which they dropped to 3.5±3.3-fold at 120 min. In the case of p-JNK-2 
levels in MM418-C1 cells, UVA irradiation increased these levels in the first 5 min 
(0.9±0.4-fold) compared to sham-irradiated controls (0.2±0.1-fold) at 0 min (Figure 
6.6B). Following this, these levels dropped to 0.7±0.1-fold at 15 min, before rising 
again to a peak at 60 min (1.3±0.1-fold), after which they fell to 0.8±0.1-fold at 120 
min. 
In response to UVB radiation, p-JNK-1 levels increased gradually reaching a peak of 
9.7±6.9-fold at 30 min compared to sham irradiated controls (0.8±0.1-fold) at 0 min. 
However, these levels decreased to 5.3±2.6-fold at 60 min before increasing again to 
8.0±3.9-fold at 120 min.  On the other hand, UVB radiation had less effect on the 
expression of p-JNK-2 in MM418-C1. There was a gradual increase in p-JNK-2 
levels from 0.2±0.1-fold at 0 min reaching a peak (1.2±0.7-fold) at 30 min. At 60 
min, p-JNK-2 levels fell to 0.7±0.1-fold, before rising to 0.9±0.4-fold at 120 min.  
177 | P a g e  
 
 
(A) 
 
 
(B) 
 
 
 
Figure ‎6.6 Time course of p-JNK 1/2 expression in UV-irradiated MM418-C1 cells 
The effect of UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation on the expression of (A) p-JNK-1 and (B)      
p-JNK-2 proteins at different time points (0-120 min) were determined by western blots. Expression of p-JNK-1 
and p-JNK-2 was calculated as the relative component of the total level of p-JNK (1+2) found in the sham-
irradiated controls. Data is represented as the mean±SEM from three separate experiments. 
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Exposure to UVAB immediately increased p-JNK-1 levels from 0.8±0.1-fold at 0 
min to 4.3±2.8-fold at 30 min. These levels fell to 3.9±2-fold at 60 min before 
increasing again to 4.1±2.6-fold at 120 min. On the other hand, the levels of p-JNK-2 
in general were unaffected in the cells following exposure to UVAB radiation. 
In general, UVA radiation had little or no effect on either p-JNK-1 or p-JNK-2 
levels, whereas UVB and UVAB increased p-JNK-1 levels within the cell and once 
activated, they remained high for up to 2 h post-irradiation.  This differed to that 
seen for p-JNK-2 in general, where UV radiation did not alter expression levels over 
the 2 h post-irradiation period. 
 
6.2.1.1.4 Effect of UV radiation on p38 activity  
The p38 protein is also a member of MAPK family and, like JNK, is activated when 
the cell is exposed to external stressors such as UV radiation (171). In this 
experiment, the levels of phosphorylated p38 (p-p38) were observed at different time 
points post-UV exposure. A polyclonal antibody was used to probe for p-p38 protein 
(43 kDa) in western blots, as seen in Figure 6.7. 
In UV-irradiated MM418-C1 cells, there was a rapid increase in p-p38 levels after 5 
min (3.0±1.2-fold) (Figure 6.8). After which, the p-p38 levels fell to 1.7±0.3-fold at 
15 min before rising to maximal levels (8.0±5.0-fold) at 60 min, before falling to 
2.3±1.1-fold at 120 min.  
When the cells were exposed to UVB radiation, p-p38 levels rapidly increased from 
1.0±0.1-fold at 0 min, peaking at 30 min (11.3±6-fold), before falling to 10.5±3.6-
fold at 120 min.  
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Figure ‎6.7 A representative Western blot showing changes in p-p38 levels in UV-irradiated MM418-C1 cells 
during the first 120 min post-exposure 
MM418-C1 cells were exposed to either UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation. At different time 
points post-irradiation (0, 5, 15, 30, 60 and 120 min), cell lysates were run on western blots. The blots were 
probed with an anti-p-p38 and an anti-GAPDH antibody which was used to monitor protein levels in the cell 
lysates (see Section 2.8).  
 
 
A similar observation was seen in cells exposed to UVAB radiation. Here p-p38 
levels rapidly increased to a peak of 12.5±1.5-fold after 15 min, where they remained 
constant over the next 105 min (11.2±0.7-fold at 120 min).  
In summary, it can be seen that UVR enhanced p-p38 levels in the MM418-C1 cells 
following exposure. Maximal increases in p-p38 levels were seen when the cells 
were exposed to UVB or UVAB radiation, but not UVA radiation. This finding 
agrees with what was seen in previous studies (37, 177).  
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Figure ‎6.8 Time course of p-p38 expression in UV-irradiated MM418-C1 cells 
The effect of UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation on the expression of p-p38 protein at different 
time points (0-120 min) were determined by western blots. Expression of p-p38 was calculated as the relative 
component of the total level found in the sham-irradiated controls. Data is represented as the mean±SEM from 
three separate experiments. Statistical significance was calculated by one-way ANOVA followed by Bonferroni’s 
multiple comparisons post-test. Significant difference between sham and UVAB is represented by (*). *p ≤ 0.05; 
**p ≤ 0.01; ***p ≤ 0.001 
 
 
 
6.2.1.2 Effect of UV radiation on cell signalling pathway activity in MM418-C5 
cells 
6.2.1.2.1 Effect of UV radiation on B-RAF activity 
The level of p-B-RAF in UV (A and/or B)-irradiated MM418-C5 cells was observed 
at different time points up to 120 min post-exposure. A polyclonal antibody was 
used to probe for p-B-RAF protein (86 kDa) in western blots, as seen in Figure 6.9. 
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Figure ‎6.9 A representative Western blot showing changes in p-B-RAF levels in UV-irradiated MM418-C5 
cells during the first 120 min post-exposure  
MM418-C5 cells were exposed to either UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation. At different time 
points post-irradiation (0, 5, 15, 30, 60 and 120 min), cell lysates were run on western blots. The blots were 
probed with an anti-p-B-RAF antibody and an anti-GAPDH antibody, which was used to monitor protein levels 
in the cell lysates (see Section 2.8).  
 
 
In UVA-irradiated MM418-C5 cells, p-B-RAF levels fell over the first 60 min 
reaching minimum levels (0.7±0.2-fold) at 60 min before returning to untreated 
control levels at 120 min (Figure 6.10). In the UVB-irradiated cells, p-B-RAF levels 
fell to 0.6± 0.1-fold at 15 min and remained relatively constant for the next 105 min 
(0.6±0.1-fold at 120 min). When exposed to UVAB radiation, p-B-RAF levels 
increased to 1.5±0.1-fold after 5 min and remained elevated until 60 min (1.4±0.1-
fold) before returning to control levels at 120 min.  
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Figure ‎6.10 Time course of p-B-RAF expression in UV-irradiated MM418-C5 cells 
The effect of UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation on the expression of p-B-RAF was measured at 
different time points (0-120 min). Data is represented as the mean±SEM from three separate experiments. 
 
 
6.2.1.2.2 Effect of UV radiation on p-ERK-1/2 activity 
In this experiment, the level of phosphorylated ERK-1/2 was observed at different 
time points post-UV exposure in MM418-C5 cells. A polyclonal antibody was used 
to probe for p-ERK-1/2 protein (44/42 kDa) in western blots (Figure 6.11). 
Exposure to UVA resulted in the gradual increase of phosphorylated ERK-1 levels 
from 0.4±0.1-fold at 0 min, to a peak of 0.6±0.1-fold at 30 min.  After which levels 
fell to 0.3±0.1-fold at 120 min (Figure 6.12). 
In response to UVB exposure, p-ERK-1 levels gradually increased from 0.4±0.1-fold 
at 0 min reaching 0.5±0.1-fold at 120 min. 
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Figure ‎6.11 A representative Western blot showing changes in p-ERK-1/2 levels in UV-irradiated MM418-C5 
cells during the first 120 min post-exposure 
MM418-C5 cells were exposed to either UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation. At different time 
points post-irradiation (0, 5, 15, 30, 60 and 120 min), cell lysates were run on western blots. The blots were 
probed with an anti-p-ERK-1/2 and an anti-GAPDH antibody, which was used to monitor protein levels in the 
cell lysates (see Section 2.8).  
 
 
In response to UVAB radiation, p-ERK-1 levels rose from 0.4±0.1-fold at 0 min to 
0.8±0.1-fold at 60 min before falling slowly to 0.7±0.1-fold at 120 min. UVA 
radiation increased p-ERK-2 levels from 0.6±0.1-fold at 0 min, peaking at 0.8±0.2-
fold at 30 min before falling to 0.5±0.1-fold at 120 min (Figure 6.12B). In UVB-
irradiated MM418-C5 cells, p-ERK-2 levels fell from 0.7±0.1-fold at 0 min to 
0.5±0.1-fold at 5 min, after which they increased to 0.7±0.1-fold at 30 min and 
remained constant for the next 90 min. Exposure to UVAB resulted in an increase in 
p-ERK-2 levels from 0.7±0.1-fold at 0 min to a peak of 1.6±0.5-fold at 60 min, after 
which they fell to 1.0±0.2-fold at 120 min.  
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(A) 
 
 
(B) 
 
 
 
Figure ‎6.12 Time course of p-ERK-1/2 expression in UV-irradiated MM418-C5 cells 
The effect of UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation on the expression of (A) p-ERK-1 and (B)     
p-ERK-2 proteins at different time points (0-120 min) were determined by western blots. Expression of p-ERK-1 
and p-ERK-2 was calculated as the relative component of the total level of p-ERK (1+2) found in the sham-
irradiated controls. Data is represented as the mean±SEM from three separate experiments. 
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6.2.1.2.3 Effect of UV radiation on p-JNK-1/2 activity 
In this experiment, the levels of phosphorylated JNK-1/2 were observed at different 
time points post-UV exposure in MM418-C5 cells. A polyclonal antibody was used 
to probe for p-JNK-1/2 protein in western blots (Figure 6.13). 
 
 
 
Figure ‎6.13 A representative Western blot showing changes in p-JNK-1/2 levels in UV-irradiated MM418-C5 
cells during the first 120 min post-exposure 
MM418-C5 cells were exposed to either UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation. At different time 
points post-irradiation (0, 5, 15, 30, 60 and 120 min), cell lysates were run on western blots. The blots were 
probed with an anti-p-JNK-1/2 and an anti-GAPDH antibody, which was used to monitor protein levels in the 
cell lysates (see Section 2.8).  
 
When the cells were exposed to UVA radiation, p-JNK-1 levels increased from 
0.7±0.1-fold peaking at 4.5±1.7-fold at 30 min, before falling to 2.9±1.3-fold at 120 
min (Figure 6.14).  In the UVB-irradiated cells, p-JNK-1 levels gradually increased 
from 0.7±0.1-fold at 0 min reaching a peak at 60 min (4.8±0.6-fold), before falling to 
2.9±0.1-fold at 120 min. UVAB radiation caused p-JNK-1 levels to rise from 
0.7±0.1-fold to 1.9±0.1-fold at 5 min. There was a sharp significant increase in        
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p-JNK-1 levels which peaked at 15 min (6.8±0.2-fold) and stayed significantly 
elevated at 30 min (6.5±0.3-fold) before falling to 3.6±0.3-fold at 120 min. 
UVA slightly increased p-JNK-2 levels from 0.3±0.1-fold at 0 min to 0.3±0.1-fold at 
15 min. The levels continued to increase and peaked at 30 min (0.6±0.4-fold), before 
falling to 0.3±0.1-fold at 120 min (Figure 6.14B). UVB radiation did not alter         
p-JNK-2 levels during the first 5 min (0.3±0.1-fold), after which these levels 
increased reaching a peak at 30 min (0.8±0.4-fold) before falling to 0.4±0.2-fold at 
120 min. Exposure to UVAB radiation caused the p-JNK-2 levels to increase from 
0.3±0.1-fold at 0 min to a peak of 1.2±0.2-fold at 30 min, after which it fell to 
0.4±0.2-fold at 120 min.  
  
187 | P a g e  
 
 
(A) 
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Figure ‎6.14 Time course of p-JNK-1/2 expression in UV-irradiated MM418-C5 cells 
The effect of UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation on the expression of (A) p-JNK-1 and (B)      
p-JNK-2 proteins at different time points (0-120 min) were determined by western blots. Expression of p-JNK-1 
and p-JNK-2 was calculated as the relative component of the total level of p-JNK (1+2) found in the sham-
irradiated controls. Data is represented as the mean±SEM from three separate experiments. Statistical 
significance was calculated by one-way ANOVA followed by Bonferroni’s multiple comparisons post-test. 
Significant difference between sham and UVAB is represented by (*). *p ≤ 0.05 
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6.2.1.2.4 Effect of UV radiation on p-p38 activity 
In this experiment, the levels of phosphorylated p38 were observed at different time 
points post-UV exposure in the MM418-C5 cells. A polyclonal antibody was used to 
probe for p-38 protein in western blots (Figure 6.15). 
 
 
 
Figure ‎6.15 representative Western blot showing changes in p-p38 levels in UV-irradiated MM418-C5 cells 
during the first 120 min post-exposure 
MM418-C5 cells were exposed to either UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation. At different time 
points post-irradiation (0, 5, 15, 30, 60 and 120 min), cell lysates were run on western blots. The blots were 
probed with an anti-p-p38 and an anti-GAPDH antibody, which was used to monitor protein levels in the cell 
lysates (see Section 2.8).  
 
In the UVA-irradiated MM418-C5 cells, p-p38 levels increased over time reaching a 
peak (11.2±3.9-fold) at 30 min, before falling to 2.2±0.5-fold at 120 min, as seen in 
Figure 6.16.  
Following exposure to UVB radiation, p-p38 levels rapidly increased significantly 
over the first 15 min (16.5±2.0-fold) before significantly increasing to a peak 
(17.4±2.0-fold) at 60 min, after which it fell to 15.8±1.9-fold at 120 min, which 
remain significantly higher than the 0 min time point.  
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In the UVAB-irradiated cells, p-p38 levels sharply increased reaching a significant 
peak (38.7±6.4-fold) at 30 min. At 120 min, p-p38 levels fell to 24.8±1.7-fold, which 
was significantly higher than the 0 min time point. 
 
 
Figure ‎6.16 Time course of p-p38 expression in UV-irradiated MM418-C5 cells 
The effect of UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation on the expression of p-p38 protein at different 
time points (0-120 min) were determined by western blots. Expression of p-p38 was calculated as the relative 
component of the total level found in the sham-irradiated controls. Data is represented as the mean±SEM from 
three separate experiments. Statistical significance was calculated by one-way ANOVA followed by Bonferroni’s 
multiple comparisons post-test. Significant difference between sham and UVB is represented by (#). Significant 
difference between sham and UVAB is represented by (*). #,*p ≤ 0.05; ##, **p ≤ 0.01; ***p ≤ 0.001 
 
6.2.1.3 Effect of antioxidants on UV-activated cell signalling pathways in 
MM418-C1 cells 
In this study, 30 min was chosen as the time point to measure the effect of 
antioxidants on the expression of signalling intermediate pathways in UV-irradiated 
cells. This time point was chosen as it can be seen that the majority of 
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phosphorylated signalling intermediates (Section 6.2.1.1 and 6.2.1.2) were at 
maximal levels 30 min post-irradiation. 
 
6.2.1.3.1 Effect of antioxidants on B-RAF activity in irradiated MM418-C1 cells 
A sample blot of p-B-RAF expression in the UV-irradiated MM418-C1 cells treated 
with antioxidants is seen in Figure 6.17. 
 
  
  
Figure ‎6.17 A representative western blot showing changes in p-B-RAF levels in 30 min post-UV irradiated 
MM418-C1 cells pre-treated with antioxidants for 24 h 
The effect of UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation on the expression of p-B-RAF was measured at 
30 min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), 
trolox: 0.1 mM) for   24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-B-RAF 
and an anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
 
The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on            
p-B-RAF levels in MM418-C1 cells were measured 30 min post-UV (A and/or B) 
exposure. In the sham-irradiated cells, only vitamin C slightly decreased p-B-RAF 
levels (28%) in the cells, while DMSO and trolox treatment had no effect (Figure 
6.18). 
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In the UVA-irradiated cells, p-B-RAF levels in untreated cells were similar to that 
seen in the sham-irradiated controls. While treatment with vitamin C and DMSO 
caused a slight increase in p-B-RAF levels (35% and 38%, respectively), trolox had 
no effect.  
p-B-RAF levels were increased (86%) in UVB-irradiated cells when compared to the 
sham-irradiated controls. When these irradiated cells were treated with vitamin C 
and DMSO, p-B-RAF levels increased (75% and 33%, respectively), while trolox 
caused a slight reduction. 
In the UVAB-irradiated cells, p-B-RAF levels were higher than that seen for UVB-
irradiated cells and were 187% higher than that of unirradiated controls. Treatment 
with vitamin C, DMSO or trolox reduced p-B-RAF levels in these irradiated cells 
(32%, 56% and 58%, respectively). 
 
 
Figure ‎6.18 Effect of antioxidants on p-B-RAF levels in UV-irradiated MM418-C1 cells 
MM418-C1 cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) 24 h before 
exposure to either UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation.  At 30 min post-irradiation, the effect of 
these treatments on      p-B-RAF expression in the cells was determined using western blots. Data is represented 
as the mean±SEM from three separate experiments. 
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6.2.1.3.2  Effect of antioxidants on ERK-1/2 activity in irradiated MM418-C1 cells 
A sample blot of p-ERK-1/2 expression in the UV-irradiated MM418-C1 cells 
treated with antioxidants is seen in Figure 6.19. 
 
 
Figure ‎6.19 A representative western blot showing changes in p-ERK-1/2 levels in 30 min post-UV irradiated 
MM418-C1 cells pre-treated with antioxidants for 24 h 
The effect of UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation on the expression of p-ERK-1/2 was measured 
at 30 min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), 
trolox: 0.1 mM) for   24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-ERK-1/2 
and an anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
 
The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on           
p-ERK-1 and p-ERK-2 levels were measured 30 min post-UV (A and/or B) exposure 
in MM418-C1 cells as seen in Figure 6.20. Treatment of the cells with vitamin C, 
DMSO and trolox increased    p-ERK-1 expression in the sham-irradiated cells. The 
largest increase (200%) was seen in those cells treated with trolox. 
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(A) 
 
(B) 
 
Figure ‎6.20 Effect of antioxidants on p-ERK 1/2 levels in UV-irradiated MM418-C1 cells 
MM418-C1 cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) 24 h before 
exposure to either UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation. At 30 min post-irradiation, the effect of 
these treatments on (A) p-ERK-1 and (B) p-ERK-2 expression in the cells was determined using western blots. 
Data is represented as the mean±SEM from three separate experiments. 
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UVA radiation increased p-ERK-1 levels by 65% compared to that seen in the sham-
irradiated cells. Treatment with vitamin C, DMSO and trolox slightly increased       
p-ERK-1 levels, but these were not statistically significant. 
UVB radiation increased p-ERK-1 levels by 120% in the MM418-C1 cells. 
Treatment with vitamin C and DMSO slightly enhanced p-ERK-1 levels, while 
trolox caused a slight reduction (15%), however none of these changes were 
statistically significant. 
p-ERK-1 levels were increased by 85% in the UVAB-irradiated cells which was less 
than that seen following UVB radiation. Treatment with vitamin C, DMSO and 
trolox slightly reduced p-ERK-1 levels, but these were not statistically significant.  
In the sham-irradiated controls, p-ERK-2 levels were higher than that of p-ERK-1 
(66% and 34%, respectively). Like that seen for p-ERK-1 levels in MM418-C1 cells, 
pre-treatment with vitamin C, DMSO and trolox enhanced p-ERK-2 levels in the 
unirradiated cells (Figure 6.20B). The greatest increase (63%) in p-ERK-2 levels 
were seen in those cells treated with trolox.  
In the UVA-irradiated MM418-C1 cells, p-ERK-2 levels were 40% higher than that 
in sham-irradiated controls. However, when these cells were treated with vitamin C, 
DMSO and trolox, no statistically significant effects on p-ERK-2 levels were seen. 
 UVB radiation increased p-ERK-2 levels by 80% to that seen in sham-irradiated 
controls. Treatment with vitamin C and DMSO slightly increased p-ERK-2 levels in 
these cells, while trolox had no effect. 
Exposure to UVAB caused a 40% increase in p-ERK-2 levels compared to that seen 
in sham-irradiated controls. Treatment with vitamin C, DMSO and trolox caused a 
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slight reduction (33%, 41% and 48%, respectively) in p-ERK-2 levels post-UV 
exposure in these cells.  
 
6.2.1.3.3  Effect of antioxidants on JNK-1/2 activity in irradiated MM418-C1 cells 
A sample blot of p-JNK-1/2 expression in the UV-irradiated MM418-C1 cells 
treated with antioxidants is seen in Figure 6.21.  
 
 
Figure ‎6.21 A representative western blot showing changes in p-JNK-1/2 levels in 30 min post-UV irradiated 
MM418-C1 cells pre-treated with antioxidants for 24 h 
The effect of UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation on the expression of p-JNK-1/2 was measured 
at 30 min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), 
trolox: 0.1 mM) for 24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-JNK-1/2 
and an anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
 
The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on           
p-JNK-1/2 levels in MM418-C1 cells were measured 30 min post-UV (A and/or B) 
exposure. 
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Treatment with vitamin C, DMSO and trolox caused a slight reduction in p-JNK-1 
levels compared to that seen in the untreated sham-irradiated controls (Figure 
6.22A). These changes were not statistically significant. 
In the UVA-irradiated MM418-C1 cells, p-JNK-1 levels were slightly lower than 
that seen in the sham-irradiated controls. Treatment with vitamin C had no effect, 
while that of DMSO and trolox slightly increased p-JNK-1 levels in these irradiated 
cells. 
 UVB radiation increased p-JNK-1 levels (670%) compared to that seen in the sham-
irradiated controls. Treatment of the irradiated cells with vitamin C, DMSO and 
trolox slightly increased p-JNK-1 levels post-UVB exposure (32%, 48% and 11%, 
respectively) however these changes were not statistically significant. 
In the UVAB-irradiated cells, p-JNK-1 levels were 236% higher than that seen in the 
sham-irradiated controls, but this increase was not statistically significant. Treatment 
of these cells with vitamin C, DMSO and trolox had no effect on p-JNK-1 levels. 
In the sham-irradiated controls, p-JNK-1 levels were 2.5-fold higher than that of     
p-JNK-2. Treating the sham-irradiated cells with vitamin C, DMSO or trolox caused 
a slight decrease in p-JNK-2 levels compared to that seen in the untreated cells 
(Figure 6.22B).  
In the UVA-irradiated cells, p-JNK-2 levels fell by 49% compared to that seen in the 
sham-irradiated controls. The addition of vitamin C, DMSO or trolox did not alter 
the p-JNK-2 levels in these irradiated cells. 
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In the UVB-irradiated cells, p-JNK-2 levels were 40% higher than that seen in the 
sham-irradiated controls. When these cells were treated with vitamin C, DMSO or 
trolox, no changes in p-JNK-2 levels were observed. 
In the UVAB-irradiated MM418-C1 cells, p-JNK-2 levels were 49% higher than that 
seen in the sham-irradiated controls. Treatment with vitamin C, DMSO or trolox 
caused a slight reduction (16%, 48% and 63%, respectively) in the levels of p-JNK-2 
in these irradiated cells, however none of these changes were statistically significant.  
(A) 
 
(B) 
 
 
Figure ‎6.22 Effect of antioxidants on p-JNK-1/2 levels in UV-irradiated MM418-C1 cells 
MM418-C1 cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) 24 h before 
exposure to either UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation. At 30 min post-irradiation, the effect of 
these treatments on (A) p-JNK-1 and (B) p-JNK-2 expression in the cells was determined using western blots. 
Data is represented as the mean±SEM from three separate experiments. 
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6.2.1.3.4  Effect of antioxidants on p-p38 activity in irradiated MM418-C1 cells 
A sample blot of p-p38 expression in the UV-irradiated MM418-C1 cells treated 
with antioxidants is seen in Figure 6.23. 
 
 
Figure ‎6.23 A representative western blot showing changes in p-p38 levels in 30 min post-UV irradiated 
MM418-C1 cells pre-treated with antioxidants for 24 h 
The effect of UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation on the expression of p-p38 was measured at 30 
min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), trolox: 
0.1 mM) for 24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-p38 and an     
anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
 
The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on p-p38 
levels in MM418-C1 cells were measured 30 min post-UV (A and/or B) exposure. In 
the case of sham-irradiated controls, trolox increased p-p38 levels in MM418-C1 by 
57%, while vitamin C and DMSO had no significant effects (Figure 6.24).  
Exposure to UVA enhanced p-p38 levels by 86% compared to that seen in the sham-
irradiated controls. Treatment with the antioxidants further increased p-p38 levels in 
the UVA-irradiated cells, with the highest increase (82%) due to DMSO treatment.  
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In the UVB-irradiated cells, p-p38 levels were 470% higher than that seen in the 
sham-irradiated controls. Neither vitamin C nor DMSO had an effect on the p-p38 
levels, but trolox increased these levels by 78% compared to the untreated UVB-
irradiated cells, however this was not statistically significant.  
In the UVAB-irradiated cells p-p38 levels were 1238% higher than that seen in the 
sham-irradiated controls. Treatment with vitamin C resulted in a further 9% increase 
in p-p38 levels. However, treatment with both DMSO and trolox resulted in a drop 
in p-p38 levels in these cells. The largest decrease was caused by trolox (31%), 
however this was not statistically significant. 
 
  
Figure ‎6.24 Effect of antioxidants on p-p38 levels in UV-irradiated MM418-C1 cells 
The effect of UVA (0.8 J/cm2) and/or UVB (0.04 J/cm2) radiation on the expression of p-p38 was measured at 30 
min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), trolox: 
0.1 mM) for 24 h prior to being exposed to UV-radiation. Data is represented as the mean±SEM from three 
separate experiments. Statistical significance from sham was calculated using a one-way ANOVA followed by 
Bonferroni’s multiple comparisons post-test. *p ≤ 0.05 
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6.2.1.4 Effect of antioxidants on UV-activated cell signalling pathways in 
MM418-C5 cells 
6.2.1.4.1 Effect of antioxidants on B-RAF activity in irradiated MM418-C5 cells 
A sample blot of p-B-RAF expression in the UV-irradiated MM418-C5 cells treated 
with antioxidants is seen in Figure 6.25. 
 
 
Figure ‎6.25 A representative western blot showing changes in p-B-RAF levels in 30 min post-UV irradiated 
MM418-C5 cells pre-treated with antioxidants for 24 h 
The effect of UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation on the expression of p-B-RAF was measured at 
30 min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), 
trolox: 0.1 mM) for   24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-B-RAF 
and an anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
 
The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on           
p-B-RAF levels in MM418-C5 cells were measured 30 min post-UV (A and/or B) 
exposure. In the sham-irradiated controls, while treatment with vitamin C, DMSO 
and trolox slightly decreased p-B-RAF levels, these were not statistically significant 
(Figure 6.26).  
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In the UVA-irradiated MM418-C5 cells, p-B-RAF levels were 26% lower than that 
of the unirradiated controls. Treatment with the antioxidants did not have any 
significant effect on p-B-RAF levels in these irradiated cells. 
In the UVB-irradiated cells, p-B-RAF levels were similar to that seen in the sham-
irradiated controls. As with that seen in the UVA-irradiated cells, antioxidant 
treatment had no effect on p-B-RAF levels.  
Like that seen for UVB, exposure of MM418-C5 cells to UVAB radiation did not 
alter p-B-RAF levels. When these cells were treated with the antioxidants, no effects 
on p-B-RAF levels were seen. 
 
 
Figure ‎6.26 Effect of antioxidants on p-B-RAF levels in UV-irradiated MM418-C5 cells 
MM418-C5 cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) 24 h before 
exposure to either UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation.  At 30 min post-irradiation, the effect of 
these treatments on p-B-RAF expression in the cells was determined using western blots. Data is represented as 
the mean±SEM from three separate experiments. 
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6.2.1.4.2 Effect of antioxidants on ERK-1/2 activity in irradiated MM418-C5 cells 
A sample blot of p-ERK-1/2 expression in the UV-irradiated MM418-C5 cells 
treated with antioxidants is seen in Figure 6.27. 
 
 
 
Figure ‎6.27 A representative western blot showing changes in p-ERK-1/2 levels in 30 min post-UV irradiated 
MM418-C5 cells pre-treated with antioxidants for 24 h 
The effect of UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation on the expression of p-ERK-1/2 was measured 
at 30 min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), 
trolox: 0.1 mM) for 24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-ERK-1/2 
and an anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
 
The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on           
p-ERK-1 and p-ERK-2 levels were measured 30 min post-UV (A and/or B) exposure 
in MM418-C5 cells as seen in Figure 6.28. Treatment of the cells with vitamin C, 
DMSO and trolox caused no effect on p-ERK-1 expression in the sham-irradiated 
cells (Figure 6.28). 
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UVA radiation had no effect on p-ERK-1 levels when compared to that seen in the 
sham-irradiated controls. Treatment with vitamin C and DMSO had no effect on     
p-ERK-1 levels, while trolox decreased these levels by 23%. 
(A) 
 
(B) 
 
 
 
Figure ‎6.28 Effect of antioxidants on p-ERK-1/2 levels in UV-irradiated MM418-C5 cells 
MM418-C1 cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) 24 h before 
exposure to either UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation. At 30 min post-irradiation, the effect of 
these treatments on (A) p-ERK-1 and (B) p-ERK-2 expression in the cells was determined using western blots. 
Data is represented as the mean±SEM from three separate experiments. 
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There was a 20% increase in p-ERK-1 levels in the UVB-irradiated cells compared 
to that of the sham-irradiated controls. Antioxidant (vitamin C, DMSO or trolox) 
treatment had no effect on p-ERK-1 levels in these irradiated cells.  
In the UVAB-irradiated cells, p-ERK-1 levels were 41% higher than that seen in the 
sham-irradiated controls. When these cells were treated with DMSO and trolox,      
p-ERK-1 levels fell by 17% and 33%, respectively, while vitamin C had no effect. 
In sham-irradiated controls, p-ERK-2 levels were two-fold higher than that of          
p-ERK-1 (Sham irradiated control p-ERK-1: 0.34-fold and p-ERK-2: 0.66-fold). 
When these cells were treated with the antioxidants, there was a slight decrease in    
p-ERK-2 levels, but these were not statistically significant (Figure 6.28B). 
In the UVB-irradiated cells, p-ERK-2 levels were 71% higher than that seen in the 
sham-irradiated controls. Treatment of these cells with vitamin C, DMSO or trolox 
caused a slight increase in p-ERK-2 levels by 12%, 15% and 36% respectively, 
although none were statistically significant.   
In the UVA-irradiated MM418-C5 cells, p-ERK-2 levels fell by 14% when 
compared to the sham-irradiated controls. Treatment with vitamin C or DMSO did 
not affect p-ERK-2 levels, however trolox caused these levels to fall by 16%, but this 
was not statistically significant. 
UVAB radiation caused a 41% increase in p-ERK-2 levels compared to that seen in 
the sham-irradiated controls. Treatment of the cells with vitamin C, DMSO or trolox 
reduced p-ERK-2 levels, and while trolox caused the greatest reduction in p-ERK-2 
levels (36%), this was not statistically significant.  
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6.2.1.4.3 Effect of antioxidants on p- JNK-1/2 activity in irradiated MM418-C5 
cells 
A sample blot of p-JNK-1/2 expression in the UV-irradiated MM418-C5 cells 
treated with antioxidants is seen in Figure 6.29. 
 
 
Figure ‎6.29 A representative western blot showing changes in p-JNK-1/2 levels in 30 min post-UV irradiated 
MM418-C5 cells pre-treated with antioxidants for 24 h 
The effect of UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation on the expression of p-JNK-1/2 was measured 
at 30 min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), 
trolox: 0.1 mM) for 24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-JNK-1/2 
and an anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
 
 
The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on           
p-JNK-1/2 levels in MM418-C5 cells were measured 30 min post-UV (A and/or B) 
exposure. Treating the cells with vitamin C, DMSO or trolox increased p-JNK-1 
levels (20%, 20% and 35%, respectively) compared to that seen in the untreated 
sham-irradiated cells (Figure 6.30A). 
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In the UVA-irradiated cells, p-JNK-1 levels were increased by 200%, however this 
was not significant. Treatment of these cells with the antioxidants had no effect on 
these levels. 
In the UVB-irradiated cells, p-JNK-1 levels increased by 353% to that seen in the 
sham-irradiated controls. Treatment with vitamin C or trolox further increased         
p-JNK-1 levels by 41% and 96%, respectively, while DMSO had no effect.  
UVAB radiation increased p-JNK-1 levels by 892% to that seen in the sham-
irradiated controls. While vitamin C treatment further enhanced p-JNK-1 levels by 
33%, neither DMSO nor trolox had any effect.  
In the sham-irradiated controls, p-JNK-1 levels were higher than that of p-JNK-2 
(89% and 11%, respectively). When the cells were treated with antioxidants,           
p-JNK-2 levels fell by 62% when compared to the untreated controls (Figure 6.30B). 
UVA radiation caused a 65% increase in p-JNK-2 levels compared to that seen in the 
sham-irradiated controls. Antioxidant (vitamin C, DMSO or trolox) treatment was 
shown to have no effect on p-JNK-2 levels in these cells. 
UVB radiation caused a 1018% increase in p-JNK-2 levels compared to that seen in 
the sham-irradiated controls, however this increase was not significant. Antioxidant 
treatment had no effect on the p-JNK-2 levels in these irradiated cells. 
Like that seen for UVB, UVAB radiation increased p-JNK-2 levels in the cells by 
936% compared to that observed in the sham-irradiated controls, however this 
increase was not significant. Treating the cells with antioxidants was shown to have 
no effect on p-JNK-2 levels in these cells. 
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(A) 
 
 
(B) 
 
 
Figure ‎6.30 Effect of antioxidants on p-JNK-1/2 levels in UV-irradiated MM418-C5 cells 
MM418-C5 cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) 24 h before 
exposure to either UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation. At 30 min post-irradiation, the effect of 
these treatments on (A) p-JNK-1 and (B) p-JNK-2 expression in the cells was determined using western blots. 
Data is represented as the mean±SEM from three separate experiments. 
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6.2.1.4.4 Effect of antioxidants on p38 activity in irradiated MM418-C5 cells 
A sample blot of p-p38 expression in the UV-irradiated MM418-C5 cells treated 
with antioxidants is seen in Figure 6.31. 
 
 
Figure ‎6.31 A representative western blot showing changes in p-p38 levels in 30 min post-UV irradiated 
MM418-C5 cells pre-treated with antioxidants for 24 h 
The effect of UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation on the expression of p-p38 was measured at 30 
min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), trolox: 
0.1 mM) for 24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-p38 and an     
anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
 
 
The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on p-p38 
levels in MM418-C5 cells were measured 30 min post-UV (A and/or B) exposure. In 
the sham-irradiated controls, vitamin C and trolox increased p-p38 levels (30% and 
80%, respectively) in these cells while DMSO had no effect (Figure 6.32). 
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Figure ‎6.32 Effect of antioxidants on p-p38 levels in UV-irradiated MM418-C5 cells 
The effect of UVA (0.6 J/cm2) and/or UVB (0.03 J/cm2) radiation on the expression of p-p38 was measured at 30 
min. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), trolox: 0.1 mM) for 24 
h prior to being exposed to UV-radiation. Data is represented as the mean±SEM from three separate experiments. 
Statistical significance from sham was calculated using a one-way ANOVA followed by Bonferroni’s multiple 
comparisons post-test. *p ≤ 0.05; **p ≤ 0.01 
 
In the UVA-irradiated cells, p-p38 levels were 850% higher than that seen in the 
sham-irradiated controls. Vitamin C and trolox treatment reduced p-p38 levels by 
43% and 33%, respectively in the cells, while DMSO had no effect. 
UVB exposure significantly increased (4480%) p-p38 levels compared to that seen 
in the sham-irradiated controls. When the cells were treated with vitamin C and 
DMSO, p-p38 levels were increased, however trolox had no effect. 
The p-p38 levels in the UVAB-irradiated cells were significantly higher (7810%) 
than that seen in the sham-irradiated controls. Treatment of these irradiated cells 
with the antioxidants did not cause any significant changes in p-p38 levels in these 
cells.  
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6.2.1.5 Effect of antioxidants on UV-activated cell signalling pathways in HEM 
cells 
The effect of antioxidants on cell signalling pathway activity was also examined in 
UV-irradiated HEM cells 30 min post-UV exposure. Due to material limitations, the 
time course study for HEM was not performed. As the results for the time course 
study for MM418-C1 and MM418-C5 cells were similar, it was assumed that it 
would also be the same in HEM cells. Moreover, Muthusamy and Piva (2013) 
observed that the time course of UV activated cell signalling pathway activity was 
similar in HEM and MM96L melanoma cells (177), and as such it supports this 
assumption made above. 
 
6.2.1.5.1 Effect of antioxidants on B-RAF activity in irradiated HEM cells 
A sample blot of p-B-RAF expression in the UV-irradiated HEM cells treated with 
antioxidants is seen in Figure 6.33. 
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 Figure ‎6.33 A representative western blot showing changes in p-B-RAF levels in 30 min post-UV irradiated 
HEM cells pre-treated with antioxidants for 24 h 
The effect of UVA (3.2 J/cm2) and/or UVB (0.16 J/cm2) radiation on the expression of p-B-RAF was measured at 
30 min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), 
trolox: 0.1 mM) for 24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-B-RAF 
(86 kDa) and an anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
  
 
The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on           
p-B-RAF levels were measured 30 min post-UV (A and/or B) exposure in HEM 
cells, as seen in Figure 6.34. Treatment with vitamin C, DMSO or trolox did not alter 
p-B-RAF levels in the sham-irradiated cells (Figure 6.34).  
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Figure ‎6.34 Effect of antioxidants on p-B-RAF levels in UV-irradiated HEM cells 
HEM cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) 24 h before 
exposure to either UVA (3.2 J/cm2) and/or UVB (0.16 J/cm2) radiation.  At 30 min post-irradiation, the effect of 
these treatments on p-B-RAF expression in the cells was determined using western blots. Data is represented as 
the mean±SEM from three separate experiments. 
 
UVA radiation did not alter the p-B-RAF levels in these cells. Treatment with the 
antioxidants did not alter p-B-RAF levels in these irradiated cells.  
UVB radiation increased p-B-RAF levels by 80% compared to that seen in the sham-
irradiated controls. While treatment with vitamin C had no effect on p-B-RAF levels, 
DMSO and trolox reduced these levels by 29 % and 24%, respectively. None of 
these changes were statistically significant. 
UVAB radiation increased p-B-RAF levels by 290% compared to that of the sham-
irradiated cells. In comparison with that seen in the UVB-irradiated cells, treatment 
with vitamin C, DMSO and trolox decreased p-B-RAF levels, although these 
changes were not statistically significant. 
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6.2.1.5.2 Effect of antioxidants on p-ERK-1/2 activity in HEM irradiated cells 
A sample blot of p-ERK-1/2 expression in the UV-irradiated HEM cells treated with 
antioxidants is seen in Figure 6.35. 
 
 
Figure ‎6.35 A representative western blot showing changes in p-ERK-1/2 levels in 30 min post-UV irradiated 
HEM cells pre-treated with antioxidants for 24 h 
The effect of UVA (3.2 J/cm2) and/or UVB (0.16 J/cm2) radiation on the expression of p-ERK-1/2 was measured 
at 30 min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), 
trolox: 0.1 mM) for 24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-ERK-1/2 
(42 kDa) and an anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
 
 
The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on           
p-ERK-1 and p-ERK-2 levels were measured 30 min post-UV (A and/or B) exposure 
in HEM cells, as seen in Figure 6.36. In the sham-irradiated controls, while vitamin 
C, DSMO and trolox increased p-ERK-1 levels by 18%, 33% and 36%, respectively 
(Figure 3.36A), these changes were not significant. 
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In the UVA-irradiated cells, p-ERK-1 levels were 57% higher to that seen in the 
sham-irradiated controls. When these cells were treated with vitamin C, DMSO or 
trolox, p-ERK-1 levels fell by 15%, 60 % and 67 %, respectively; however these 
changes were not statistically significant. 
UVB radiation did not alter p-ERK-1 levels when compared to that seen in the sham-
irradiated controls. Vitamin C treatment increased p-ERK-1 levels by 30%, while 
DMSO and trolox were less stimulatory. However, none of these changes were 
statistically significant. 
In the UVAB-irradiated HEM cells, p-ERK-1 levels were 42% higher than that seen 
in the sham-irradiated controls. Vitamin C treatment further increased p-ERK-1 
levels by 30%, while DMSO and trolox were inhibitory (40% and 48%, 
respectively), however these changes were not statistically significant.  
 In the sham-irradiated controls, p-ERK-2 levels were higher than that of p-ERK-1 
(67% and 33%, respectively). In the sham-irradiated cells, treatment with vitamin C, 
DMSO or trolox slightly increased p-ERK-2 levels, however these were not 
statistically significant. 
UVA radiation increased p-ERK-2 levels by 53% compared to that seen in the sham-
irradiated controls. Treatment with vitamin C, DMSO and trolox reduced p-ERK-2 
levels in these cells. Trolox treatment had the greatest effect and reduced p-ERK-2 
levels by 64%, however this was not statistically significant. 
 
 
215 | P a g e  
 
 
(A) 
 
(B) 
 
 
Figure ‎6.36 Effect of antioxidants on p-ERK-1/2 levels in UV-irradiated HEM cells 
HEM cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) 24 h before 
exposure to either UVA (3.2 J/cm2) and/or UVB (0.16 J/cm2) radiation. At 30 min post-irradiation, the effect of 
these treatments on (A) p-ERK-1 and (B) p-ERK-2 expression in the cells was determined using western blots. 
Data is represented as the mean±SEM from three separate experiments. 
 
 
In the UVB-irradiated cells, p-ERK-2 levels were similar to that seen in the sham-
irradiated controls. Treatment with vitamin C, DSMO and trolox slightly increased 
p-ERK-2 levels, however these changes were not statistically significant. 
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Exposure to UVAB radiation increased p-ERK-2 levels by 95% compared to the 
sham-irradiated controls. Treatment with vitamin C slightly increased p-ERK-2 
levels while DMSO and trolox decreased these levels. However these changes were 
not statistically significant. 
 
6.2.1.5.3 Effect of antioxidants on p-JNK-1/2 activity in irradiated HEM cells 
A sample blot of p-JNK-1/2 expression in the UV-irradiated HEM cells treated with 
antioxidants is seen in Figure 6.37. 
 
  
Figure ‎6.37 A representative western blot showing changes in p-JNK-1/2 levels in 30 min post-UV irradiated 
HEM cells pre-treated with antioxidants for 24 h 
The effect of UVA (3.2 J/cm2) and/or UVB (0.16 J/cm2) radiation on the expression of p-JNK-1/2 was measured 
at 30 min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), 
trolox: 0.1 mM) for 24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-JNK-1 (46 
kDa), anti-p-JNK-2 (54 kDa) and an anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
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The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on           
p-JNK-1/2 levels in HEM cells were measured 30 min post-UV (A and/or B) 
exposure, as seen in Figure 6.38. In the sham-irradiated cells, treatment with vitamin 
C, DMSO or trolox had no effect on p-JNK-1 expression in these cells (Figure 6.38).  
 
(A) 
 
(B) 
 
 
Figure ‎6.38 Effect of antioxidants on p-JNK-1/2 levels in UV-irradiated HEM cells 
HEM cells were pre-treated with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) 24 h before 
exposure to either UVA (3.2 J/cm2) and/or UVB (0.16 J/cm2) radiation. At 30 min post-irradiation, the effect of 
these treatments on (A) p-JNK-1 and (B) p-JNK-2 expression in the cells was determined using western blots. 
Data is represented as the mean±SEM from three separate experiments. 
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Exposure to UVA radiation slightly decreased p-JNK-1 levels in these cells 
compared to unirradiated controls. Treating these irradiated cells with vitamin C, 
DMSO and trolox had no effect on p-JNK-1 levels. 
UVB radiation increased p-JNK-1 levels by 356% compared to that seen in sham-
irradiated controls. When these cells were treated with vitamin C or trolox, p-JNK-1 
levels were slightly increased, while DMSO had no effect, however these changes 
were not statistically significant. 
In the UVAB-irradiated cells, p-JNK-1 levels were 186% higher than that seen in the 
UVB-irradiated cells. Treating the cells with vitamin C slightly increased p-JNK-1 
levels, while DMSO and trolox reduced these levels by ~51%, however, these 
changes were not statistically significant. 
In the sham-irradiated HEM cells, treatment with vitamin C, DMSO and trolox had 
no effect on cellular p-JNK-2 levels (Figure 6.38B). Exposure to UVA radiation had 
no effect on p-JNK-2 levels in the HEM cells. When these cells were treated with 
vitamin C, DMSO or trolox, no effect on p-JNK-2 levels were observed. UVB 
radiation caused a 119% increase in p-JNK-2 levels in the cells which was not 
significant. When these cells were treated with vitamin C, DMSO or trolox no effect 
on p-JNK-2 levels were observed. Exposure to UVAB radiation also slightly 
increased p-JNK-2 levels in the cells, which was not statistically significant. When 
these cells were treated with vitamin C and DMSO, no effects on p-JNK-2 levels 
were seen, while trolox was slightly inhibitory.   
219 | P a g e  
 
 
6.2.1.5.4 Effect of antioxidants on p-p38 activity in irradiated HEM cells 
A sample blot of p-p38 expression in the UV-irradiated HEM cells treated with 
antioxidants is seen in Figure 6.39. 
 
 
Figure ‎6.39 A representative western blot showing changes in p-p38 levels in 30 min post-UV irradiated HEM 
cells pre-treated with antioxidants for 24 h 
The effect of UVA (3.2 J/cm2) and/or UVB (0.16 J/cm2) radiation on the expression of p-p38 was measured at 30 
min post-irradiation. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), trolox: 
0.1 mM) for 24 h prior to being exposed to UV-radiation. The blots were probed with an anti-p-p38 (43 kDa) and 
an anti-GAPDH antibody to monitor the level of protein in the cell lysates. 
 
 
The effects of vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) on p-p38 
levels in HEM cells were measured 30 min post-UV (A and/or B) exposure. In the 
sham-irradiated HEM cells, vitamin C, DMSO and trolox treatment had no effect on 
p-p38 levels in these cells (Figure 6.40). 
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Figure ‎6.40 Effect of antioxidants on p-p38 levels in UV-irradiated HEM cells 
The effect of UVA (3.2 J/cm2) and/or UVB (0.16 J/cm2) radiation on the expression of p-p38 was measured at 30 
min. The cells were pre-treated with antioxidants (Vitamin C: 1 mM, DMSO: 0.1% (v/v), trolox: 0.1 mM) for 24 
h prior to being exposed to UV-radiation. Data is represented as the mean±SEM from three separate experiments. 
Statistical significance from sham was calculated using a one-way ANOVA followed by Bonferroni’s multiple 
comparisons post-test. *p ≤ 0.05 
 
UVA radiation increased p-p38 levels by 250% compared to the sham-irradiated 
controls. Treatment of these cells with vitamin C and trolox reduced (15% and 50%, 
respectively) in   p-p38 levels, while DMSO had no effect, however these changes 
were not statistically significant. 
UVB radiation increased p-p38 levels by 1410% compared to that seen in the sham-
irradiated controls, however these changes were not statistically significant. Treating 
the cells with vitamin C, DMSO or trolox had no significant effect on p-p38 levels. 
In the UVAB-irradiated cells the p-p38 levels were significantly higher (2460%) 
than that seen in the sham-irradiated controls. The addition of vitamin C and DMSO 
had no effect on p-p38 levels in these cells, however trolox caused a 29% reduction 
in these levels, but this was not statistically significant.   
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6.3 Discussion 
The most prevalent genetic alteration in human melanoma is the B-RAF mutation, of 
which the V600E point mutation is the most prominent (151). In cell culture and 
animal models, the B-RAF
V600E
 mutation in melanocytes results in senescence (348-
350). The B-RAF
V600E
 mutation on its own does not induce melanoma formation 
under in vitro or in vivo conditions (348-350). Therefore, to achieve at least partial 
suppression of the senescence response, additional genetic alterations are needed for 
the B-RAF
V600E
 expressing melanocytes to become cancerous (350). 
Luo et al. (2013) reported that a loss of ARF is able to enhance spontaneous 
melanoma formation and cause profound sensitivity to neonatal UVB exposure in a 
transgenic B-RAF
V600E
 mouse model (350). Moreover, they suggested that the ARF 
deletion promotes melanomagenesis by acting in concert with B-RAF
V600E
 to 
increase the load of DNA damage caused by UVR, but not by abrogating p53 
activation (350).  
UVR is epidemiologically-linked to cutaneous melanoma development, however the 
molecular mechanisms caused by sunlight exposure that drive melanomagenesis are 
still poorly understood (282, 351). In a recent study, Viros et al. (2014) investigated 
the role of UVR in accelerating oncogenic B-RAF-driven melanomagenesis (352). 
They found that, a single dose of UVR that represented mild sunburn in humans 
induced clonal expansion of the melanocytes. Exposure to repeated doses of UVR 
increased melanoma burden in genetically-modified mice which expressed B-
RAF
V600E
 in their melanocytes (352). Moreover, this study observed that the use of 
sunscreen (UVA superior: UVB SPF50) delayed the onset of UVR-driven melanoma 
in these mice. However, the use of sunscreen only provided limited protection to 
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these mice (352). They also observed that the mutant Trp53 accelerated B-RAF
V600E
-
driven melanomagenesis in these mice (352). 
B-RAF
V600E
 is not a direct UV signature mutation (153). In MM418-C1 and 
MM418-C5 cells, which contain the B-RAF
V600E
 mutation, UVR did not 
significantly increase p-B-RAF expression in both cell lines and their expression 
remains constant post-UVR. The HEM cells used in this study possess wild type    
B-RAF, and as such, UVR was shown to not enhance p-B-RAF levels in these cells. 
I was unable to find in the literature if UVR modulated B-RAF signalling in 
melanocytic-derived cells.  
When the melanoma cells and HEM cells were treated with vitamin C and trolox, 
there was no effect on the expression of B-RAF post UV-exposure. These findings 
suggest that vitamin C and trolox do not have an effect on B-RAF expression in 
these cells post-UV irradiation, which may be due to the fact that UVR does not 
activate signalling via this molecule.   
Alsina et al. (2003) found that MEK/ERK activation is increased in melanoma cells 
possessing B-RAF and N-RAS mutations (353). Collisson et al. (2003) also 
observed that treating melanoma cells with MEK inhibitors (CI1040) resulted in the 
inhibition of cell proliferation in melanoma cells possessing mutant RAS/B-RAF but 
not in those cells having unmutated proteins (354). Uribe et al. (2006) found that the 
activation of ERK in melanocytic nevi was not correlated with B-RAF mutations 
(355). Also, they found that beside B-RAF mutations, many other factors can 
activate ERK in these cells. These factors include regulation by suppression of RAS 
kinase inhibitors and the overexpression of B-RAF (355).  
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A recent study by Gu et al. (2014)  has shown that exposing melanocytes from skin 
phenotype III to UVB radiation (20 mJ/cm
2
) daily for 5 days induced the activation 
of melanogenesis, the expression of JNK, p38, MITF and tyrosinase, but it did not 
activate ERK (298). UVR did not enhance the phosphorylation of ERK-1/2 in both 
the HEM and melanoma cell lines used in this study; which was in agreement with 
that seen in Gu et al.’s study (298). The results suggest that UV does not directly 
activate ERK these cells.  
In the UVB-irradiated HEK cells, there was an increase in the phosphorylation of 
EGFR, ERK-1/2 and p38 pathway intermediaries (128). Pre-treatment of these HEK 
cells with trolox resulted in a reduction in phosphorylated signalling intermediaries. 
This reduction was due to the inhibitory effect of trolox on the generation of 
intracellular H2O2 in HEK cells post-UVB irradiation (128). However, in my 
experiments using melanocyte-derived cells, neither vitamin C nor trolox had an 
effect on ERK levels post-UV exposure. This may not be unexpected as UV-
radiation was shown not to stimulate ERK-1/2 in the melanocyte-derived cells. 
In the case of p38, a member of the MAPK family believed to be activated 
differently post-exposure to different types of UV, Muthusamy and Piva (2013) 
found that p38 MAPK and JNK pathways were activated differently in melanocytes 
and melanoma cells (MM96L) post-UV exposure  (177). They found that exposing 
MM96L to UVA (40 kJ/m
2
) and UVAB (40 kJ/m
2
 + 2 kJ/m
2
) (1 MED) radiation 
resulted in a sharp increase of p-p38 levels after 5 min, however UVB (2 kJ/m
2
) had 
a less stimulatory effect on p-p38 levels. When the HEM cells were exposed to the 
same doses of UV, the activation of p38 was less pronounced (177). UVB stimulated 
p-p38 levels in HEM to a greater extent than that seen in MM96L cells. This 
suggests that the p38 signalling pathway is both UV type and dose dependent  (177). 
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This finding was supported by Liu et al.’s (2010) results indicating that UVA, but 
not UVB, degraded the transcription factor MITF in melanocytes and melanoma 
cells, which showed that both UV types were activated differently in these cells 
(340). My results indicated that UVAB significantly increased p38 activation at 30 
min post-exposure in both melanoma (MM418-C1 and MM418-C5) cells. Exposure 
to UVB caused a non-significant increase in the activation of p38 in both cell lines. 
However UVA only induced a small increase in p-p38 levels in both melanoma cell 
lines. This finding agrees with Muthusamy and Piva (2013) regarding the effect of 
different UV types on melanoma cell lines in the activation of p38; however it differs 
depending on the dose and types of UV to which these cells are exposed. Thus, these 
results are supported by the previous study, which suggested that p38 signalling 
pathway seemed to be both UV type and dose dependent in melanoma cells (177). 
Moreover, my results show that UVB and UVAB resulted in an increase in the 
activation of p38 in MM418-C5 cells which was twice that seen in MM418-C1 cells. 
This suggests that p38 may have a role in the regulation of melanin in melanoma 
cells post-UVR, and by increasing the levels of p38 that can modulate melanin 
synthesis, the deleterious effect of UV radiation can be minimised. This suggestion 
is supported by studies reported that UVR plays a role in the activation of MAPK 
family of signalling molecules, including JNK-1/2, p38 MAPK and ERK-1/2 in 
melanocytes, which regulate the synthesis of melanin (356-358).   
The effect of UVR on HEM was also investigated, and like that seen in both 
melanoma cell lines, UVAB-irradiation caused a significant increase in p38 
compared to that of UVA and UVB alone. These results are in agreement with 
Muthusamy and Piva (2013), who found that UVB increased the activation of p38 in 
HEM to a much greater extent to that seen in MM96L cells (177). My results 
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showed that both UVB and UVAB increased the p38 activation in HEM more than 
in MM418-C1 cells. However, in MM418-C5 cells, UVB and UVAB had the highest 
effect on p38 activation compared to MM418-C1 and HEM cells. As mentioned 
previously, this may be due to the role that p38 plays in the modulation of melanin 
synthesis post-UVB and -UVAB radiation in these cells. Unfortunately, the effect of 
UVR on HEM cells over 120 min could not be investigated due to time and material 
limitations. Muthusamy and Piva (2013) found that the effect of UVR on both HEM 
and melanoma cells were similar, in that both JNK and p38 were activated post-UV. 
It was expected that the same result would be seen if HEM cells used in this study 
were exposed to UVR. 
Furthermore, my results looked at the effect of antioxidants on p38 activation at 30 
min post-UVR in MM418-C1, MM418-C5 and HEM cells. The cells were treated 
with vitamin C (1 mM), DMSO (0.1% v/v) and trolox (0.1 mM) for 24 h before-UV 
and for 30 min post-UV exposure. No significant effects due to antioxidants 
treatment were observed in p38 levels post-UVR in all three cell lines. As mentioned 
earlier in Chapter 3, this study showed that neither vitamin C nor trolox had any 
significant suppressing effect on the generated peroxide level post-UV radiation in 
these cells. From these findings, it can be suggested that these antioxidants do not 
have an effect on ROS generation and so does not have an effect on the activation of 
p38 post-UVR. This suggestion is supported by Peus et al. (2001), who found that 
exposing HEK cells to physiological doses of UVB induced the phosphorylation of 
EGFR, ERK-1/2 and p38 pathway (128). It was found that these activations were 
modulated by pre-treatment of trolox via the suppressing effect of this molecule on 
the generation of intracellular peroxide levels post-UVB in HEK cells (128).   
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Moreover, Muthusamy et al. (2011) found that p38 activation post-UVB in MM96L 
melanoma and HEM cells was not significantly affected by treating these cells with              
α-tocopherol, CO2 SFE and 5β-scymnol. They suggested that these compounds may 
have a protective effect from UV radiation in these cells. However these compounds 
have been suggested to have no direct effect on p38 activation post-UV radiation 
(196). In this study, the results showed that neither vitamin C nor trolox had a 
significant effect on p38 activation post-UV radiation, which agreed with that seen 
previously (196).     
Alexaki et al. (2008) mentioned that G2/M cycle arrest induced by JNK inhibition 
was shown to render melanoma cells more susceptible to death (343). Johnson and 
Nakamura (2007) mentioned that JNK signalling pathway, including both isoforms 
JNK-1/2, are activated predominately in skin cells (181). Moreover, Muthusamy and 
Piva (2013) suggested that JNK and two other signalling pathways (p38 and NF-kB) 
also play a role in the progression and metastasis of melanoma (177).  
In this study, UVA, UVB and UVAB were shown to increase the phosphorylation of 
JNK-1 to a greater extent than of JNK-2 in both melanoma cells over 120 min. These 
results agreed with that seen previously (196). This study  suggested that JNK-1 was 
mainly activated post-UVR, unlike that of JNK-2 (177). Alexaki et al. (2008) found 
that some melanoma cells had a high ratio of JNK-1 to JNK-2 (e.g. WM852, WM 
793 and sk28 melanoma cell lines), however other melanoma cell lines had a low 
ratio (e.g. 888mel, WM983A and Gerlach melanoma cell lines) in response to UVR 
(343). Additionally, the role that each isoform of JNK played in melanoma cells is 
still not well understood (343). Alexaki et al. (2008) found that siRNA of JNK-1 
inhibited the growth of melanoma cells in WM852, WM 793 and sk28 cell lines 
expressing high JNK-1. On the other hand, inhibition of JNK-induced apoptosis but 
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did not affect cell growth in WM983B melanoma cell line, which possess high ratio 
of    JNK-1/2 (343). 
Also, my results found that UVB and UVAB increased JNK-1 levels more than 
those of JNK-2 in the HEM and melanoma cells. Moreover, similar to the effect of 
UVR on p38 activation, UVR induced a greater activation of JNK-1 in MM418-C5 
than that seen in MM418-C1 and HEM cells. In addition to that, UVR had its lowest 
effect on JNK-1 activation in MM418-C1 cells. This suggests that the activation 
JNK differs in depending on the cell types and UVR. It is possible that melanin may 
also have an effect on JNK activation post-UVR. Furthermore, treating the cells with 
antioxidants had a significant effect of UVR-induced JNK-1 activation in      
MM418-C1, MM418-C5 and HEM cells. This suggests that these antioxidants are 
not protective to these cells through the activation of JNK in UV-induced cell 
damage.  
To summarise, in this study the signalling pathways examined in the chosen cell 
lines were UV-dose and type dependent. B-RAF and ERK signalling pathways were 
not significantly activated post different types of UVR in both the melanoma cells 
and melanocytes, while JNK and p38 were activated differently in all cell lines in 
response to different types of UVR. Also, because p38 and JNK levels were higher 
in MM418-C5 compared to MM418-C1, a correlation between melanin and these 
pathways in response to UVR is suggested. This relationship can be explained by the 
studies showing that JNK-1/2 and p38 MAPK in melanocytes can be activated by 
UVR, and that these activations regulate the synthesis of melanin (356-358). 
Moreover, treating the cells with antioxidants did not show a significant effect on 
these signalling pathways post-UV radiation. The reasons for this could be due to the 
fact that no significant effects of antioxidants on ROS generation were observed         
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post-UVR in these cell lines. Also, this may be due to the high UV doses chosen for 
these experiments which caused ~50% cell death. Further investigations could be 
conducted to see whether antioxidant pre-treatments would confer protection to UV-
irradiated cells exposed to doses which caused less cell death (e.g. 25-30%). 
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CHAPTER 7 
GENERAL DISCUSSION, 
CONCLUSION AND FURTHER 
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Chapter 7. General discussion, conclusions and further 
investigation 
7.1 General discussion 
The melanoma cell lines MM418-C1 (lightly pigmented) and MM418-C5 (darkly 
pigmented), as well as others, have been used in studies on the inhibitory effect of 
cystamine on melanin synthesis (359) and HOX genes (360). Cultured melanoma 
cells are an appropriate model system to study the effect of UVA radiation in vitro, 
because it has been shown that UVA may induce the alterations of skin tissue at a 
structural and functional level (361, 362). Previous studies have suggested that 
melanoma cells behave slightly differently from normal primary melanocytes with 
regards to their antioxidant response to ROS (362, 363). 
Three different human melanocyte-derived cell types were used in this study: 
MM418-C1, MM418-C5 and HEM (Human Epidermal Melanocytes). These cells 
were used to: (a) study the effect of UV-radiation between normal and cancerous 
melanocytes with regards cell viability, ROS generation, tyrosinase expression, 
melanin synthesis, MAPK signalling pathways, TNF-α formation, and the expression 
of TACE and furin; and (b) to study the effect of antioxidants on these responses and 
the extent that melanin levels moderated these responses. 
UVA and UVB radiation were used in this study – but not UVC. This is because 
UVC radiation is essentially blocked by the ozone layer, and thus does not reach the 
Earth’s surface or the skin (39). Hence, the irradiations performed in this thesis were 
only UVA and/or UVB.  
In order to investigate the effect of antioxidants on UV-irradiated melanocytes and 
pigmented melanoma cells, the cells were exposed to UVA and/or UVB doses that 
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caused ~50% cell death (Table 2.1). Furthermore, the effect of acute or chronic dose 
of UV radiation were examined in order to see if a single large UV dose enhanced 
tyrosinase expression, or increased melanin levels to a greater extent than did two 
smaller doses (with 0.5 single dose each exposure) given 24 h apart.  
In this study, both melanoma cells were more susceptible to UVR than were the 
HEM cells (Figure 3.3 and Table 2.1). These results were in agreement with 
Muthusamy et al. (2013) who suggested that melanocytes either have a more 
efficient DNA repair mechanism in comparison to melanoma cells, or reliable 
factor(s) can be conferred on them from UV radiation. These authors suggested that 
melanin plays a role in absorbing UVR and reducing its cytotoxic effect (177). 
However, the darkly pigmented melanoma cells (MM418-C5) used in this study 
were shown to be more susceptible to UVR than both the lightly pigmented   
MM418-C1 and HEM cells. This result can be explained by Jenkins et al. (2013) 
who mentioned that the presence of melanin in the skin seems to be a “double-edged 
sword” with UV exposure. That is, by absorbing UV radiation, melanin has a 
protective role for melanocytes and keratinocytes in the skin; however the synthesis 
of melanin in melanocytes is also involved in the generation of high levels of 
intracellular ROS that may initiate melanoma (116). Thus, the high melanin levels in 
MM418-C5 cell may make these cells more sensitive to UVR.  
In this study, only UVB and UVAB significantly increased peroxide levels in both 
melanoma cell lines and melanocytes, with the lowest increase observed in   
MM418-C5 cells (Figure 3.10). This suggests that melanin may regulate the 
production of peroxide post-UVR exposure, as these cells (MM418-C5) contained 
the highest level of this pigment. On the other hand, all types of UVR did not 
significantly change superoxide levels in these cell lines. Jenkins et al. (2013) 
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suggested a link between ROS and melanin synthesis, where inhibition of 
melanogenesis decreased intracellular ROS levels (116). In the cell lines used in this 
study, the acute and chronic doses of all types of UV did not significantly increase 
tyrosinase levels, which is one of the main enzymes involved in melanin synthesis 
(280). While only acute doses of UVB and UVAB significantly increased melanin 
levels in the MM418-C1 cells, no effect was seen in MM418-C5 cells. These results 
suggest that the increase of melanin synthesis is correlated with high levels of 
peroxide post-UVR, which is in agreement with earlier studies (116). While melanin 
levels in melanocytes could not be detected, these experiments will need to be 
repeated in order to examine the effect that antioxidants have on the levels of this 
pigment in these cells following exposure to UVR. 
UVR has been shown to play a role in the activation of MAPK family of signalling 
molecules, including JNK-1/2, p38 MAPK and ERK-1/2 in melanocytes (356-358).  
It has been suggested that MAPK pathways regulate the synthesis of melanin, and 
ROS have been shown to stimulate the activation of ERK and JNK signalling (356-
358), which are known to modulate MITF activation, which in turn regulates 
melanogenesis (356). The activation of p38 MAPK also contributes to melanin 
synthesis by activating the cAMP response element-binding protein (CREB), which 
in turn activates MITF expression (357). 
In this study, the activation of the B-RAF, ERK-1/2, p38 MAPK and JNK pathways 
in UV-irradiated melanocyte-derived cells was also examined. As seen in Chapter 6, 
exposure to the different UV types elicited different responses in these cellular 
signalling pathways in the different cell lines. In these cells, neither B-RAF (MAPK 
upstream) nor its downstream (ERK-1/2) signalling molecules were significantly 
activated (phosphorylated) following exposure to UVA and/or UVB radiation. The 
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lack of effect elicited by UVR on p-B-RAF levels was expected, as it is not a UV 
signature mutation (153). While environmental stressors such as UVR can activate 
p38 MAPK and JNK signalling pathways in melanocytes (177, 196, 356), UVB and 
UVAB were both shown to significantly increase p-p38 levels 30 min post-exposure 
in all three cell lines, with the highest increase seen in MM418-C5 cells. These 
results suggest that the higher melanin levels in MM418-C5 cells may correlate to 
the increased level of p38 activation in the UV-irradiated melanoma cells. JNK was 
also activated in response to UVR (177, 196). JNK-1 was the main JNK isoform 
activated following exposure to UVR, which was similar to that seen in other 
irradiated melanoma cells (177, 343). In this study, UVB and UVAB increased  
JNK-1 activation in the three cells, with the highest activation observed in HEM 
cells 30 min post-UVAB exposure.  
As mentioned earlier, the oxidative stress/damage induced by UVR can contribute to 
the pathogenesis of melanoma (55, 261) and that antioxidants may be used as preventive 
therapy. Antioxidants may reduce the levels of ROS that are induced by UVR in the skin 
(248). The effect of vitamin C and the analog of vitamin E (trolox) were investigated 
in UV-irradiated pigmented melanoma cells and melanocytes. The results in this 
study showed that only vitamin C conferred protection to MM418-C1 cells exposed 
to UVB irradiation, however this was not due to quenching peroxide levels. This 
protection was most likely due to a different ROS and further investigation on the 
roles played by vitamin C in conferring cell protection is warranted.  
In both pigmented melanoma cells and melanocytes, neither vitamin C nor trolox 
conferred any significant effect on cell viability, ROS levels, melanin content and 
signalling pathways activity post-UVA and/or UVB exposure. In the conditions of 
this project, the results suggested that these antioxidants do not exert strong 
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protective effects on these melanocyte-derived cells from UV-induced stress. Thus, 
various non-enzymatic antioxidants – including GSH and ubiquinol – should be 
examined to see whether they confer protection to these cells from UV-induced 
damage. Also, other components including carotenoids, sulfhydryls and uric acid 
have been suggested as potent antioxidants in the skin (364).  
TNF-α plays an important role in many different biological processes, such as 
inflammation, cellular proliferation, apoptosis, differentiation and  tumorigenesis 
(187). Werth et al. (1999) found that the synergistic effect of UVB and IL-1α 
upregulated TNF-α levels secreted by fibroblasts. However, the combination of 
UVA and IL-1α did not increase TNF-α levels in these cells (202). 
Muthusamy et al. (2013) observed that while UVB and UVAB induced the 
production of TNF-α in melanocytes and MM96L melanoma cells, the addition of 
IL-1α significantly increased these levels (196). In this study, UVB and UVAB were 
shown to not significantly increase TNF-α levels in MM418-C1 cells treated with 
IL-1α. On the other hand, the addition of IL-1α to MM418-C5 did not induce TNF-α 
formation in either the sham- or UV-irradiated cells (Figure 5.2). Interestingly, the 
TNF-α levels released from the UV-irradiated MM418-C1 were about 8-10 times 
higher than that released from the MM418-C5 cells, and suggests that high melanin 
levels may negatively regulate TNF-α formation/release from these irradiated cells. 
Further studies on the role that melanin plays in modulating TNF-α release from UV-
irradiated melanocyte-derived cells are warranted. 
Englaro et al. (1999) showed that in mouse B16 melanoma cells, TNF-α inhibited 
both the activity and expression of tyrosinase (192). Subsequently, this led to a 
down-regulation of the activity of the tyrosinase promoter in both basal and    
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cAMP-induced melanogenesis. Moreover, they found that the activation of NF B 
led to the inhibitory effect of TNF-α on melanogenesis (192). Thus, a link can be 
suggested between the presence of melanin or melanogenesis and TNF-α secretion in 
melanoma cells; however further studies will be needed to elucidate this relationship. 
Neither vitamin C nor trolox reduced TNF-α release from either cell line exposed to 
UVB or UVAB radiation. These results suggest that these antioxidants may not 
regulate TNF-α release from MM418-C1 post-UVR. Prolonging the pre-treatment of 
the cells with antioxidants prior UV-exposure may suppress the TNF-α released from 
the cells, though further studies will be needed to confirm this suggestion. 
Through the action of the metalloprotease tumour necrosis factor-α converting 
enzyme (TACE), sTNF-α is cleaved from its membrane bound precursor mTNF-α 
(189, 321). Furin plays an important role not only in the activation of TACE, but 
also that of matrix metalloproteases (MMP) from their respective preproforms (146, 
187, 209, 325, 326). As the effect of UVR on TACE and furin expression in 
melanocytes and melanoma cells is poorly understood, the effect of different types of 
UVR on both pigmented melanoma cells were examined in this study. However, due 
to time and materials constraints, the effects of antioxidants on the secretion of  
TNF-α and that of TACE and furin expression in UV-irradiated melanocytes were 
not examined. Muthusamy et al. (2011) observed that antioxidants reduced TNF-α 
secretion from UV-irradiated melanocytes, but they did not examine the effect UVR 
had on the expression of TACE and furin in these cells (196).  
TACE can exist in two forms, pTACE and mTACE, where the former is cleaved by 
furin to become activated (187). In both melanoma cells, mTACE was the main 
isoform present. In these cells, UVR did not change the expression of TACE in the 
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presence or absence of IL-1α. IL-1α only enhanced TACE expression in UVA-
irradiated MM418-C1 cells, however in general, UVR did not increase the 
expression of TACE in either melanoma cell lines. These results suggest that in these 
cells UVR and IL-1α do not have a synergistic effect on TACE expression. Future 
studies should investigate if this also occurs in melanocytes.  
In both melanoma cell lines, furin expression was not changed in the presence or 
absence of IL-1α post-UVR. This finding was similar to that observed by Ravi 
(2010) who found that neither UV and/or IL-1α had a stimulatory effect on furin 
expression in primary keratinocytes, HaCaT or Colo 16 cell lines (146).  
The effect of vitamin C and trolox on TACE and furin expression post-UVR in the 
presence or absence of IL-1α was also investigated. As UVR did not alter TACE and 
furin expression in both cell lines, treatment with the antioxidants did not show any 
significant effects on the levels of these proteins. 
 
7.2 Conclusions 
In conclusion, UVR elicited different cellular effects depending on the type of 
radiation and the different melanocytic cell that was examined. Normal and 
malignant cell types revealed different cellular responses post-UVR. UVB radiation 
was more cytotoxic with respect to cell viability in all three cell lines, when 
compared to UVA radiation. HEM was also less susceptible to UVR at the same 
dose, when compared to the two melanoma cell lines.  
Treatment with antioxidants showed that only vitamin C conferred protection to 
MM418-C1 cells post-UVB, while trolox had no significant effects post-UVR. Pre-
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treatment with vitamin C for 1 h conferred no protective effects, however 24 h pre-
treatment did confer protection to MM418-C1 cells against UVB. On the other hand, 
trolox did not confer protection to the cells at either time point. These results suggest 
that prolonged pre-treatment with antioxidants may confer better protection to the 
cells from UVR.  
UVB and UVAB significantly increased peroxide levels in all three cell lines, with 
the increase observed in MM418-C5 cells being the lowest. No changes in 
superoxide levels were observed in all cell post-UV exposure.  Overall, these results 
suggest that peroxide is one of the main ROS involved in UV-induced stress in these 
cells. Also, it can be seen that melanin may play a role in reducing peroxide levels in 
the irradiated cells. However, none of the tested antioxidants quenched the ROS 
levels in these UV-irradiated cells. 
The expression of tyrosinase (the main enzyme involved in melanin synthesis), did 
not increase in all cells following exposure to either an acute or chronic dose of 
UVR. While only acute UVB and UVAB exposure significantly increased melanin 
levels in MM418-C1 cells, but not in MM418-C5 cells, this suggested that higher 
cellular melanin levels minimised the effect of UVR on its production. Treatment 
with antioxidants had no effect on melanin levels in the irradiated cells. 
Neither B-RAF, nor its downstream signalling molecule ERK, was affected by UVR 
in all three cell lines, which agrees with earlier studies showing that the former is not 
upregulated by UVR. Both melanoma cell lines possess the B-RAF
V600E
 mutation, 
while the melanocytes contained B-RAF
WT
. As neither isoform was affected by 
UVR, it confirms previous observations that UVR does not signal via this molecule. 
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Other MAPK signalling pathway intermediaries, such as JNK 1/2 and p-38 MAPK, 
were shown to be responsive to UVR radiation in all three cell lines. 
JNK-1, but not JNK-2, was the main isoform activated by UVR in these cells. 
Moreover, UVAB caused the highest increase in p-JNK-1 in these cells compared to 
either UVA or UVB. The greatest activation of p-JNK occurred in UV-irradiated 
MM418-C5 cells compared to the other cell lines. As MM418-C5 cells had high 
melanin levels, it suggests that it may play a role in enhancing JNK activation post-
UVR. Treatment with the antioxidants was unable to reduce the activation of p-JNK 
in these irradiated cells.  
Exposure to UVB and UVAB activated p-p38 levels in all three cell lines. Like that 
seen with JNK, the highest activity of p-p38 was seen post-UVAB exposure in 
MM418-C5 cells. However when the cells were treated with antioxidants, there was 
no significant reduction in p-p38 levels in all three cell lines.  
TNF-α levels were non-significantly increased in MM418-C1 cells. No increase was 
observed in MM418-C5 cells following IL-1α treatment. Exposure to UVB and 
UVAB non-significantly increased TNF-α levels in both cell lines, however the 
levels released from MM418-C1 cells were higher than that seen in MM418-C5 
cells. This suggests that high melanin levels may reduce the stimulatory effect of 
UVR on the release of TNF-α from these cells. Antioxidant treatment did not 
moderate the release of TNF-α from these irradiated cells. 
Furin is responsible for the activation of TACE that, when activated, cleaves sTNF-α 
from its membrane precursor mTNF-α. The expression of both of these enzymes in 
the melanoma cells were unaffected by UVR, which suggests that their expression is 
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not moderated by this stimulus. Treatment with the antioxidants had no effect on the 
expression of these proteins in the irradiated cells.  
Therefore in summary, the antioxidants (vitamin C and vitamin E) did not confer a 
significant protective effect to UV-irradiated melanocytes and melanoma cells with 
respect to cell viability, melanin and ROS levels, intracellular signalling pathway 
activities, cytokine release and of the enzymes involved in this process. These results 
suggest that the UV doses used in this study may have been too high (causing 50% 
loss of cell viability) and this may have prevented the protective effects of these 
antioxidants from being observed. While the findings of these studies do not directly 
support the use of antioxidants in sunscreens or pre-/after-sun skin care lotions, there 
are several further studies that are warranted. Future studies should investigate the 
protective effect of the antioxidants on the cells exposed to lower doses of UVR, as 
well as that on their ability to enhance the repair of DNA damage (e.g. using the 
comet assay), which may help elucidate the protective role that these molecules may 
play in those epidermal cells exposed to high doses of sunlight. 
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7.3 Future Directions 
7.3.1 UVR doses 
As mentioned earlier in this thesis, the selected UV doses used in these experiments 
were ones which caused 50% cell death. This dose may have been one which 
overwhelmed the cell’s ability to overcome such damage, and thereby we may not 
have seen any protective effects that the antioxidants may confer. If a lower UV dose 
(e.g. ~25-30% cell death) was used, the effects elicited by the antioxidants may be 
more pronounced than that seen when the cells were exposed to a much higher UV 
dose. 
 
7.3.2 Antioxidants 
It was found in numerous biological systems, that vitamins C and E elicit a 
synergistic effect. This occurs when vitamin E is regenerated in the membrane by 
vitamin C, when the former becomes oxidized by free radicals (240). Lin et al. 
(2003) found that combination of 15% (w/v) ascorbic acid (vitamin C) and 1% (w/v) 
α-tocopherol (Vitamin E) conferred significant protection against erythema and 
sunburn cell formation in UV-irradiated pig skin (240).  In our study, we examined 
the effect of vitamin C and trolox separately on UV-irradiated melanocytes derived 
cells. Thus, as further experiments, it would be appropriate to look at the synergistic 
effects of vitamin C and E on MAPK cell signalling pathways, TNF-α, melanin and 
ROS levels in the UV-irradiated cells. 
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7.3.3 Different cells lines 
In this study I used two different pigmented melanoma cell lines. However, these 
two cell lines were grown from the same primary tumour. Thus, further studies using 
cell lines obtained from primary and secondary melanomas are required to see 
whether the levels of furin, TACE and TNF-α released in these cells are related to 
the metastatic potential of these cells, as well as the effect UVR may have on these 
levels. 
 
7.3.4  Enhancement of melanin levels in the cells 
In this study, we were unable to detect melanin levels in the primary melanocytes. 
Consequently, it was not possible to investigate the effect that antioxidants had on 
melanin levels when these cells were exposed to UV-radiation. Thus, enhancements 
of melanin levels are needed in order to be able to observe the effect that 
antioxidants and/or UVR have on their cellular levels in the melanocytes. Kvam et 
al. (2003) found that the tyrosine enhancer modulates melanin synthesis in 
melanocytes post-UVA. In their experiments, they used three immortalized mouse 
melanocyte cell lines that possessed different levels of pigmentation. A tissue culture 
medium containing low tyrosine concentrations was used to grow these melanocytes. 
Melanin synthesis was shown to be enhanced when the media concentration of 
tyrosine was increased (267).  
In addition to tyrosine, α-MSH and IBMX were also shown to regulate the 
expression of enzymes involved in melanin synthesis, such as tyrosinase, TRP-1 and 
TRP-2 (365). This regulation occurs via by controlling the transcription activation 
transcription factors, such as MITF and CREB and also the protein kinase A 
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signalling pathways (365). Park et al. (2011) showed that α-MSH and IBMX 
induced tyrosinase, TRP-1 and TRP-2 expression, as well as melanin synthesis in 
mouse B16F10 melanoma cells. They also found that, treating the cells with 
Aromatic (ar)-turmerone (naturally occurring turmeric oil), inhibited α-MSH and 
IBMX-induced melanin synthesis, as well as tyrosinase, TRP-1 and TRP-2 activity 
(297). Therefore, from studies by Kyam et al. (2003) and Park et al. (2011), the 
addition of a melanin precursor such as tyrosine and IBMX might be needed to 
induce melanin synthesis in melanocytes; thereby allowing for the effect of 
antioxidants on UV-irradiated melanocytes to be investigated (297, 365). 
 
7.3.5 Tumour suppressor genes  
Two tumour suppressor genes, p53 and p16 (Section 1.5.2), play an important role in 
regulating the cell cycle. p53 acts as a regulator of the genotoxic response controlling 
several signalling pathways that respond to stimuli, such as oxidative stress and 
DNA damage (46, 81), whereas p16 responds to oxidative stress in UV-irradiated 
melanocytes (82). In melanoma patients, these tumour suppressor genes were often 
found to be either mutated or deleted, and therefore inactive (82).  
Although it has been shown that p16 is activated by UVB radiation (83), there are 
altering opinions as to whether p53 is also activated by UVR (366, 367). The effect 
of different doses of different types of UVR (UVA and/or UVB) on the expression of 
p16 and p53 post-UV exposure could be examined in a range of melanocyte-derived 
cells. Furthermore, if an effect is observed, treatment with antioxidants (vitamin C 
and trolox) may be investigated to see whether they confer a protective effect in cells 
exposed to UVR.  
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7.3.6 N-RAS signalling pathway 
As discussed previously (Section 1.5.5.1), oncogenic RAS alone does not appear 
able to induce melanoma transformation unless combined with other genetic 
alterations (93). Almost 80% of melanomas have either B-RAF or NRAS mutations, 
with 15–30% involving NRAS mutation (93). 
Recently, it was found that B-RAF/NRAS
WT
 melanomas may contain a high 
mutation load as a result of extensive UV induced damage (368). This strong 
association with UV damage has been evidenced clinically by the higher degree of 
solar elastosis observed in vivo (368). The effect of different doses and types of UVR 
on the activation of NRAS may be investigated in the melanocyte-derived cell lines, 
as well as the effect that antioxidant treatments may have on this process. 
 
7.3.7 DNA damage  
UVR has been shown to play a role in causing DNA mutations. Mainly because 
UVB can cause direct damage when absorbed by DNA, resulting in the formation of 
cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4PPs). UVB can 
also cause indirect damage to proteins and lipids, resulting in cellular damage. UVA 
can indirectly initiate DNA damage by increasing ROS levels in the cell. In addition, 
ROS can cause 8-oxoGua, which is a type of oxidative DNA damage (74). Thus, it is 
important to investigate the protective effect that antioxidants have on UV-irradiated 
melanocytes to see if they can confer protection to DNA in UV-irradiated cells.  
The comet assay is a simple method for measuring damage to DNA as strand breaks 
in eukaryotic cells (369). By measuring the comet tail, DNA repair can be measured 
and compared to that of unrepaired DNA (369). This will allow us to observe the 
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protective effect that antioxidants may confer to the cell’s DNA following exposure 
to UVR. 
 
7.3.8 Co-culture model and skin tissue samples 
As melanocytes and keratinocytes are found together in the epidermis (370), the 
former transfers melanin to the later to confer protection against UVR (370), it 
would be physiologically relevant to grow these cells in co-culture to study the effect 
that antioxidants would have following UV exposure. Melanocyte–keratinocyte co-
cultured models have been previously used to test compounds for potential effects on 
pigmentation (370). This model was reported to be sensitive, reproducible, and 
reliable for testing melanogenic regulators standardised with known melanogenic 
inhibitors (370). 
In a different study, a co-culture model of melanocytes-keratinocytes was 
successfully used as an alternative system for research and testing in place of 
laboratory animals, to examine the biology and pathophysiology of pigmentation and 
vitiligo (371). Melanocytes-keratinocytes were cultured from control and vitiligo 
patients and co-culture models were prepared. The levels of tyrosinase activity, 
melanin content and cell proliferation were increased in co-cultured cells when 
compared to that seen in mono-cultured cell lines. After treating the co-culture with 
melanogenic inhibitor, they found that tyrosinase activity, melanin content and cell 
proliferation was reduced (371). 
In addition, a biopsy of skin tissue samples may be used to study the effect of UVR 
on UV-induced damage in melanocytes as seen in situ. Due to time constraints, the 
effect of antioxidants on the expression of p16 in UV-irradiated skin tissue was not 
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investigated. Thus, this experiment should be performed to see if antioxidants confer 
a protective effect to the epidermal cells when applied directly to irradiated skin 
tissue under in situ conditions.  
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Chapter 9.  Appendices 
9.1 Appendix 1 – Conference Presentations from this Thesis 
Conference abstracts 
Oral Presentations  
• A. Banjar, B.N. Feltis, P.FA. Wright, G.M. Boyle & T.J. Piva (2013) The 
effect of antioxidants on UV-irradiated pigmented melanoma cells. The 6
th
 Asia and 
Oceania Conference on Photobiology (AOCP), Sydney. 10-13 November 2013. 
• A. Banjar, B.N. Feltis, P.FA. Wright, T.J. Piva (2014) The effect of 
antioxidants on UV-irradiated melanocyte-derived cells. The Australian Health & 
Medical Research Congress, Melbourne. 16-19 November 2014. 
 
Poster Presentations  
• A. Banjar, B.N. Feltis, P.FA. Wright, G.M. Boyle & T.J. Piva (2014) The 
effect of antioxidants on UV-irradiated melanocyte-derived cells. XXII International 
Pigment Cell Conference (IPCC), Singapore. 4-7 September 2014. 
• Banjar A, Feltis BN, Wright PFA, Boyle GM & Piva TJ (2014) The effect of 
antioxidants on UV-irradiated melanocyte-derived cells.  ComBio, Canberra. 28 
September -2 October 2014.. 
• X.Y. Chan, N.F. Abdul Rashid, A. Banjar, N. Hayward, T. Piva (2014) 
Growth factor signalling in melanoma cells. The Australian Health & Medical 
Research Congress, Melbourne. 16-19 November 2014. 
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9.2 Appendix 2 – Cell protein lysate preparation solutions 
9.2.1 Cell Lysis Buffer 
100 mM NaCl, 20 mM Tris (pH8), 1 mM EDTA, 0.5% (v/v) BRIJ35, 4% (v/v) 
protease inhibitor, 1% (v/v) phosphatase inhibitor (Roche – prepared as per the 
manufacturer’s instructions)  
9.2.2 Laemmli’s sample buffer 
250 mM Tris (pH6.8), 40% (v/v) Glycerol, 10% (v/v) β-Mercaptoethanol, 5% 
(w/v) SDS (Sodium Dodecyl Sulfate) and 0.1% (w/v) Bromophenol Blue 
 
9.3 Appendix 3 – Western blotting gels 
9.3.1 Running gel (10%) 
1.875 ml of 40% (w/v) Polyacrylamide Bis solution, 1.875 ml 1.5 M Tris (pH8.8), 
3.59 ml H2O, 0.075 ml 10% (w/v) SDS, 0.075 ml 10% (w/v) Ammonium Persulfate 
and 0.003 ml TEMED  
 
9.3.2 Stacking gel 
0.3125 ml 40% (v/v) Acrylamide Bis solution, 0.3125 ml 1 M Tris solution (pH6.8), 
1.825 ml H2O, 0.025 ml 10% (w/v) SDS, 0.025 ml 10% (w/v) Ammonium Persulfate 
and 0.0025 ml of TEMED 
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9.4 Appendix 4 – Calculating changes in protein expression 
 
The protein bands in the Western blots were analysed for densitometry using 
Quantity One Digital Imaging Software Version 4.5.1 (BioRad).  In the case of JNK 
or ERK expression where more than one isoform has been detected, calculating the 
change in the expression of each isoform was as follows: 
Assume that we obtained the following readings for p-JNK1 and p-JNK2 from a 
scanned blot. 
 
                                Density (INT/mm
2
) 
      Lanes 
 
p-JNK1 p-JNK2 
Lane 1 : 0 min (sham-irradiated control) 120 95 
Lane 2 : 5 min post UVB-irradiation 480 160 
 
Percentage of p-JNK1 in Lane 1 : [ 120 / (120 + 95) ] * 100% = 56%  
Percentage of p-JNK2 in Lane 1 : [ 95 / (120 + 95) ] * 100% = 44% 
Therefore, percentage of total p-JNK1/2 in sham-irradiated control is 100%.  
Percentage of p-JNK1 in Lane 2 : [ 480 / (120 + 95) ] * 100% = 223% 
Percentage of p-JNK2 in Lane 2 : [ 160 / (120 + 95) ] * 100% = 74% 
